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CHAPTER 1 
 
General introduction 
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Comprehensive development of diagnostic and monitoring technologies in 
modern medicine has helped to better understand the complex pathophysiology 
of acute circulatory failure in critical cases such as surgical patients or patients 
admitted to the intensive care unit (ICU). In critical care settings it is vital to as-
sess the patient’s hemodynamic status for optimization of end-organ tissue 
oxygenation to prevent or minimize morbidity and mortality.1 
It is, however, challenging to monitor the state of tissue oxygenation accurately. 
The use of standard hemodynamic parameters such as blood pressure and 
pulse oximetry for assessing tissue blood flow is less than accurate.2,3 Despite 
apparently normal macroperfusion (capillary refill, cardiac output, blood pres-
sure), tissue hypoperfusion can persist as a result of microcirculatory perfusion 
defects.4 Various approaches have been introduced to avoid such hypoperfu-
sion - mostly with disappointing or controversial results. As an illustration, a 
recent study showed that the early goal-directed therapy strategy for septic 
shock not only proves no survival benefits but also might increase the risk of 
fluid overload.5 Thus, measuring heart rate, cardiac output, arterial blood pres-
sure, and mixed venous oxygen saturation solely provides information regarding 
the patient’s central hemodynamic status, reflecting macroperfusion, and nor-
malization of these hemodynamic variables does not ensure sufficient oxygena-
tion at the peripheral tissue level.6 
The introduction of near-infrared spectroscopy (NIRS) for assessing the ade-
quacy of regional tissue perfusion was an important landmark in the history of 
tissue monitoring.7 Since then, monitoring regional tissue oxygenation has 
gained wide interest, and studies began to address the importance of monitor-
ing tissues susceptible to hypoperfusion. This has led to growing interest in non-
invasive methods designed to evaluate regional perfusion as a valuable adjunct 
to standard global parameters to predict or diagnose tissue hypoperfusion. 
How common is tissue hypoxia or tissue desaturation during 
the perioperative period? 
Tissue hypoxia and arterial desaturation events in the perioperative period may 
be more common than is recognized. In a recent blinded study by Sun et al., 
arterial desaturation events (defined as ≥10 min/h with raw pulse oximetry val-
ues <90%) were reported to occur in 21% of non-cardiac surgical patients.8 An 
important finding in their study is that 90% of these hypoxemic events went 
undetected at the nursing floor. In a comparable patient population, Ehrenfeld et 
al. showed a prevalence of 6.8% for hypoxemic events (pulse oximetry values 
<90%, ≥2 minutes in duration) and 3.5% for severe hypoxemic events (pulse 
oximetry values ≤85%, ≥2 minutes in duration).9 In the cardiac surgical popula-
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tion, hypoxic events were found to be more common, as illustrated by Ranucci 
et al. who observed hypoxia in 30.6% of patients (defining hypoxia as a 
PaO2/FiO2 ratio <200 mmHg).10 In another study, Wang et al. reported even 
higher rates following aortic dissection (49.5%) using the same definition for 
hypoxia.11 Interventions to correct pulse oximeter-measured oxygen saturation 
can avert major undesirable outcomes. In a study by Taenzer et al. pulse oxi-
metry monitoring at a medical ward reduced serious adverse outcomes such as 
ICU admissions.12 Although pulse oximetry showed clinical benefit in detection 
of hypoxemia and hypoxia, discordance on the relationship between pulse oxi-
metry monitoring and complication rate remains to exist.13 
Desaturation events may occur in the operating room or at the post-anesthesia 
care unit where patients are closely monitored, but frequently these episodes of 
a dysbalanced regional oxygen supply/demand occur during the postoperative 
period when patients are less strictly monitored and exposed to the respiratory 
depressant effects of opioid pain medications. Some of these desaturations 
occur in the postoperative period14 and to date it is unknown whether intraoper-
ative or postoperative events are more important for clinical outcome.15 
Physics and principles of near-infrared spectroscopy (NIRS) 
The physics and mathematics of NIRS are based on a modified version of the 
Beer-Lambert law, which states that a proportion of light transmitted through a 
solution containing a colored compound (chromophore) is absorbed by the 
compound. As a result, the intensity of the emerging light is reduced. 
 
The relationship between the absorption and concentration of a chromophore is 
described by the following Beer-Lambert equation: 
 
A = log (l0 /l) = ε∙c∙d, 
 
where A is the absorption of light, expressed as optical density (log of the ratio 
of the intensities of incident (I0) and transmitted (I) light), c the chromophore 
concentration, ε its extinction coefficient, and d the width (optical path length) 
through the solution or medium.16 The Beer-Lambert law also explains the dif-
ference observed when light passes through large versus small blood vessels. If 
near-infrared light photons pass through a single red blood cell, only a small 
percentage of photons is absorbed. However, if the photons were to pass 
through a blood vessel of 1 mm thickness, absorbance would be 0.8 and thus 
only 10% of the impacting photons would remain unabsorbed.17 
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Tissue oxygenation is the result of a complex interaction of perfusion, arterial 
oxygen tension, hemoglobin (Hb) level and dissociation conditions, and local 
oxygen consumption. Consequently, each oxygen-monitoring method involves 
specific assumptions and limitations. Tissue oximetry with near-infrared light is 
a non-invasive, optical technique that integrates blood oxygenated hemoglobin 
(HbO2) saturation in an anatomical region of interest (Figure 1). 
 
 
 
Figure 1. Near-infrared spectra of oxygenated hemoglobin (HbO2) and hemoglobin (Hb).18 
 
 
By nature of the technique, measurement is limited to the intravascular com-
partment. It combines measurements of arterial, venous, and capillary blood, 
depending on the absorbance of different wavelengths of near-infrared light. 
Unlike pulse oximetry, NIRS does not involve detection of a pulsatile tissue 
component but relies entirely on the Beer-Lambert law that relates the concen-
tration of a substance to its light absorption.19 The ability to discriminate various 
types of chromophores varies with the number of wavelengths; for example, a 
NIRS device using two distinct wavelengths cannot discriminate between the 
levels of oxyhemoglobin, reduced Hb, oxymyoglobin, and reduced myoglobin.20 
This can be a significant issue when, for example, comparing the readings of an 
NIRS device on the forehead and thenar muscles, with obvious differences in 
the amount of myoglobin present in the two tissues. For cerebral NIRS devices, 
the assumption is that myoglobin is only a minor contributor to the signal and 
that the vascular Hb-oxygen component predominates.21 Cerebral oximeters 
are calibrated by the manufacturer assuming a constant 70% or 75% weighting 
toward venous blood saturation.22,23 Oxygen consumption with insufficient oxy-
gen delivery will lead to an increased concentration of reduced Hb, and since 
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Hb chromophores dominate the near-infrared absorption spectrum, the estima-
tion of Hb-oxygen saturation is arguably less susceptible to errors and signal-to-
noise problems than NIRS-based assessment of cytochrome redox status. An 
in vivo calibration can be accomplished with direct measurement of cerebral 
venous and arterial saturation in blood samples.23 This calibration, incorporated 
into the calculation algorithm that determines the displayed value of regional 
oxygen saturation (rSO2), should theoretically reduce the interfering effects of 
different Hb concentrations and variations in tissue light transmission. However, 
this calibration approach assumes that all individuals have the same constant 
ratio of cerebral venous to arterial blood within the tissue where the measure-
ment is performed. Given the great inter- and intrapersonal variations in hemo-
dynamics and anatomy, this assumption is likely incorrect. 
NIRS accuracy for measuring brain tissue oxyhemoglobin 
saturation 
Today, physicians can choose from a wide variety of devices for monitoring 
rSO2, including INVOSTM (Medtronic, Minneapolis, MN, USA), FORE-SIGHTTM 
(CAS Medical Systems, Branford, CT, USA), EQUANOXTM (Nonin Medical Inc., 
Plymouth, MN, USA), CerOxTM (Ornim Medical, Lod, Israel), NIROTM (Hamama-
tsu Photonics, Hamamatsu City, Japan), and TOS-96TM (Tostec Co., LTD., To-
kyo, Japan). 
Although spatially resolved spectroscopy can be used to compute a scaled con-
centration of tissue Hb and relative concentrations of oxy- and deoxyhemoglo-
bin, currently manufactured cerebral oximeters are not designed to provide an 
“absolute” measurement of regional tissue oxygen saturation.23 A study evaluat-
ing the accuracy of cerebral oximeters by Bickler et al.23 revealed the between-
subject variability and dynamic error of readings that constitute to a challenge in 
determining absolute thresholds for predicting tissue injury. Furthermore, the 
measured ratio of venous to arterial blood in brain tissue is variable and about 
50:5024, whereas oximeter manufacturers calibrate to fixed venous to arterial 
volume ratios of 70:30 or 75:25.23 Moreover, changes in cerebral venous and 
arterial blood volumes, carbon dioxide or oxygen concentrations will violate 
assumptions on constancy of arterial to venous blood volume.24 Signal contam-
ination originating from blood in extracranial tissue within the sampled volume of 
interest also complicates the clinical utility of this technology.25 Administration of 
peripherally acting vasoconstrictors (e.g. phenylephrine or norepinephrine) is 
one example that can affect the contribution of extracranial blood and possibly 
alter tissue oximetry readings.24 In addition, sympathetically-mediated vasocon-
striction from pain, hypothermia, and hypovolemia significantly alters peripheral 
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tissue oxygenation and may also influence the extracranial component of the 
reading. Therefore, the measurements are at best relative assessments of tis-
sue oxygenation and are useful as trend monitors, not threshold of injury moni-
tors. 
How widespread is the use of tissue oximetry? 
Given the diversity of technologies currently available to assess tissue oxygena-
tion status, it is important to consider its various applications in current clinical 
practices using NIRS. 
Brain monitoring 
The brain is the organ most commonly directly assessed with regional tissue 
oximetry using NIRS. Although monitoring cerebral oxygenation to prevent the 
adverse consequences of acute cerebral hypoperfusion is supportable with 
current knowledge, the issue of predicting longterm outcomes remains less 
clear.27 During cardiac surgery with cardiopulmonary bypass (CPB), (undetect-
ed) episodes of hypoperfusion predispose the patient to an increased risk of 
postoperative neurological complications (PNC). Despite this, routine evaluation 
of cerebral hemodynamics is still not part of standard clinical practice. Non-
invasive tissue oximetry has been advocated to minimize and even prevent 
vulnerable episodes characterized by a disbalance between regional oxygen 
supply and demand. In one study, Murkin proposed that cerebral oximetry can 
be used as an organ index, meaning that maintaining adequate rSO2 levels is 
beneficial for all vital organs.19 The technique has been widely applied in clinical 
centers and multiple studies have been conducted, suggesting that intraopera-
tive optimization of cerebral oximetry-derived values aids in preventing PNC.19 
This contributed to the conclusions drawn in systematic reviews that tissue oxi-
metry is a promising technique for preventing PNC following surgical proce-
dures.28 The evidence linking rSO2 values and PNC remains doubtful due to the 
lack of intervention-guided studies that focus on the causality of the proposed 
relation between rSO2 and adverse clinical outcome.27 Moreover, studies also 
failed to prove that intraoperative interventions to correct cerebral rSO2 lead to 
improved neurological outcome.27 Part of the explanation can be found in the 
fact that due to its measurement principle, cerebral oximetry does not take cer-
ebral autoregulatory activity into account. Cerebral autoregulation (CA) is the 
intrinsic system that maintains adequate cerebral blood flow at a wide range of 
different perfusion pressures. One example can be found in cerebral hyper-
perfusion, also referred to as brain luxury perfusion.29 In this case, cerebral 
oximetry readings can be close to baseline values while the CA is severly dis-
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turbed, thereby predisposing the patient to increased risk of cerebral edema 
and hemorrhage. In order to preserve CA, arterial blood pressure among other 
factors need to be strictly controlled within certain limits. Together with avoiding 
large fluctuations in hemodynamic parameters, this may contribute to minimize 
PNC occurrence in patients undergoing CPB. 
Somatic tissue monitoring 
Besides brain monitoring, tissue oximetry has also been used in various other 
clinical applications. Continuous assessment of oxygenation in peripheral tissue 
or free skin flaps may contribute to early detection of circulatory compromise, as 
indicated by previous work.30-32 Despite this, tissue oximetry is not an integrated 
part of routine monitoring in surgical or ICU patients susceptible to ischemic 
tissue damage. 
Aims and outline of this thesis 
Since the introduction of non-invasive tissue oximetry as a continuous monitor 
for tissue perfusion, implementation into routine clinical practice has been an 
ongoing process. For the most part this is due to uncertainties regarding ade-
quate interpretation of rSO2 values and trends. This thesis focuses on current 
and prospective applications of non-invasive tissue oxygenation monitoring 
using NIRS, with the intent to describe the current state of knowledge on non-
invasive tissue oximetry and clinical outcome parameters, and to identify the 
gaps in knowledge and technology that would help to resolve the remaining 
unknowns. 
 
First, the clinical application of non-invasive tissue oximetry in brain monitoring 
during CPB is described and discussed in chapter 2. The current evidence of a 
link between cerebral rSO2 readings and the occurrence of PNC following car-
diac surgery with CPB is systematically reviewed. In addition, elucidation is 
provided on the role and importance of intact CA as part of brain protection 
during bypass. 
Adequate prevention of ischemic complications contributing to PNC requires 
knowledge of the modifiable factors that determine the extent of CA functionality 
in patients during CPB. Among these modifiable factors, hemodynamic stability, 
arterial carbon dioxide level and hemodilution appeared to play a substantial 
role in CA efficacy (chapters 3 and 4). 
During cardiac surgery with CPB, several actions performed by the cardiotho-
racic surgeon, clinical perfusionist and anesthesiologist affect oxygen supply to 
the brain. Non-invasive tissue oximetry could aid in early detection of decreas-
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ing cerebral oxygenation in case of e.g., iatrogenic events, preventing possibly 
harmful ischemic episodes. It is therefore important to evaluate whether cere-
bral rSO2 readings are responsive to certain iatrogenic events and if so, the 
magnitude of the induced change (chapter 5). 
Besides its application in CPB during cardiac surgical procedures, patients ad-
mitted to the ICU in need of prolonged cardiopulmonary support may also bene-
fit from tissue oximetry measurements (chapter 6). In the case of femoral ac-
cess, specifically, concerns regarding variations in oxygenation associated with 
compromised brain and limb perfusion remain to exist. Continuous monitoring of 
peripheral tissue as well as brain rSO2 may contribute in preventing complica-
tions. Tissue oximetry may possibly be superior to existing monitoring methods 
due to the absence of a clear time delay in the representation of impaired tissue 
perfusion. 
 
In addition to steady-state tissue oxygen saturation monitoring, dynamic as-
sessment of tissue oxygenation may provide valuable information regarding 
peripheral vascular reactivity (chapter 7). Identification of microvascular dys-
function is of clinical importance due to its relationship with consequential tissue 
malperfusion. Adequate assessment of vascular reactivity can avert ischemic 
tissue damage by enabling intervention at the stage where only microvascular 
dysfunction is apparent, prior to the occurrence of hypoxia. 
Another application of tissue oximetry in peripheral tissue monitoring is as-
sessing free flap viability following autologous reconstructive surgery (chapter 
8). In the first critical hours following free flap transplantation, the risk of arterial 
or venous thrombosis is highest and constitutes to risk of partial or complete 
flap loss as a result of liquefactive fat necrosis. Therefore, extensive and con-
tinuous monitoring is warranted to allow timely intervention.  
GENERAL INTRODUCTION 
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Abstract 
Postoperative neurological complications (PNCs) following cardiac surgery with 
cardiopulmonary bypass (CPB) is a detrimental complication, contributing to 
increased mortality rates and health care costs. To prevent intraoperative cere-
bral desaturations associated with PNC, continuous brain monitoring using 
near-infrared spectroscopy has been advocated. However, clear evidence for a 
defined desaturation threshold requiring intervention during CPB is still lacking. 
Since cerebral oximetry readings are nonspecific, cerebral tissue oxygenation 
values need to be interpreted with caution and in the context of all available 
clinical information. Therefore, maintaining an intact autoregulatory activity dur-
ing CPB rather than solely focusing on regional cerebral oxygen saturation 
measurements will collectively contribute to optimization of patient care during 
CPB. 
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Introduction 
The advancement of extracorporeal circulation techniques in recent decades 
has played an essential role in minimizing complications following cardiac sur-
gery with cardiopulmonary bypass (CPB).1 The technical advancements have 
been, however, partially offset by changes in the patient population. These 
changes involve a more complex disease at advanced age and significant 
comorbidities2-4, resulting in convoluted and lengthier procedures. Moreover, in 
older patients, the atherosclerotic disease process is farther advanced, which 
may nourish an increased risk for postoperative complications including periop-
erative stroke and neurocognitive impairment, including delirium.1,4,5 From 
these, stroke has been reported to be the most detrimental with rates varying 
from 1.5 to 11%.6-10 Furthermore, these postoperative neurological complica-
tions (PNC) contribute to prolonged hospital stay, increased mortality rates and 
health care costs, constituting to an increased burden for health care provid-
ers.11,12 
The mechanism of cerebral injury following cardiac surgery with CPB is not yet 
clearly understood. Development of PNC possibly involves embolization or hy-
poperfusion causing cerebral ischemia.5,11,13,14 To prevent intraoperative cere-
bral desaturations associated with ischemic complications of the brain, continu-
ous brain monitoring using near-infrared spectroscopy (NIRS) has been advo-
cated. 15,16 Although multiple studies proposed cerebral oximetry as a viable 
monitoring method to prevent these neurologic complications, clear threshold 
determinants for acute intervention are still lacking.14,17 
Furthermore, there seems to be a link between disturbed intraoperative cerebral 
autoregulation (CA) and PNC.18-21 The neuroprotective autoregulatory system 
prevents both hypo- and hyperperfusion by reactive vasodilation and con-
striction following changes in arterial blood pressure (ABP) and arterial partial 
pressure for carbon dioxide (PaCO2), also referred to as modifiable factors.13 
These factors are mostly based on maintaining a mean ABP of 50-60 mmHg22 
and PaCO2 is only measured intermittently during CPB. Obviously, there is a 
lack of optimal control for CA functionality. 
Clinical application of cerebral oximetry, its limitations and association with PNC 
as well as the role of modifiable factors influencing the neuroprotective autoreg-
ulatory system during CPB are subsequently reviewed. 
Cerebral tissue oximetry 
Cerebral oximetry allows clinicians to monitor regional cerebral tissue oxygen 
saturation (rSO2) real-time in a non-invasive manner. Cerebral rSO2 is depend-
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ent on several physiological variables that affect oxygen supply and consump-
tion of the brain, including cardiac output, inspired oxygen concentration, pul-
monary function, cerebral metabolism, temperature, and hemoglobin concentra-
tion.23,24 Cerebral oximetry readings are proposed to reflect the balance be-
tween regional oxygen supply and demand and thereby local cerebral metabo-
lism.11,25-27 More specifically, a decreasing cerebral rSO2 due to regional or 
global ischemia can be explained as an oxygen supply insufficient to meet the 
metabolic demand caused by, e.g., a decreased cardiac output.26,28 Unlike 
mixed venous oxygen saturation that is measured continuously via a pulmonary 
artery catheter, cerebral oximetry has shown to reflect alterations in blood pres-
sure real-time.29 This suggests that cerebral oximetry enables prompt assess-
ment of tissue oxygenation, serving as a potential early indicator of neurologic 
injury. 
 
The technique applied in cerebral oximetry uses NIRS based on the Beer-
Lambert law.14,30 The elementary particles of near-infrared light are photons that 
penetrate tissue before reaching the underlying capillary network. Near-infrared 
light of different wavelengths within the so-called biological spectroscopic win-
dow is emitted to penetrate the skin, skull, and dura matter to reach the frontal 
lobe of either the left or right cerebral hemisphere.11 The photons emitted 
through a NIRS sensor travel via a banana-shaped pathway before being 
measured by photodiode detectors positioned at a fixed distance from the light 
emitter when they resurface. Within tissue, the light is partly reflected, scattered, 
and absorbed. To minimize residual error, two measurements with different 
emitter-diode spacings are performed simultaneously, resulting in a shallow-
deep detector difference. With the light intensity held constant, the quantity of 
light absorbed by chromophores varies with the ratio of oxygenated hemoglobin 
relative to the total concentration of hemoglobin, which is used to estimate local 
oxygen content.14,17 Most clinical devices use one near-infrared light emitter in 
combination with two near-infrared light detectors, whereas other devices use 
several detectors per emitter. The latter may contribute to the accuracy of cere-
bral rSO2 estimation; however, the measurement principle remains the same. In 
addition, the algorithm for estimating the oxygen content in cerebral blood re-
quires an assumption on the ratio venous to arterial blood volume, which differs 
between clinical oximeter devices. The Food and Drug Administration approved 
four monitoring devices for clinical use in the United States, which include the 
Fore-sight cerebral oximeter (Cas Medical Systems, Inc., Branford, CT, USA), 
Equanox (Nonin Medical Inc., Plymounth, MN, USA), INVOS 5100C (Medtronic, 
Minnesota, MN, USA), and the CerOx (Ornim Medical, Lod, Israel). Both Fore-
sight and Equanox use the ratio of 70% venous blood to 30% arterial blood, 
whereas INVOS 5100C and CerOx use a ratio of 75% venous to 25% arterial 
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blood.29,31 Additionally, cerebral oximeters may provide one or several types of 
measurement, estimating absolute rSO2 values (Fore-sight and Equanox), or 
values intended for trend monitoring (INVOS 5100C and CerOx).  
Corresponding to the cerebral oximetry measurement principle, rSO2 values can 
only partially reflect oxygen saturation in the anterior circulation of the prefrontal 
cortex, thereby limiting its monitoring ability to an area of approximately 
1 cm³.23,29,32 Also extracerebral tissues including skin, bone, and connective 
tissue may contaminate the estimation of rSO2.33 In addition, tissue oximetry 
derived values are nonspecific, meaning that a decreasing rSO2 may be the 
result of hypoperfusion, relative hypoxemia, and/or an increased metabolic 
rate.14 Hence, when interpreting changes in cerebral rSO2 it is necessary to 
consider all available clinical information.23 
The algorithm to estimate cerebral rSO2 takes the predominant venous part of 
the cerebral blood volume into account that is reflected by a strong correlation 
between rSO2 and jugular venous oxygen saturation, an early indicator of brain 
ischemia.34,35 Other studies, however, reported that rSO2 is unable to reflect 
changes in jugular venous bulb oximetry in the case of head injury.36,37 Never-
theless, a recent observational study has shown that cerebral oximetry is sensi-
tive enough to effectively identify changes in rSO2 following iatrogenic events 
including anesthetic induction, aortic cross clamping, and onset and termination 
of bypass.38 In addition, cerebral oximetry has shown to effectively depict the 
concomitant decline in cerebral oxygen saturation during cannula malposition39-
41, a failing oxygen line to the oxygenator in the CPB circuit42 and acute innomi-
nate artery dissection.43 These findings indicate that cerebral oximetry may aid 
in early detection of potential adverse neurologic events and contribute toward 
preventing PNC by enabling alteration of current patient management. 
Although absolute (fixed value for rSO2) and relative (percentage of baseline 
rSO2) desaturation thresholds have been previously applied44,45, to date no con-
sensus has been reached on the use of either an absolute or personalized cut-
off value requiring prompt intervention.17,46 Nonetheless, it is generally accepted 
that both the extent and duration of cerebral desaturation are important.14,46 
Furthermore, this lack of standardization may be related to the different monitor-
ing devices which use varying numbers and wavelengths of light emitted as well 
as sensor-emitter spacings, affecting both the measurement itself and the rSO2 
calculation.3,30 Differences in applied algorithm between the devices further 
challenge cerebral oximetry standardization. Moreover, the algorithm itself can-
not accommodate for inter-individual differences including variations in cranial 
anatomy (e.g., asymmetrical brain circulation23, different percentages of venous 
cerebral blood circulating in the frontal lobe47 and the influence of non-
modifiable patient characteristics on baseline rSO2 readings).25 The algorithm 
requires the assumption of a constant optical path length that is actually de-
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creased during CPB due to hemodilution, altering the absorbance of near-
infrared light by chromophores. This may introduce an error in the estimation of 
the local oxygen content.30 In summary, focusing on an rSO2 threshold as sug-
gested by Douds et al.48 would be a provocative step towards the use of cere-
bral oximetry as a preemptive marker for perioperative morbidity to optimize 
postoperative recovery. 
Cerebral tissue oximetry and PNCs 
Since the widespread clinical application of tissue oximetry, several studies 
investigated the relationship between cerebral oximetry readings and PNC. The 
current evidence on the relationship between cerebral desaturations as identi-
fied by cerebral oximetry and PNC following cardiac surgery with CPB is sys-
tematically reviewed in this section. 
To identify relevant publications, PubMed and MEDline databases were 
searched for articles originating from January 2006 to August 2016. Two re-
searchers searched and screened articles on title, abstract, and full text inde-
pendently. Additional studies were identified by screening the references in the 
retrieved papers to capture articles that might have been missed. 
The articles included were studies that focused on the relationship between 
cerebral oximetry readings and cognitive decline following cardiac surgery with 
CPB in adults. The search was limited to publications in English. Studies that 
were not published as a full-length article or did not discuss PNC outcome in 
relation to cerebral oximetry readings were excluded. Free search terms were 
divided in two main groups, the first representing cerebral oximetry and the 
second representing cardiac surgery with CPB. The cerebral oximetry category 
included the search terms “near infrared spectroscopy”, “infrared spectroscopy”, 
“NIRS”, “cerebral oximetry” and “cerebral oxygen saturation” while the cardiac 
surgery with CPB category included the search terms “cardiac surgery”, ‘’CPB’’, 
“coronary artery bypass grafting” (CABG), “CABG”, and “coronary bypass graft”. 
For each search, one of the aforementioned search terms from both groups was 
combined. 
Results 
The initial search focusing on cerebral oximetry resulted in 507 publications 
using all combinations of free search terms. Review of the title and abstract led 
to inclusion of 21 out of 507 articles. A total of 13 observational and 7 interven-
tional studies were identified as depicted in Table 1. 
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Several studies found a relationship between cerebral desaturations and neuro-
logical complications, including a study by Colak et al. who showed an in-
creased occurrence of stroke in patients with cerebral desaturations, defined by 
both absolute (area under the curve of >50 minutes·% under 50% absolute 
rSO2) and relative (area under the curve >150 minutes·% under 20% of base-
line rSO2) thresholds.45 Similarly, Slater et al. and de Tournay-Jetté et al. found 
a signficant relationship with early postoperative neurocognitive decline when 
the absolute desaturation threshold of 50% rSO2 was exceeded.50,63 In patients 
undergoing aortic arch surgery, Fischer et al. noted more conservative absolute 
desaturation thresholds of 65% and 60% to indicate an increased risk of ad-
verse outcome.51 Contrastingly, Kok et al. in a pilot study failed to show a rela-
tionship between cerebral desaturation and PNC.64 
Moving forward to interventional-guided studies, Slater et al. through a prospec-
tive randomized interventional trial found a positive relation between cerebral 
desaturations and PNC using the mini-mental state examination (MMSE).63 In 
another prospective randomized interventional trial, Murkin et al. studied cere-
bral desaturations and postoperative morbidity in cardiac surgical patients un-
dergoing CPB.62 More patients in the control group (n=96), (i.e., no intervention 
based on normalization of intraoperative rSO2 within 75% of baseline) under-
went prolonged cerebral desaturation episodes compared to the intervention 
group (n=98). Stroke rate, however, did not significantly differ between groups. 
The authors attributed this finding to the fact that their study lacked adequate 
statistical power for assessment of stroke (n=4 in the control group, versus n=1 
in the intervention group), as the a priori power analysis was based on major 
organ morbidity and mortality. Nevertheless, they conclude that intraoperative 
monitoring and management using cerebral oximetry may have a clinical benefit 
for the cardiac surgical patient.
Ta
ble
 1.
 O
ve
rvi
ew
 of
 th
e s
tud
ies
 in
clu
de
d i
n t
he
 sy
ste
ma
tic
 lit
era
tur
e s
ea
rch
. 
au
tho
r 
ye
ar 
typ
e 
of stu
dy
 
de
vic
e u
se
d 
n 
rel
ati
on
 
rS
O 2
- 
PN
C 
rS
O 2
 th
res
ho
ld 
ou
tco
me
 m
ea
su
red
 
me
as
uri
ng
 co
mp
lic
ati
on
s 
Ne
ga
rga
r49
 
20
07
 
PO
 
IN
VO
S 
72
 
no
 
ab
so
lut
e d
ec
rea
se
 
<4
0%
 an
d 5
0%
, 
>2
0%
 ab
so
lut
e 
de
sa
tur
ati
on
 fro
m 
ba
se
lin
e 
ne
uro
ps
yc
ho
log
ica
l s
tat
e 
MM
SE
 
De
 To
urn
ay
-
Je
tté
50
 
20
11
 
PO
 
IN
VO
S 
61
 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<5
0%
, >
30
% 
de
cre
as
e f
rom
 
ba
se
lin
e 
ea
rly
 (4
-7 
da
ys
) a
nd
 la
te 
(1 
mo
nth
) P
OC
D 
(dr
op
 of
 1S
D 
fro
m 
ba
se
lin
e (
the
 da
y b
efo
re 
su
rge
ry)
 on
 ≥2
 m
ore
 
ne
uro
ps
yc
ho
log
ic 
ind
ice
s) 
Tr
ail
 M
ak
ing
 Te
st 
pa
rt A
 an
d B
, V
erb
al 
Flu
en
cy
 Te
st,
 R
ay
's 
Au
dit
ory
 V
erb
al 
Le
arn
ing
 Te
st,
 Lo
gic
al 
Me
mo
ry 
Su
bte
st 
(R
ive
rm
ea
d b
att
ery
), d
igi
t s
ym
bo
l, 
St
roo
p T
es
t 
Fis
ch
er5
1  
20
11
 
PO
 
Fo
re-
sig
ht 
30
 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<5
0%
, <
55
%,
 <6
0%
, 
<6
5%
 
se
ve
re 
ad
ve
rse
 ou
tco
me
, 
inc
lud
ing
 st
rok
e 
no
t s
pe
cif
ied
 
Sc
ho
en
52
 
20
11
 
PO
 
IN
VO
S 
23
1 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<5
0%
 ab
so
lut
e, 
>8
0%
 de
cre
as
e 
ba
se
lin
e 
de
liri
um
 
MM
SE
, C
AM
-IC
U 
Ho
ng
53
 
20
08
 
PO
 
IN
VO
S 
10
0 
no
 
ab
so
lut
e d
ec
rea
se
 
<4
0%
, 5
0%
, >
20
% 
de
cre
as
e f
rom
 
ba
se
lin
e 
PO
CD
 
MM
SE
, T
rai
l-M
ak
ing
 Te
st 
(P
art
 A
), 
Gr
oo
ve
d P
eg
bo
ard
 Te
st 
Fu
dic
ka
r54
 
20
11
 
PO
 
Ni
ro 
35
 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<6
5%
 
po
sto
pe
rat
ive
 co
gn
itiv
e d
efi
cit
 
Tr
ail
 M
ak
ing
 Te
st,
 V
erb
al 
Le
arn
ing
 
Te
st,
 R
ay
's 
Au
dit
ori
al 
Ve
rba
l F
lue
nc
y 
Te
st,
 D
igi
t S
ym
bo
l S
ub
sti
tut
ion
 Te
st,
 
Di
git
 S
pa
n T
es
t 
Ol
ss
on
55
 
20
06
 
RO
 
IN
VO
S 
46
 
ye
s 
no
ne
 
str
ok
e 
ne
w 
ne
uro
log
ic 
de
fic
it t
ha
t d
id 
no
t 
res
olv
e b
efo
re 
dis
ch
arg
e c
on
firm
ed
 by
 
CT
 an
d/o
r s
pe
cia
lis
t n
eu
rol
og
ic 
as
se
ss
me
nt 
24 
au
tho
r 
ye
ar 
typ
e 
of stu
dy
 
de
vic
e u
se
d 
n 
rel
ati
on
 
rS
O 2
- 
PN
C 
rS
O 2
 th
res
ho
ld 
ou
tco
me
 m
ea
su
red
 
me
as
uri
ng
 co
mp
lic
ati
on
s 
Ur
ba
ns
ki5
6  
20
13
 
PO
 
Ni
ro 
12
2 
no
 
ab
so
lut
e d
ec
rea
se
 
≤5
5%
, <
80
% 
ch
an
ge
 
fro
m 
ba
se
lin
e 
ad
ve
rse
 ne
uro
log
ica
l 
ou
tco
me
 (p
erm
an
en
t fo
ca
l 
ne
uro
log
ica
l d
efi
cit
 or
 
tem
po
rar
y n
eu
rol
og
ica
l 
dy
sfu
nc
tio
n) 
pe
rm
an
en
t fo
ca
l n
eu
rol
og
ica
l d
efi
cit
: 
co
nfi
rm
ed
 by
 a 
ne
uro
log
ist
 an
d C
T o
r 
MR
I. T
em
po
rar
y n
eu
rol
og
ica
l 
dy
sfu
nc
tio
n: 
co
nfu
sio
n, 
de
liri
um
, 
ag
ita
tio
n o
r te
mp
ora
ry 
foc
al 
de
fic
its
 
wi
tho
ut 
ev
ide
nc
e o
n C
T o
r M
RI
. 
Ka
kih
an
a57
 
20
12
 
PO
 
Ha
ma
ma
tsu
 
10
 
ye
s 
no
ne
 
str
ok
e 
MM
SE
 
Ha
ss
an
58
 
20
10
 
PO
P 
Fo
re-
sig
ht 
1 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<5
5%
 
ne
uro
co
gn
itiv
e d
efi
cit
 
no
t re
po
rte
d 
Gr
ee
nb
erg
59
 
20
13
 
PO
 
Fo
re-
sig
ht 
53
 
no
 
ab
so
lut
e d
ec
rea
se
 
<6
0%
 ≥6
0 s
ec
on
ds
 
in 
≥1
 he
mi
sp
he
re 
de
liri
um
 
no
t re
po
rte
d 
Se
na
na
ya
ke
60
 
20
12
 
PO
 
IN
VO
S 
27
 
ye
s 
no
ne
 
pe
rm
an
en
t o
r te
mp
ora
ry 
ne
uro
log
ica
l d
efi
cit
 
Pe
rm
an
en
t n
eu
rol
og
ica
l d
efi
cit
: a
ny
 
ne
w 
po
sto
pe
rat
ive
 ne
uro
log
ica
l d
efi
cit
 
tha
t in
clu
de
d n
ew
 fo
ca
l s
tro
ke
 or
 gl
ob
al 
co
ma
 w
hic
h d
id 
no
t re
so
lve
 by
 
dis
ch
arg
e, 
an
d c
on
firm
ed
 by
 a 
ne
w 
ce
reb
ral
 in
fra
cti
on
 on
 C
T. 
Te
mp
ora
ry 
ne
uro
log
ica
l d
efi
cit
: a
ny
 po
sto
pe
rat
ive
 
ne
uro
log
ica
l d
efi
cit
 th
at 
inc
lud
ed
 m
oto
r 
de
fic
it, 
co
nfu
sio
n, 
ag
ita
tio
n, 
or 
tra
ns
ien
t 
de
liri
um
 th
at 
res
olv
ed
 sp
on
tan
eo
us
ly 
be
for
e d
isc
ha
rge
 w
ith
 no
 ne
w 
ce
reb
ral
 
inf
arc
tio
n o
n C
T. 
Ka
me
ns
ka
ya
61
 
20
15
 
PO
 
IN
VO
S 
61
 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<4
0%
 
ne
uro
log
ica
l c
om
pli
ca
tio
ns
 
(en
ce
ph
alo
pa
thy
, s
tro
ke
) 
MM
SE
, G
CS
 
Mu
rki
n62
 
20
07
 
PR
I 
IN
VO
S 
19
4 
no
 
AU
C<
70
% 
of 
ba
se
lin
e >
15
0 
mi
n∙%
, d
es
atu
rat
ion
 
AU
C 
<4
0%
 as
bo
lut
e 
str
ok
e 
foc
al 
ne
uro
log
ic 
de
fic
it p
ers
ist
ing
 
>2
4h
rs 
an
d c
on
firm
ed
 by
 C
T 
25 
au
tho
r 
ye
ar 
typ
e 
of stu
dy
 
de
vic
e u
se
d 
n 
rel
ati
on
 
rS
O 2
- 
PN
C 
rS
O 2
 th
res
ho
ld 
ou
tco
me
 m
ea
su
red
 
me
as
uri
ng
 co
mp
lic
ati
on
s 
Co
lak
45
 
20
15
 
PI
 
IN
VO
S 
20
0 
ye
s 
ab
so
lut
e d
ec
rea
se
 
<5
0%
, A
UC
 
>1
50
%∙
mi
n <
20
% 
of 
ba
se
lin
e, 
AU
C 
>5
0m
in∙
% 
 
co
gn
itiv
e d
ec
lin
e 
MM
SE
, C
olo
r T
rai
l T
es
t 1
, G
roo
ve
d-
Pe
gb
oa
rd 
Te
st 
Sla
ter
63
 
20
09
 
PR
I 
IN
VO
S 
24
0 
ye
s 
de
sa
tur
ati
on
 sc
ore
 
>3
00
0 
ea
rly
 P
OC
D 
 
ne
uro
co
gn
itiv
e t
es
t b
att
ery
 
Ko
k64
 
20
14
 
PI
P 
IN
VO
S 
(bu
t 
bo
th 
IN
VO
S 
an
d F
ore
-
sig
ht 
we
re 
me
as
ure
d) 
60
 
no
 
AU
C 
40
% 
>1
0 
mi
n∙%
 
po
sto
pe
rat
ive
 co
gn
itiv
e 
de
cli
ne
 (4
 da
ys
 (e
arl
y) 
an
d 3
 
mo
nth
s (
lat
e))
 
Co
gS
tat
e b
rie
f c
om
pu
ter
ise
d c
og
nit
ive
 
tes
t b
att
ery
 
Mo
ha
nd
as
65
 
20
13
 
PI
 
Eq
ua
no
x 
10
0 
ye
s 
>2
0%
 de
cre
as
e f
rom
 
ba
se
lin
e 
PN
C 
MM
SE
, A
SE
M 
Co
lak
66
 
20
12
 
PI
 
IN
VO
S 
58
 
ye
s 
AU
C>
15
0 m
in∙
% 
for
 
<2
0%
 of
 ba
se
lin
e o
r 
>5
0 m
in∙
% 
for
 <5
0%
 
of 
ab
so
lut
e v
alu
e 
str
ok
e, 
co
ma
, s
tup
or 
Co
ma
: p
rof
ou
nd
 st
ate
 of
 
un
co
ns
cio
us
ne
ss
 w
ith
ou
t re
sp
on
se
 to
 
ve
rba
l c
all
, p
ain
 or
 an
y o
the
r s
tim
ulu
s. 
St
up
or:
 st
ate
 of
 un
co
ns
cio
us
ne
ss
 fro
m 
wh
ich
 pa
tie
nt 
ca
n b
e a
rou
se
d o
nly
 by
 
vig
oro
us
 ph
ys
ica
l s
tim
ula
tio
n. 
St
rok
e: 
ac
ute
 on
se
t o
f a
 ne
uro
log
ic 
de
fic
it t
ha
t 
pe
rsi
sts
 fo
r a
t le
as
t 2
4 h
ou
rs 
an
d 
ref
lec
ts 
foc
al 
inv
olv
em
en
t o
f th
e c
en
tra
l 
ne
rvo
us
 sy
ste
m.
 
De
liri
um
/en
ce
ph
alo
pa
thy
: c
on
fus
ion
, 
ag
ita
tio
n, 
dis
ori
en
tat
ion
, d
ec
rea
se
d 
ale
rtn
es
s, 
sle
ep
 di
stu
rba
nc
es
, m
em
ory
 
de
fic
it o
r s
eiz
ure
 w
ith
ou
t o
bv
iou
s f
oc
al 
ne
uro
log
ica
l d
efi
cit
. 
26 
au
tho
r 
ye
ar 
typ
e 
of stu
dy
 
de
vic
e u
se
d 
n 
rel
ati
on
 
rS
O 2
- 
PN
C 
rS
O 2
 th
res
ho
ld 
ou
tco
me
 m
ea
su
red
 
me
as
uri
ng
 co
mp
lic
ati
on
s 
Mu
rki
n67
 
20
11
 
PI
 
IN
VO
S 
57
 
no
 
de
cre
as
e <
75
% 
of 
ba
se
lin
e >
15
 
se
co
nd
s. 
ne
w-
on
se
t s
tro
ke
, m
ajo
r-
org
an
 m
orb
idi
ty 
an
d m
ort
ali
ty 
un
cle
ar 
AS
EM
: a
nti
sa
cc
ad
ic 
ey
e 
mo
ve
me
nt,
 A
UC
: a
rea
 u
nd
er 
cu
rve
, C
AM
-IC
U:
 c
on
fus
ion
 a
ss
es
sm
en
t m
eth
od
 o
n 
the
 in
ten
siv
e 
ca
re 
un
it, 
CT
: c
om
pu
ted
 to
mo
-
gra
ph
y, 
GC
S:
 G
las
go
w 
co
ma
 sc
ale
, M
MS
E:
 m
ini
 m
en
tal
 st
ate
 ex
am
ina
tio
n, 
MR
I: m
ag
ne
tic
 re
so
na
nc
e i
ma
gin
g, 
PI
: p
ros
pe
cti
ve
 in
ter
ve
nti
on
al,
 P
IP
: p
ros
pe
c-
tiv
e 
int
erv
en
tio
na
l p
ilo
t, 
PN
C:
 p
os
top
era
tiv
e 
ne
uro
log
ica
l c
om
pli
ca
tio
ns
, P
O:
 p
ros
pe
cti
ve
 o
bs
erv
ati
on
al,
 P
OC
D:
 p
os
top
era
tiv
e 
co
gn
itiv
e 
dy
sfu
nc
tio
n, 
PO
P:
 
pro
sp
ec
tiv
e o
bs
erv
ati
on
al 
pil
ot,
 P
RI
: p
ros
pe
cti
ve
 ra
nd
om
ize
d i
nte
rve
nti
on
al,
 R
O:
 re
tro
sp
ec
tiv
e o
bs
erv
ati
on
al,
 rS
O 2
: r
eg
ion
al 
ce
reb
ral
 tis
su
e o
xy
ge
n s
atu
ra-
tio
n.
27 
CHAPTER 2 
28 
Interpretation 
Several studies suggest that cerebral oximetry is a valuable monitoring tool and 
implicate that early intervention based on cerebral oximetry monitoring can po-
tentially prevent or decrease the occurrence of PNC. Murkin even proposed that 
cerebral oximetry can be applied as an index organ, indicating that maintaining 
adequate cerebral rSO2 values is beneficial for all vital organs.15 Despite these 
findings it remains unclear if this is part of a causal relationship or just a reflec-
tion of overall morbidity.14  
In a recent systematic review, data on the specificity of rSO2 monitoring to en-
sure cerebral perfusion could not be established, i.e., the absence of acute re-
ductions in rSO2 did not ensure adequate cerebral blood flow (CBF).17 Further-
more, Kok et al. reported no relationship between cerebral desaturations and 
PNC, which can be explained by the fact that low rSO2 occurred only sporadi-
cally in their patient population.64 This suggests that factors other than in-
traoperative hypoxic episodes contribute to the development of PNC. Moreover, 
the incidence of PNC following cardiovascular procedures is relatively low, 
which affects the ability of studies to demonstrate a signficant association with 
cerebral desaturations.3,4,68 A plausible explanation for the low PNC occurrence 
can be found in the applied perfusion protocol, which includes maintaining the 
mean ABP within a certain range (70-90 mmHg), maintaining normoxia (partial 
arterial oxygen pressure between 11.0-14.0 kPa or 83-105 mmHg) and 
normocapnia (PaCO2 4.5-5.5 kPa or 34-41 mmHg), with a hematocrit level 
>28% throughout the intraoperative period.69 Further, it has been shown that 
avoiding large fluctuations in hemodynamic parameters during CPB decreases 
the risk of postoperative neurologic complications.70 
Besides perfusion protocols, additional factors that likely alter the risk of PNC 
occurrence include patient and surgery-related parameters. Previous studies 
identified the factors advanced age, a history of neurologic events, insulin-
dependent diabetes mellitus, congestive heart failure, peripheral vascular dis-
ease, prolonged CPB time, and a more complex surgical procedure to be linked 
to PNC occurrence.6-9,17,20,45,68,71-74 In contrast, Fink et al. in a recent review 
state that the evidence linking cardiovascular procedures to cognitive outcome 
is scarce, and persistent postoperative cognitive impairment may solely reflect 
the presence of cognitive impairment prior to surgery.3  
Moreover, the lack of standardization in the diagnosis of PNCs makes compari-
son between studies focusing on its determinants challenging. In the current 
literature, different cognitive assessment methods are applied to identify cogni-
tive decline, of which the MMSE is most frequently used.12 These tests require 
measurements to be performed at different time points prior to and following 
surgical intervention. For diagnosis of stroke additional computed tomography 
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scanning or magnetic resonance imaging is required.75 Furthermore, the MMSE 
does not account for frontal lobe abnormalities, which is the typical area for 
cerebral rSO2 measurement76, possibly causing a false-negative test result. 
In summary, there is a lack of intervention-guided trials linking disturbances in 
cerebral oxygen saturation to occurrence of PNC. It is therefore doubtful wheth-
er regional rSO2 can be used as a specific brain monitor. 
Cerebral autoregulation 
Besides intraoperative cerebral desaturations, disturbances in the neuroprotec-
tive cerebral autoregulatory system are known to result in adverse neurological 
outcome.18,77,78 The definition of CA is the intrinsic ability of the cerebral vascu-
lature to provide a constant CBF despite changes in cerebral perfusion pres-
sure.79 In case of an intact CA, the cerebral perfusion pressure is coupled with 
the cerebral metabolic demands, preventing both ischemia and hyperemia.77 
The central homeostatic system of CA provides neuroprotection against hypo-, 
hyperperfusion, and ischemia through vasodilation and vasoconstriction of the 
cerebral vasculature. Proportionate alterations in CBF and subsequent mainte-
nance of brain metabolism ensure adequate oxygen saturation and removal of 
carbon dioxide and other metabolites. The cerebral vasculature receives its 
postganglionic sympathetic innervation from the superior cervical ganglion con-
taining neuropeptide Y and norepinephrine. This vascular response is depend-
ent on vessel size and mostly initiated by the pial arteries extending from the 
circle of Willis.80 In case of a sudden increase in blood pressure, the cerebral 
autoregulatory response prevents cerebral hyperemia and disruption of the 
blood-brain barrier.81 This is reflected by the fact that when the CA fails, wors-
ened clinical outcome can be expected, including an increased risk of PNC.82 
According to previous studies, cerebral oximetry reflects CA by close associa-
tion with a determinant of autoregulation, i.e., the cross-correlation between 
middle cerebral artery blood flow velocity and mean ABP.83,84 Likewise, the 
positive association of a change in rSO2 with a change in ABP is thought to 
reflect the absence of CA, also referred to as pressure passive cerebral perfu-
sion.85,86 On the other hand, in the case of hyperperfusion (also referred to as 
luxury brain perfusion87, cerebral rSO2 values can be close to baseline while the 
CA is severely disturbed. This can be explained by the fact that the cross-
correlation between middle cerebral artery blood flow velocity and mean ABP is 
merely an intermediate indicator of CA, as the phase relationship in the auto-
regulatory response is not taken into account.88 
For assessing cerebral autoregulatory activity, either its efficiency or its efficien-
cy combined with the time necessary for cerebrovascular resistance to adapt 
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can be determined. These two methods are also referred to as steady-state CA 
or static CA and dynamic CA, respectively.89 In both static and dynamic as-
sessment of CA, ABP as well as CBF velocity (CBFV) need to be taken into 
account. Mostly transcranial Doppler is used for quantification of CBFV, utilizing 
high-frequency sound waves to penetrate the acoustic temporal window of the 
cranium. One commonly used method validated for determining the current 
state of CA using transcranial Doppler is transfer function analysis that esti-
mates phase shift, coherence, and gain. The phase shift is the time difference 
observed between ABP (input) signal and the CBFV (output) signal, whereas 
coherence reflects the strength of the the magnitude of the transfer function 
between CBFV and ABP.90 The result of the transfer function analysis is an 
autoregulation index ranging from 0 (absence of autoregulatory activity) to 9 
(strongest autoregulatory activity).91 In patients, fluctuations in ABP and thereby 
CBFV need to be initiated to provoke adaptation in cerebrovascular resistance. 
In awake subjects, this can be achieved through metronome-triggered breathing 
while during CPB the indexed pump flow can be varied in a cyclic manner.69 
Although the association between cerebral desaturations and PNC remains 
inconclusive, the link between disturbances in the intrinsic autoregulatory sys-
tem and PNC occurrence is well recognized.18,21,77,82,92-94 Despite this fact, dis-
turbances in the CA are reported to occur relatively frequently, in 20% of pa-
tients undergoing CPB.18 The primary requisite to maintain an intact CA is tar-
geting a mean ABP within a certain range, i.e., the lower and upper autoregula-
tory limits. A range of 60-150 mmHg has been recommended to attain intact 
CA, although these pressures can be affected by sympathetic nervous activity95, 
which is the case in chronic hypertension.81 Also, the lower limit of CA has a 
wide inter-individual range, and thereby poses a challenge to predict an intact 
CA based on preoperative measurements.84 Within the autoregulatory range, 
CBF velocity appears unaffected by CPB pump flow.96 However, when ABP 
falls below the lower limit of CA, cerebral hypoperfusion and ischemia can re-
sult, as the cerebral vasculature cannot compensate any further for the reduc-
tion in perfusion pressure.97 Low CBF increases the risk of ischemic brain le-
sions leading to functional neuronal impairment or possibly even permanent 
neuronal injury.77 This has been confirmed by multiple studies reporting a posi-
tive relationship between a lowered mean ABP and the occurrence of adverse 
neurologic events.18,92,94 More specifically, a >15 mmHg reduction in ABP 
caused a 10% cerebral desaturation.98 In addition, a lowered perfusion pressure 
during bypass (60-70 mmHg) has been previously associated with an increased 
occurrence of postoperative delirium, while no differences in intraoperative cer-
ebral oximetry values were found between a low and high systemic perfusion 
pressure group.99 On the other hand, an ABP above the upper limit leads to 
cerebral hyperperfusion and possibly even edema, swelling, and hemorrhag-
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es77,78,100, predisposing the patient to an increased risk of postoperative deliri-
um.94 Thus, maintenance of an adequate target ABP is important to enable 
autoregulatory vascular compensation17 and thereby minimizing thrombotic and 
hypoxic events contributing to PNC.101,102 A recent study by Moerman et al. 
described several patterns of autoregulatory activity in response to a 20% 
change in blood pressure by administration of vasoactive drugs.29 One would 
expect that when CA is intact, CBF and rSO2 remain constant despite changes 
in perfusion pressure. However, Moerman et al. observed a paradoxical re-
sponse in some of the patients, i.e., a decrease in rSO2 when the perfusion 
pressure was increased and an increase in rSO2 when the perfusion pressure 
was decreased under normocapnic conditions. The authors contributed this 
phenomenon to an overcompensation of CA and considered it part of the nor-
mal physiologic response. Since multiple reaction patterns in cerebral autoregu-
latory activity were observed, they concluded that individualization of ABP tar-
gets might be the optimal approach in order to prevent hypo- and hyperperfu-
sion. For example, in traumatic brain injury patients, CA may vary within a short 
time scale, underlining the importance of continuous CA monitoring.82 
Presumably this may prove beneficial in terms of PNC risk. Although carbon 
dioxide reactivity has shown to influence CBF and thus CA, all measurements in 
the study of Moerman et al. were performed at normocapnia, thereby precluding 
analysis of individual patterns of CA at different levels of PaCO2. 
Apart from the influence of mean ABP, several studies showed elevated levels 
of PaCO2 to be accompanied by a decreased level of CA69,87,103, affecting he-
moglobin saturation and CBF.23 The report by Ševerdija et al. illustrated that 
hypercapnia is associated with a decreased autoregulatory activity (compared 
to normocapnia), whereas under hypocapnic conditions the level of CA is rela-
tively close to baseline values.69 This effect has been elucidated through sever-
al studies and can be explained by the phenomena of hypocapnia causing an 
expansion of the autoregulatory plateau, resulting in improved CA functionali-
ty.104-106 In other words, both ABP and PaCO2 influence cerebral CBF and are 
still not tightly controlled within the autoregulatory limits during CPB (mean ABP 
between 60 and 150 mmHg and PaCO2 between 4.7 and 5.3 kPa or 35 and 40 
mmHg).69,107 
Additionally, the extent of hemodilution (hematocrit level ≤18% or <19%) 
showed to be related to PNC and possibly an increased risk of mortality.108,109 
Mathew et al. even had to prematurely terminate their study due to the occur-
rence of adverse events attributed to profound hemodilution.108 Specifically, 
hemodilution has been associated with perioperative stroke in cardiac surgical 
patients.110 This relation can be partially explained by its adverse effects on 
CA.111 Ševerdija et al. showed that patients with a reduced hematocrit (<28%) 
during bypass have decreased levels of CA69, whereas Karkouti et al. reported 
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that a 12% decrease in hematocrit is associated with neurocognitive decline.110 
Hemodilution combined with hypercapnia even resulted in the largest decrease 
in autoregulatory activity during CPB.69 These studies, therefore, emphasize the 
adverse effects of nadir hemodilution during CPB. 
In conclusion, disturbances in CA are associated with cerebral malperfusion, 
contributing to adverse neurological outcome following cardiac surgery with 
CPB. Therefore, tight control of mean ABP within the autoregulatory range, 
avoiding hypercapnia and minimizing hemodilution and hemodynamic fluctua-
tions during CPB will collectively contribute to preservation of CA and a further 
decrease in PNC occurrence. Although the literature linking cerebral oximetry 
readings and PNC remains inconclusive, clinicians should prioritize maintaining 
an intact CA rather than solely focusing on maintaining rSO2 values above a 
certain threshold. Future studies should aim at determining personalized values 
of mean ABP and PaCO2 in order to preserve an intact CA.  
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Abstract 
Objective: To investigate the influence of hemodilution and arterial PCO2 on 
cerebral autoregulation and cerebral vascular CO2 reactivity. 
Design: Prospective interventional study. 
Setting: University hospital-based single-center study. 
Participants: Forty adult patients undergoing elective cardiac surgery using 
normothermic cardiopulmonary bypass. 
Interventions: Blood pressure variations induced by 6/minute metronome-
triggered breathing (baseline) and cyclic 6/min changes of indexed pump flow at 
3 levels of arterial PCO2. 
Measurements and main results: Based on median hematocrit on bypass, pa-
tients were assigned to either a group of a hematocrit ≥28% or <28%. The auto-
regulation index was calculated from cerebral blood flow velocity and mean 
arterial blood pressure using transfer function analysis. Cerebral vascular CO2 
reactivity was calculated using cerebral tissue oximetry data. Cerebral auto-
regulation as reflected by autoregulation index (baseline 7.5) was significantly 
affected by arterial PCO2 (median autoregulation index amounted to 5.7, 4.8, 
and 2.8 for arterial PCO2 of respectively 4.0, 5.3, and 6.6 kPa, p≤0.002) respec-
tively. Hemodilution resulted in a decreased autoregulation index; however, 
during hypocapnia and normocapnia, there were no significant differences be-
tween the two hematocrit groups. Moreover, the autoregulation index was low-
est during hypercapnia when hematocrit was <28% (autoregulation index 3.3 
versus 2.6 for hematocrit ≥28% and <28%, respectively, P=0.014). Cerebral 
vascular CO2 reactivity during hypocapnia was significantly lower when periop-
erative hematocrit was <28% (P=0.018). 
Conclusions: Hemodilution down to a hematocrit of <28% combined with hyper-
capnia negatively affects dynamic cerebral autoregulation, which underlines the 
importance of tight control of both hematocrit and PaCO2 during CPB. 
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Introduction 
Cardiopulmonary bypass (CPB) enables complex cardiac surgery. Neurologic 
complications, however, still remain a major concern and may be linked to al-
tered brain perfusion.1 In general, reduced vasomotor reactivity has been asso-
ciated with an increased risk of death.2 In cardiac surgical patients, impaired 
cerebral autoregulation has been associated with an adverse cognitive out-
come.1 Others found a clear relationship between perioperative stroke risk and 
nadir hematocrit values.3 An interventional study by Mathew et al. on hemodilu-
tion with subsequent decreased levels of hematocrit during hypothermic CPB 
had to be preliminarily terminated, because of significant occurrence of adverse 
events in the low hematocrit group.4 Moreover, increased levels of arterial CO2 
have shown to decrease cerebral autoregulation.5 To the best of the authors’ 
knowledge, however, there is no literature available that combines cerebral 
autoregulation and/or cerebral vasomotor reactivity with both hematocrit level 
and arterial partial gas pressure of CO2 (PaCO2). 
 
The aim of this study was to investigate cerebral autoregulation and cerebral 
vascular reactivity with respect to hemodilution and arterial CO2 levels during 
normothermic CPB. 
Methods 
Study population 
To study dynamic cerebral autoregulation and cerebral vascular reactivity for 
CO2, 40 random male patients scheduled for elective coronary bypass surgery 
in the time period July 2009 through July 2012 were included in this prospective 
explorative study. Presence of an adequate temporal acoustic window was the 
main inclusion criterion, along with absence of neurologic, renal, liver, or severe 
pulmonary disorders, diabetes, and severe atherosclerosis of carotid and/or 
middle cerebral arteries. 
The study was approved by the medical ethical committee of the Maastricht 
University Medical Center (Dutch trial registration: NTR1723). All patients gave 
written informed consent. 
Patient management and conduct of CPB 
General anesthesia was induced with infusion of 1.0 µg/kg of sufentanil (Ha-
meln Pharmaceuticals, Hameln, Germany), 2.0 mg/kg of propofol (Fresenius 
Kabi, Zeist, The Netherlands) and 1.0 mg/kg rocuronium bromide (Fresenius 
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Kabi, Zeist, The Netherlands). A subsequent propofol infusion (Fresenius Kabi, 
Zeist, the Netherlands) was set to 5.0 mg/kg/h. 
During normothermic nonpulsatile CPB using central cannulation, the centrifu-
gal pump bypass flow rate was targeted at 2.4 l/min/m2 body surface area. 
Mean arterial blood pressure was kept near the preoperative baseline value 
(between 70 mmHg and 90 mmHg) using phenylephrine titration (pharmacy of 
Radboud UMC, Nijmegen, The Netherlands) via an infusion pump if necessary. 
Arterial partial gas pressure of O2 was kept between 13 and 20 kPa. Cardiac 
arrest was induced using crystalloid cardioplegia (St. Thomas II, St. Thomas 
Hospital, Exeter, United Kingdom). 
 
Radial arterial blood pressure (ABP) was measured continuously using a patient 
monitoring system (Philips Healthcare, Eindhoven, The Netherlands). Pump 
flow was measured using an ultrasonic flow monitor (Transonic Systems Inc., 
Ithaca, NY). Cerebral blood flow velocity (CBFV) was measured from the left 
and right middle cerebral arteries at a depth ranging from 45 to 56 mm using 
two 2 MHz transcranial Doppler probes (ST3, Spencer Technologies, Seattle, 
WA) respectively. Data signals of ABP, pump flow, and CBFV were collected 
and recorded using a data acquisition system (IDEEQ, Maastricht Instruments, 
Maastricht, The Netherlands). Cerebral tissue oxygen saturation (SctO2) was 
monitored continuously using near-infrared spectroscopy (ForeSight, Casmed, 
Branford, CT). Hematocrit, PaCO2 and pH were measured inline continuously 
(CDI500, Terumo, Tokyo, Japan). 
Dynamic assessment of cerebral autoregulation 
Cerebral autoregulation was assessed dynamically prior to administration of 
preoperative medication in the patient ward at rest (baseline) and in the opera-
ting room during CPB. On the ward, hematocrit was determined using a blood 
sample and autoregulation was assessed analogous to Diehl et al. using me-
tronome-triggered 6/minute breathing to vary cardiac preload and resultant car-
diac output.6 CBFV was measured using transcranial Doppler sonography, and 
ABP was measured noninvasively via Portapres (Finapres Medical Systems, 
Amsterdam, The Netherlands). The cerebral autoregulation index (ARI) was 
estimated using the resulting step response function in ABP and CBFV.7,8 In the 
operating room during CPB, autoregulation was assessed with the aorta cross 
clamped and after cardioplegia administration. In contrast to the baseline mea-
surement that used manipulations in cardiac output, during CPB the indexed 
pump flow was changed in a cyclic manner. During a time frame of 300 se-
conds, flow was varied with a frequency of 6 cycles/min and 2.5 s per indexed 
flow rate (from 2.4 L/min/m2 to 2.0 L/min/m2 and back to 2.4 L/min/m2, and from 
2.4 L/min/m2 to 2.8 L/min/m2 and back to 2.4 L/min/m2, etc.), as described el-
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sewhere.9 ARI then was estimated using the recordings of pump flow, ABP, and 
CBFV. 
Assessment of cerebral vascular reactivity 
Cerebral vascular reactivity for CO2 (CO2R) was assessed using the recordings 
of SctO2 and PaCO2. The PaCO2 at start of extracorporeal circulation was main-
tained at 5.3 kPa. For measurement purposes, PaCO2 was varied stepwise from 
4.0 kPa to 5.3 kPa to 6.6 kPa by adjusting sweep gas flow to the oxygenator 
and brought back to 5.3 kPa at the end of the measurements. The induced hy-
pocapnic and hypercapnic conditions lasted for 5 minutes each. Subsequently, 
absolute cerebral CO2R (CO2Rabs) and relative cerebral CO2R (CO2Rrel) were 
calculated for each change in PaCO2 using the following formulae: 
 
 cerebral CO2Rabs = ΔSctO2/ΔPaCO2 
 and 
 cerebral CO2Rrel = (cerebral CO2Rabs/SctO2;5.3 kPa)*100% 
 
where ΔSctO2 represents the difference in SctO2 measured before and after an 
alteration of paCO2, during CPB ; ΔpaCO2 represents the difference in PaCO2. 
SctO2;5.3 kPa represents SctO2 measured at a PaCO2 of 5.3 kPa. 
Data processing and statistical analysis 
Depending on the on-bypass hematocrit level after aortic cross-clamping and 
after induction of cardiac arrest, patients were assigned to a group with a hema-
tocrit value during CPB ≥28% (high hematocrit group) or <28% (low hematocrit 
group), with 28% corresponding to the median hematocrit value calculated from 
all patients. For data of CBFV, ARI and SctO2, average values of the left and 
right cerebral hemispheres were calculated and used for statistical analysis. 
Data distribution was assessed by performing the Shapiro-Wilk test and visual 
assessment of histograms. Depending on data distribution, numerical parame-
ters are depicted either in mean and standard deviation or median and inter-
quartile range. Values for CBFV, ARI, and SctO2 acquired from both left and 
right hemispheres were averaged. The independent samples Mann-Whitney U 
test was used for comparison of numerical variables between the 2 groups of 
hematocrit. Cerebral autoregulation was tested between different levels of Pa-
CO2 by the related samples of Friedman’s two-way analysis of variance by 
ranks. If significant, the related samples of Wilcoxon signed rank test was used 
as a post-hoc test. 
Cerebral autoregulation was tested between the 2 levels of hematocrit for each 
level of PaCO2 by using the independent samples of Mann-Whitney U test. A P-
value <0.05 was considered statistically significant for all tests. 
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Results 
Patient demographics and preoperative data for all patients divided according to 
perioperative hematocrit level are shown in Table 1. Analysis revealed no signi-
ficant difference between the high (≥28%) and low hematocrit (<28%) groups 
except for preoperative hematocrit (P=0.002). 
Table 2 shows CPB time, aortic cross-clamp time, difference in perioperative 
hematocrit, and the effect of hematocrit on cerebral CO2R. Hematocrit during 
hypercapnia affected neither absolute nor relative cerebral CO2R. During hypo-
capnia, in contrast, hematocrit was noted to have a significant effect on cerebral 
CO2R (cerebral CO2Rabs,hypo and CO2Rrel,hypo, P=0.018 for both). 
 
 
Table 1. Patient demographics and preoperative data, specified for all (n=40) and per perioperative 
hematocrit group. 
hematocrit  n=40 ≥28%, (n=21) <28%, (n=19) P-value ≥28% vs<28% 
age (years) 60.1 [55.8-68.6] 58.9 [55.4-68.6] 61.2 [56.4-68.7] 0.566 
BSA (m2) 2.1 [1.9-2.2] 2.1 [1.9-2.2] 2.0 [1.8-2.1] 0.624 
preoperative haematocrit (%) 44.0 [42.3-46.0] 46.0 [43.0-47.0] 43.0 [40.8-44.3] 0.002 
ABP (mmHg) 86.0 [78.9-97.0] 86.0 [79.3-98.7] 85.7 [78.1-95.7] 0.578 
SctO2 (%) 71.9 [70.0-73.9] 72.0 [70.4-74.7] 71.0 [68.8-72.3] 0.098 
CBFV (cm/s) 40.3 [34.5-47.6] 39.3 [34.4-47.7] 41.8 [36.5-49.7] 0.561 
ARI 7.5 [7.0-8.0] 7.4 [6.5-8.0] 7.5 [7.1-8.0] 0.671 
Data presented as median [interquartile range].  
Abbreviations : BSA, body surface area; ABP, arterial blood pressure; SctO2, cerebral tissue oxygen 
saturation; CBFV, cerebral blood flow velocity; ARI, autoregulation index. 
 
 
Comparing cerebral autoregulation at the 3 levels of PaCO2 for all 40 patients, 
regardless of hematocrit, showed autoregulation to be significantly affected by 
PaCO2 level compared to both baseline (7.5 [7.0-8.0]) and to the other PaCO2 
levels (P≤0.002); for PaCO2=4.0, 5.3, and 6.6 kPa, the median ARI was 5.7 [4.8-
6.4], 4.8 [4.0-5.7], and 2.8 [2.3-3.8], respectively. Compared to baseline and 
regardless of hematocrit, ARI proved lowest during hypercapnia (P<0.001). 
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Table 2. Perioperative data and cerebral vascular reactivity for CO2 for the high and low hematocrit 
group. 
  ≥28% (n=21) <28% (n=19) P-value 
CPB time (min) 71.0 [58.5-82.5] 82.0 [62.0-93.0] 0.231 
aortic cross clamp time (min) 49.0 [41.0-58.5] 47.0 [38.0-66.0] 0.585 
perioperative hematocrit (%) 30.0 [28.5-31.0] 23.0 [22.0-25.0] <0.001 
cerebral CO2Rabs,hypo (%SctO2/kPa) 1.5 [1.2-2.3] 0.8 [0.4-1.9] 0.018 
cerebral CO2Rrel,hypo (%SctO2/kPa) 2.3 [1.7-3.3] 1.2 [0.6-3.1] 0.018 
cerebral CO2Rabs,hyper (%SctO2/kPa) 2.3 [1.7-3.5] 2.7 [1.9-3.1] 0.856 
cerebral CO2Rrel,hyper (%SctO2/kPa) 3.6 [2.4-5.4] 4.1 [2.9-4.7] 0.705 
Data presented as median [interquartile range]. SctO2, cerebral tissue oxygen saturation; CPB, 
cardiopulmonary bypass; CO2Rabs,hypo, absolute change of cerebral vascular reactivity for CO2 when 
altering PaCO2 from 5.3 kPa to 4.0 kPa; CO2Rrel,hypo, relative change of cerebral vascular reactivity 
for CO2 when altering PaCO2 from 5.3 kPa to 4.0 kPa; CO2Rabs,hyper, absolute change of cerebral 
vascular reactivity for CO2 when altering PaCO2 from 5.3 kPa to 6.6 kPa; CO2Rrel,hyper, relative 
change of cerebral vascular reactivity for CO2 when altering PaCO2 from 5.3 kPa to 6.6 kPa. 
 
 
Table 3 shows intraoperative variables at different levels of both PaCO2 and 
hematocrit. Analyzing cerebral autoregulation with respect to hematocrit only 
showed a significant difference at hypercapnia, during which ARI was lowest in 
the <28% group (3.3 versus 2.6 for hematocrit ≥28% and <28% respectively, 
P=0.0014). A more illustrative presentation is provided by Figure 1. None of the 
authors’ study patients experienced any adverse neurological complications as 
expressed by delirium, cerebral vascular accident, and transient ischemic attack 
during the surgical procedure or in a 30 day follow-up.
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Figure 1. Cerebral autoregulation as indicated by the autoregulation index (ARI) at baseline, at 3 
levels of PaCO2, and at 2 levels of hematocrit during cardiopulmonary bypass. 
Discussion 
This study investigated dynamic cerebral autoregulation (dCA) during normo-
thermic nonpulsatile CPB. Autoregulation proved to be lower compared to 
preoperative values and was affected by intraoperative hematocrit and PaCO2. 
With impaired cerebral autoregulation being reflected by decreased ARI7, efforts 
have been made to assess normal values for ARI in both awake and anesthe-
tized patients.10,11 In the authors’ study, the preoperative median ARI in awake 
patients at rest was 7.5 (Figure 1). Tiecks et al. found ARI to amount to 5±1 in 
patients at rest during light propofol anesthesia7, to which our results closely 
correspond. The authors measured in normocapnic (PaCO2=5.3 kPa) patients a 
median ARI of 4.8 for the overall study population even though our patients 
were on full bypass and propofol anesthetized. Engelhard et al. found mean 
values for ARI to be 5.4 and 5.9 in awake patients prior to induction of anesthe-
sia11, which are lower compared to the authors’ baseline ARI of 7.5. Gommer et 
al.8 showed an average ARI of 6.7 in young healthy volunteers using paced 
breathing at a 6/min frequency, an ARI higher compared to that for spontaneous 
breathing. Additionally, Engelhard et al. reported a mean ARI of 4.9 in abdomi-
nal surgical patients during anesthesia with combined propofol and remifentanil, 
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which closely correlated to the authors’ results, showing a median of 4.8 in 
normocapnic anesthetized patients. Although the hematocrit of the patients in 
that study was not mentioned, it may be expected that those patients were not 
exposed to such a relatively high level of hemodilution with resulting low hema-
tocrit as our patients undergoing CPB (hematocritmedian=28%). The patients in 
the study of Engelhard et al., however, showed ARI values relatively similar to 
those of the authors’ patients, therefore suggesting these values to be repre-
sentative for a normal ARI in the average normocapnic propofol-anesthetized 
cardiac surgical patient on bypass. In addition, propofol is known to decrease 
CBFV by reducing the cerebral metabolic rate of oxygen.12,13 Nevertheless, 
cerebral autoregulation has shown to be unaffected by propofol anesthesia, 
which implies that normal cerebral circulation and metabolism are maintained.14 
With literature and the athors’ data showing comparable values for ARI, their 
baseline and perioperative normocapnic measurements of ARI may be consi-
dered clinically representative for unimpaired (intact) values for cerebral autore-
gulation. This suggests that their baseline values measured in awake unanes-
thetized patients also may be applicable to surgical patients in general. 
 
In surgical patients, impaired cerebral autoregulation (i.e., in the authors’ data 
represented by decreased ARI levels) has been associated with increased oc-
currence of perioperative stroke.15 Additionally, a low hematocrit during CPB is 
known to contribute to postoperative morbidity and mortality.3,4,16 The authors’ 
study investigated the effect of perioperative hematocrit on dCA, and found ARI 
to be decreased at a hematocrit level <28% (at a PaCO2 level of 6.6 kPa). The 
relation between hemodilution and impaired dCA previously was elucidated by 
Ogawa et al., but they studied awake subjects and did not include mea-
surements of PaCO2.17 Karkouti et al. found hemodilution to be associated with 
perioperative stroke.3 Roach et al. found that impaired cerebral autoregulation is 
associated with adverse neurological outcome.1 As a result of lowered periope-
rative hematocrit negatively influencing both cerebral autoregulation and posto-
perative neurological outcome, low hematocrit levels due to excessive hemodi-
lution should be avoided, and techniques limiting hemodilution could prove 
beneficial.18,19 
 
Arterial CO2 level has been demonstrated to affect cerebral blood flow by al-
tering cerebral vasomotor reactivity.20 The authors’ data also show that ARI 
decreases with increasing PaCO2. For PaCO2=4.0, 5.3, and 6.6 kPa, the index 
amounted 5.7, 4.8, and 2.8, respectively. A study conducted by Henriksen et al. 
showed a negative effect on cerebral autoregulation when PaCO2 level was 
increased.5 Moreover, Henriksen et al. found cerebral autoregulation to be near-
absent at a PaCO2 level >50 mmHg (>6.7 kPa). Although the authors used such 
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a high PaCO2 level as well, results indicated a decreased but still present level 
of cerebral autoregulation, as depicted by a 35% reduction (ARI=2.6) and 44% 
reduction (ARI=3.3) of autoregulation for the low and high hematocrit group, 
respectively, compared to baseline in awake subjects (ARI=7.5). With decrea-
sed cerebral autoregulation being associated with impaired or adverse neurolo-
gical outcome, these data underline the importance of tight control of PaCO2 
during CPB.1 
 
Cerebral autoregulation is a complex physiological mechanism, which is in-
fluenced by several factors including hematocrit and PaCO2.21,22 Ono et al. stu-
died cerebral autoregulation during CPB and found increased PaCO2 levels to 
be a factor of negative influence.15 As indicated by the authors’ data, dCA was 
reduced with a lower hematocrit (Table 3). The data also showed that increased 
levels of PaCO2 resulted in decreased ARI as well. Combining hypercapnia with 
low hematocrit (<28%) showed the largest decrease in ARI compared to base-
line (median ARIbaseline=7.5 (Fig 1). Summarized, the difference in ARI between 
patients with higher (≥28%) and lower (<28%) hematocrit (ΔARI=4.2 and 
ΔARI=4.9, respectively) was most pronounced at the lower limit of cerebral 
autoregulation (2.8 [2.3-3.8]), which is found at a PaCO2 level of 6.6 kPa. A pos-
sible explanation for the authors’ finding is that hemodilution induces a re-
duction in viscosity and compensatory vasodilatation, therefore increasing 
CBFV, which results in a decreased autoregulatory capacity.23 The detrimental 
effect of combined hypercapnia and hemodilution underlines, once more, the 
importance of adequate PaCO2 monitoring and tight perioperative PaCO2 control 
while avoiding extreme hemodilution in order to diminish the risk of cognitive 
complications and adverse neurologic clinical outcome. 
 
Cerebral CO2R plays an intricate part in the vascular autoregulatory system of 
the brain and aims at minimizing the effects of fluctuations in arterial blood 
pressure on cerebral perfusion.24 The authors’ study showed that in hypocapnia 
there was a significant positive relationship between cerebral CO2R and hema-
tocrit (Table 2). Tu et al. found similar results, reporting a decreased cerebral 
CO2R with isovolemic hemodilution.25 In contrast to Tu et al’s study, however, 
the authors included alterations of PaCO2 and showed that both hemodilution 
and arterial CO2 level affect cerebral CO2R. Henriksen also found that decrea-
sed cerebral CO2R during hypocapnia is related to distinct changes in hemato-
crit.5 This is in line with the authors’ findings of a significant difference in cere-
bral CO2R between the 2 hematocrit groups at a PaCO2 level of 4.0 kPa (Table 
2). This can be explained by the fact that although cerebral autoregulation is 
suppressed during hypercapnia, cerebral blood flow as such is present. Blood 
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flow even can be increased due to lowered viscosity as a result of hemodilution 
and increased cerebral CO2R. 
 
This study investigated cerebral autoregulation and found low hematocrit 
(<28%) combined with hypercapnia to significantly decrease ARI. None the 
authors’ study patients, however, experienced any adverse neurological compli-
cations as expressed by delirium, cerebral vascular accident, and transient 
ischemic attack during the surgical procedure or in a 30-day follow-up. This 
could be attributed to the short duration of 5 minutes in which hypercapnia was 
induced. Another explanation can be found in the authors’ protocol of keeping 
mean arterial blood pressure in the 70 mmHg-to-90 mmHg range, which is 
close to the baseline values of their patients and in which cerebral autoregula-
tion is generally considered present.26 
 
In the authors’ study, CBFV was measured using transcranial Doppler, a 
method that presumes the assumption of a constant vessel diameter.27 As pre-
viously elucidated, both PaCO2 and hemodilution significantly affect cerebral 
CO2R and thereby blood flow, two factors that were altered in the authors’ study 
subjects. However, several studies have exemplified that the diameter of larger 
arteries change minimally during hemodilution and hypercapnia.28,29 Therefore, 
changes in CBFV in the middle cerebral artery measured by Doppler legitima-
tely reflect changes in cerebral blood flow. 
 
Cerebral autoregulation is estimated by measuring CBFV at the middle cerebral 
artery using transcranial Doppler via the temporal window.24 The authors’ study 
showed preoperative CBFV in resting conditions to be around 40 cm/s (Table 
1). Liboni et al. found CBFV to amount to approximately 67 cm/s30, whereas 
Lindegaard et al. found CBFV to vary between 32 to 78 cm/s.31 Lindegaard et 
al. and the authors’ study, however, included male patients, whereas Liboni et 
al. measured CBFV in women. In women, a proper acoustic optical temporal 
window frequently is absent, which impedes measurement of cerebral autoregu-
lation.32 Although the authors’ study did not include female patients, women 
show comparable or higher CBFV values30,33 and their results on cerebral auto-
regulation may be applicable to the full cardiac surgical population, including 
both genders. 
Conclusion 
Hemodilution down to a hematocrit of <28% combined with hypercapnia negati-
vely affects dynamic cerebral autoregulation, which underlines the importance 
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of tight control of both hematocrit and PaCO2 during CPB. Perioperative cerebral 
monitoring proves a valuable tool for future studies evaluating cerebral autore-
gulation during CPB to, hopefully, clarify optimal perfusion strategies. 
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Dear Editor,  
 
Postoperative cognitive dysfunction (POCD) accompanied by short- and long-
term effects remains a major burden for patients’ recovery and quality of life 
following cardiac surgery with cardiopulmonary bypass (CPB). Several patient- 
and procedure-related factors have shown to affect the risk of POCD, as dis-
cussed by Messerotti Benvenuti et al. in a recent issue of Perfusion 
(2015l30:514-516).1 They conclude that pre-existing cognitive status and not 
the duration of CPB is associated with POCD at middle-term postoperative 
evaluation. However, the authors did not elaborate on the CPB protocol that 
was used. For adequate interpretation of POCD risk, it is necessary also to take 
the cerebral autoregulation (CA) into account, as the neuroprotective autoregu-
latory system prevents both hypo- and hyperperfusion by reactive vasodilation 
and constriction following changes in arterial blood pressure (ABP) and arterial 
carbon dioxide tension.2 To maintain an intact CA during CPB, it is, therefore, 
important to target a mean ABP within the autoregulatory range (60-150 
mmHg)2 and to maintain normocapnia (4.5-5.5 KPa).3 Moreover, it has been 
shown that avoiding large fluctuations in hemodynamic parameters during CPB 
results in a decreased risk of postoperative neurologic complications.4 
 
In summary, for middle-term evaluation of POCD, it would be interesting to in-
clude intraoperative data on hemodynamics and arterial carbon dioxide tension. 
Taking this into account, apart from the role of patient-related factors, will add to 
a better understanding of the contributors involved in POCD risk. 
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Abstract 
Previous studies showed that decreased cerebral saturation during cardiac 
surgery is related to adverse postoperative outcome. Therefore, we investigated 
the influence of intraoperative events on cerebral tissue saturation in patients 
undergoing cardiac surgery with cardiopulmonary bypass (CPB). 
A total of 52 adult patients who underwent cardiac surgery using pulsatile CPB 
were included in this prospective explorative study. Cerebral tissue oxygen sat-
uration (SctO2) was measured in both the left and right cerebral hemisphere. 
Intraoperative events, involving interventions performed by anesthesiologist, 
surgeon, and clinical perfusionist, were documented. Simultaneously, in-line 
hemodynamic parameters (partial oxygen pressure, partial carbon dioxide pres-
sure, hematocrit, arterial blood pressure, and CPB flow rates) were recorded.  
Cerebral tissue saturation was affected by anesthetic induction (P<0.001), 
placement of the sternal retractor (P<0.001), and initiation (P<0.001) as well as 
termination of CPB (P<0.001). Placement (P<0.001) and removal of the aortic 
cross-clamp (P=0.026 for left hemisphere, P=0.048 for right hemisphere) led to 
changes in cerebral tissue saturation. In addition, when placing the aortic cross 
clamp, hematocrit (P<0.001) as well as arterial (P=0.007) and venous 
(P<0.001) partial oxygen pressures changed. 
Cerebral tissue oximetry effectively identifies changes related to surgical events 
or vulnerable periods during cardiac surgery. Future studies are needed to iden-
tify methods of mitigating periods of reduced cerebral saturation. 
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Introduction 
Despite impressive improvements in the overall safety of cardiac surgery, peri-
operative cerebral injury remains a major concern.1 The two major causative 
factors for neuropsychological dysfunction after cardiac surgery are global brain 
hypoperfusion and cerebral emboli generated by either surgical or perfusion-
related interventions.2-6 Furthermore, worsened control of cerebral blood flow 
due to hypertension, diabetes, or other conditions imposes patients intraopera-
tively to increased risk of neurological complications.7,8 However, evaluation of 
cerebral hemodynamics may still not be part of routine practice.9 
Intraoperative cerebral monitoring to identify vulnerable periods during cardiac 
surgery that require prompt intervention (e.g., adjusting the partial carbon diox-
ide gas pressure or fraction of inspired oxygen) should be a major goal in the 
fields of cardiac anesthesia, surgery, and perfusion.10,11 In a randomized, blind-
ed, prospective study of 200 patients, Murkin et al.12 demonstrated that non-
invasive regional cerebral saturation monitoring is associated with a significant 
improvement in overall outcome after cardiac surgery. 
Moreover, using a protocol-based interventional strategy to maintain cerebral 
saturation within 75% of baseline values during cardiopulmonary bypass (CPB) 
may improve both neurological and multi-organ dysfunction outcomes in cardiac 
surgery.12,13 Using the brain as an index organ for adequate tissue perfusion 
may therefore be beneficial for all vital organs.14 Routine monitoring of cerebral 
saturation during cardiac surgical interventions may therefore detect early signs 
of post-surgery neurological deficits. 
In this study, intraoperative events were recorded in order to qualify the effects 
on cerebral tissue oxygen saturation (SctO2) in patients undergoing cardiac sur-
gery with pulsatile CPB. 
Materials and methods 
Patients 
This prospective, explorative non-randomized clinical study included 52 adult 
patients (38 male and 14 female) that underwent elective cardiac surgery using 
pulsatile CPB between November 2011 and May 2012. No restrictions or inclu-
sion criteria were applied. Institutional approval was received for this evaluation 
and since the study did not influence the routine care of the patient, informed 
consent was waived. 
Non-invasive absolute (SctO2) was routinely measured via near-infrared spec-
troscopy (FORE-SIGHT; CAS Medical Systems, inc., Branford, CT) by placing a 
fiber optic sensor on each side of the patient’s forehead. Cerebral oximetry was 
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measured in both the left and right hemisphere. SctO2 data were simultaneously 
recorded every 2 seconds. All intraoperative events from anesthetic induction to 
discharge from the operating room were marked including the corresponding 
time in the data file. No interventions based on SctO2 changes were applied 
intraoperatively and data used for analysis were routine measurements. 
Anesthesia 
After establishing standard anesthetic monitoring including electrocaridogram, 
oxygen saturation, and invasive arterial blood pressure (ABP) measurement, 
general anesthesia was induced with 0.5 µg/kg sufentanil, 1.5 mg/kg propofol, 
and 0.6 mg/kg rocuronium. After endotracheal intubation, the patients were 
ventilated with volume-controlled ventilation with tidal volumes of 7-8 mL/kg, 
positive end-expiratory pressure of 5 cm∙H2O, respiratory rate of 12/min, and a 
fraction of inspired oxygen of 0.4, which resulted in normocapnia and normal 
oxygen oxygen saturation. Anesthesia was maintained with sevoflurane at a 
minimal alveolar concentration of approximately 0.8. Perioperative analgesic 
regime contained continuous intravenous administration of (S)-ketamine, lido-
caine, and boluses of sufentanil. 
Prior to surgery a warming blanket (3M Bair Hugger, 3M Health Care, Delft, The 
Netherlands) was positioned to maintain normothermia. 
Cardiopulmonary bypass 
The CPB system included a standard hollow-fiber membrane oxygenator (Capi-
ox SX18R; Terumo Medical Corps,. Tokyo, Japan), a roller pump (S5; Sorin 
Group S.p.A, Mirandola, Italy), a cardiotomy reservoir (Capiox CXCRXA, Teru-
mo), a collapsible venous reservoir (JVR 1900; Maquet Cardiopulmonary AG, 
Rastatt, Germany), and an arterial line filter (Leukogard-6, Pall, East Hills, NY). 
The standard priming of the CPB circuit consisted of 1500 mL of 4% gelofusin 
(B. Braun Melsungen AG, Melsungen, Germany), 200 mL of 20% mannitol 
(Viaflo; Baxter BV, Utrecht, The Netherlands), 100 mL of 20% human albumin 
(Albuman; Sanquin, Utrecht, The Netherlands), 50 mL of 8.4% NaHCO3, and 20 
mL of 10% calcium gluconate (B. Braun Melsungen AG). The total volume of 
the CPB priming amounted to 1870 mL clear fluid, containing 7500 IU heparin 
(Leo Pharmaceutical Products BV, Weesp, The Netherlands). The activated 
coagulation time was kept >400 seconds during bypass. Myocardial preserva-
tion was provided via the aortic root or selectively via the coronary ostia by a 
single dose of cardioplegic solution (800 ± 200 mL; St. Thomas’ hospital No.1) 
at 4°C. Depending on the patients’ body surface area, the ascending aorta was 
cannulated using either a 22- or 24-Fr cannula (Maquet Cardiopulmonary AG). 
A dual-stage venous cannula (32/40 or 36/51 Fr; Edwards Lifesciences BV, 
Breda, The Netherlands) was used for gravity drainage during coronary artery 
INTRAOPERATIVE EVENTS AND TISSUE OXIMETRY 
63 
bypass grafting and aortic valve surgery. In case mitral or tricuspid valve sur-
gery was involved, the venae cavae were cannulated separately using a DLP 
single-stage metal tip cannula (28 and 31 or 24 and 28 Fr; Medtronic, Inc., Min-
neapolis, MN). 
Target flow rates of ≥2.6 L/min/m2 body surface area were maintained through-
out normothermic (36.3°C) CPB. Pulsatile flow (radial artery pulse pressure ≥25 
mmHg) was used only during the period of cross-clamping with a frequency of 
70 beats per minute, a base flow of 28% (1.4 L/min), and a pulse width of 50% 
(0.42 seconds). Mean ABP was maintained at 80±10 mmHg by titration of phe-
nylephrine (0.4 mg/mL) via an infusion pump if necessary. The sweep gas and 
fraction of inspired oxygen settings for the oxygenator were titrated to maintain 
normocapnia (arterial partial carbon dioxide pressure - PaCO2 4.5 - 5.5 kPa) and 
normoxia (partial arterial oxygen pressure - PaO2 11.0 - 14.0 kPa). All patients 
received tranexamic acid (2 mg) during CPB. The transfusion trigger during 
CPB was set at a hematocrit level <25%. Pericardial blood was drained and 
washed with a cell saver device. 
During valve and aortic root procedures carbon dioxide flooding was routinely 
used. By maintaining in-line normocapnia, no episodes of high PaCO2 that could 
have potentially influenced the cerebral saturation occurred. 
Near-infrared spectroscopy 
Cerebral tissue oximetry is measured non-invasively as described by Murkin 
and Arango.14 In short, oxygen content in the frontal lobes is measured by near-
infrared light penetrating the skin, skull, and other protective tissues. Near-
infrared light (660-940 nm) is partly scattered by chromophores within the tis-
sue, absorbed by oxyhemoglobin or deoxyhemoglobin. The fiber optic sensors 
used in this study emit light at four different wavelengths to obtain greater preci-
sion for estimation of oxygen content. 
Data processing 
To be able to relate changes in cerebral saturation to occurring events, several 
hemodynamic parameters were recorded continuously during CPB: pump flow, 
ABP, as well as continuous in-line PaCO2 and PaO2, venous saturation, and 
electrolytes measurement via an optical fluorescence and reflectance-based 
system (CDI-500, Blood Parameter Monitoring System; Terumo, Japan). Pump 
flow was recorded by an ultrasonic flow monitor (Transonic Systems Europe 
BV, Maastricht, The Netherlands). All in-line measurements except for SctO2 
were collected using a data acquisition system (M-PAQ; Maastricht Instruments, 
Maastricht, The Netherlands). To combine all data, sample frequencies had to 
be equalized in all files. To achieve this, data were either averaged (decreasing 
the frequency of measuring), or the same data point was duplicated and added 
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after its original data point (increasing the frequency of measuring). Subse-
quently, data synchronization was performed. For further data analysis, sam-
ples of 5 minutes were selected. One time sample was selected prior to the 
event, and the other one during the event. 
Statistical analysis 
Data are shown as mean ± SD or median (interquartile range), depending on 
data distribution. A P-value of <.05 was considered statistically significant. 
For events occurring before or after CPB, only cerebral SctO2 and ABP were 
compared between samples prior and during the event. For placement and 
removal of the aortic cross-clamp, cerebral SctO2, mean ABP, pump flow, and 
blood parameters (PaCO2, PaO2, PvO2 and hematocrit) were compared. If one or 
more parameters differed significantly between the two samples, a possible 
cause of the difference in SctO2 could be determined. 
Statistical analysis was performed using the Statistical Package for Social Sci-
ences version 15.0 (SPSS inc., Chicago, IL). Distribution of data was tested 
using the Shapiro-Wilk test. The paired student’s t test or Wilcoxon signed-rank 
test was used to compare cerebral saturation measurement before and during 
events. 
Results 
Demographic and baseline data for the 52 enrolled patients are listed in Table 
1. Surgical- and perfusion-related data are presented in Table 2. 
During the entire intraoperative period, cerebral SctO2 showed comparable val-
ues for both left and right hemisphere. Left and right mean SctO2 values of 
71±4% and 70±4% were found prior to CPB, 66±4% and 65±4% during CPB, 
and 70±4% and 69±5% after CPB, respectively. Since the difference between 
the left and right hemisphere can be neglected, the influence of intraoperative 
events on SctO2 are depicted in Figure 1 using mean values. 
Onset of CPB, placement and removal of the aortic cross-clamp (difference in 
significance between hemispheres, P=.026 for the left and P=.048 for right hem-
isphere) resulted in a decrease in SctO2, whereas anesthetic induction (P<.001), 
placement of the sternal retractor (P<.001), and termination of CPB (P<.001) 
showed to be related to an increase in SctO2 (Figure 1). Furthermore, phe-
nylephrine infusion (P=.356), hemofiltration (P=.892) and removal of the sternal 
retractor (P=.692 for the left hemisphere, P=0.123 for the right hemisphere) did 
not result in a significant SctO2 change. Aortic cross-clamping showed to have a 
statistically significant impact on cerebral saturation as shown in Figure 1, which 
may in part be explained by differences in arterial and venous blood gas pa-
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rameters and hematocrit. During placement of the aortic cross-clamp, hemato-
crit decreased significantly (P<.001), as well as arterial (P=.007) and venous 
(P<.001) oxygen levels (Table 3). The changes in hematocrit, arterial, and ve-
nous PO2 did not occur during removal of the aortic cross-clamp. 
In all cases, the postoperative period was uneventful and no intraoperative cer-
ebral ischemic episode occurred. 
 
 
Table 1. Demographic and baseline data.  
gender (male/female) 38/14 
age (years) 68 (59.3-75.8) 
BMI (kg/m2) 26.0 (24.4-27.8) 
diabetes Mellitus (yes/no) 7/45 
peripheral vascular disease (yes/no) 4/48 
mean ABP pre CPB (mmHg) 102.1±11.3 
SctO2 mean pre CPB (%) 70 (66-71) 
mean Hct pre CPB (%) 41.0±3.9 
ABP, arterial blood pressure; BMI, body mass index; CPB, cardiopulmonary bypass; Hct, hemato-
crit; SctO2, cerebral tissue oxygen saturation. 
Parameters in italics are shown as median (interquartile range), and remaining parameters are 
shown as absolute numbers or mean ± SD. 
 
 
 
Table 2. Surgical and perfusion data.  
isolated CABG surgery 59.7% (n=31) 
isolated valve surgery 23.1% (n=12) 
CABG + valve surgery 13.5% (n=7) 
ascending aorta replacement 3.8% (n=2) 
CPB time (minutes) 80 (69-105) 
aortic cross clamp time (minutes) 55 (43-70) 
mean Hct (%) during CPB 28 (25-29) 
mean pump flow (L/min) 4.3±0.5 
mean ABP (mmHg) during CPB 75 (71-80) 
ABP, arterial blood pressure; CABG, coronary artery bypass grafting; Hct, hematocrit. 
Data for mean pump flow is presented as mean ± SD. Data for CPB time, aortic cross-clamp time, 
Hct and ABP are presented as median (interquartile range). 
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Table 3. Influence of aortic cross clamping on hemodynamic parameters. 
Aortic cross-
clamp on   
Prior to cross-
clamping During cross-clamping P-value 
Mean ABP (mmHg) 72.4 (63.4-80.3) 73.9 (63.5-79.2) 0.420 
PaCO2 (kPa) 5.5 (5.1-5.6) 5.4 (5.0-5.6) 0.792 
PaO2 (kPa) 14.9 (12.6-18.0) 13.0 (12.3-16.5) 0.007 
pvO2 (kPa) 5.9±1.0 5.3±0.6 <0.001 
Hct (%) 28.7 (26.5-31.6) 26.4 (24.6-29.0) <0.001 
CPB flow (L/min) 4.3 (3.8-4.7) 4.4 (4.0-4.7) 0.680 
Aortic cross-
clamp off   
Prior to cross-
clamp removal 
After cross-clamp 
Removal P-value 
Mean ABP (mmHg) 74.4 (68.7-80.7) 71.6 (67.2-77.7) 0.196 
PaCO2 (kPa) 5.5 (5.2-5.7) 5.5 (5.3-5.7) 0.017 
PaO2 (kPa) 14.0±2.9 14.4±2.7 0.255 
PvO2 (kPa) 5.1±0.5 5.1±0.6 0.535 
Hct (%) 27.4 (24.0-29.0) 27.5 (23.7-29.6) 0.761 
CPB flow (L/min) 4.1 (2.0-4.7) 3.7 (0.1-4.6) 0.093 
ABP, arterial blood pressure; CPB, cardiopulmonary bypass; Hct, hematocrit; paCO2, arterial carbon 
dioxide level; paO2, arterial oxygen level; pvO2, venous oxygen level. 
 
 
 
 
Figure 1. Influence of intraoperative events on mean cerebral SctO2. CPB, cardiopulmonary bypass; 
HF, hemofiltration; SctO2, cerebral oxygenation;  SR, sternal retractor; X-clamp, aortic cross clamp. 
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Discussion 
Intraoperative events showed to affect cerebral oximetry in patients undergoing 
cardiac surgery with CPB. Since previous studies suggest that a fall in cerebral 
saturation is related to adverse neurological outcome, routine measurement of 
cerebral saturation warrants early detection of brain ischemia during surgery.12-
14 
 
Our results showed subtle changes in SctO2 readings following several events 
that appeared statistically significant while absolute differences were relatively 
small and far from the suggested 20% decrease when intervention is required.14 
Presumably the events did not provoke any therapeutically relevant changes in 
cerebral tissue saturation in our study. One can speculate that maintaining 
normocapnia, normoxia, and a tight blood pressure control led to minimized 
fluctuations in cerebral saturation. Iatrogenic events i.e., placement of the aortic 
cross-clamp can still induce changes in cerebral saturation, which do not nec-
essarily require intervention. On the other hand, the extent of cerebral desatura-
tion requiring an intervention may vary between different sensors, implying that 
no fixed thresholds have been set.15 Nonetheless, cerebral oximetry enables 
clinicians to observe slight changes in cerebral saturation, which may help to 
prevent further desaturations. 
 
Induction of general anesthesia resulted in a steep increase in cerebral SctO2, 
which may be explained by pre-oxygenation with a high-inspired fraction of oxy-
gen and unchanged cardiac output.16 Conversely, a significant decrease in 
mean SctO2 occurred with onset of CPB, which can presumably be explained by 
acute hemodilution, as the hematocrit dropped from approximately 41% to 28% 
(Tables 1 and 2). These findings are in line with the study of Han et al.17 who 
showed that acute normovolemic hemodilution is associated with a fall in cere-
bral saturation. Rapid initiation of CPB mostly provoked a drop in SctO2 as re-
sultant of assanguinous priming solution passage through the cerebral vascula-
ture with inadequate oxygen delivery to the brain. 
 
Placement of the sternal retractor is another factor influencing the cerebral satu-
ration as measured by near-infrared spectroscopy. One could hypothesize that 
the change in cerebral saturation is caused by strong pain signals transported 
via the spinal cord during the event. In theory, this causes an immediate eleva-
tion in ABP. However, this effect is not observed in this study, which is potential-
ly due to adequate anesthesia and analgesia. 
Another theory is that opening the thoracic cavity influenced intrathoracic pres-
sures and venous return, resulting in an increased cerebral saturation. On the 
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other hand, removal of the sternal retractor did not show a significant difference 
in SctO2. A plausible explanation for this observation is that the hypothesized 
pain signals were not activated or not in an extent large enough to cause a sig-
nificant difference. Also, instead of generating pressure on the site of the ster-
num and surrounding tissue (as in placement of the sternal retractor), the oppo-
site effect could have taken place i.e., relaxation. 
 
Another event that showed to affect cerebral saturation is aortic-cross clamping, 
which may in part be explained by differences in arterial and venous blood gas 
parameters and hematocrit (Table 3). Placement of the aortic cross-clamp re-
sulted in sudden excessive withdrawal of blood volume from patient to the 
heart-lung machine by lowering the CPB flow. This resulted in loss of cardiac 
output and a drop in ABP with concomitant negative consequences on oxygen 
delivery to the brain, as reflected by significantly lowered values of PO2 in both 
arterial and venous blood. CPB flow was not significantly different between 
samples of placement and removal of the cross-clamp, most likely because the 
duration of lowered flow was too short and the heart-lung machine was at opti-
mal flow before and after both these events. In contrast, the decrease in arterial 
and venous PO2 did not appear while removing the cross-clamp as by routine 
during removal of the aortic cross-clamp the CPB flow and ABP are not actively 
lowered. 
Vasoconstriction using phenylephrine infusion did not appear to affect cerebral 
saturation, which is in contrast with the results of a previous study by Moerman 
et al.18 However, Brassard et al.19 recently showed that the negative effect 
might only be present in diabetic patients. 
 
Finally, a study limitation is the lack of an intervention-guided design. Physiolog-
ic parameters are kept within a certain range, preventing major fluctuations in 
cerebral tissue saturation during the intraoperative period. Furthermore, data 
synchronization involving the equalization of the sample frequency led to data 
(pump flow and ABP) to be leveled out and small fluctuations to be diminished 
compared to the raw data. 
 
In conclusion, cerebral tissue oximetry by near-infrared spectroscopy effectively 
identifies subtle changes in cerebral saturation related to surgical events or 
vulnerable periods during cardiac surgery. Future studies in larger cohorts are 
required to identify therapeutically relevant changes in cerebral saturation as 
measured by cerebral oximetry.  
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Abstract 
Femoral access in extracorporeal life support (ECLS) has been associated with 
regional variations in arterial oxygen saturation, potentially predisposing the 
patient to ischemic tissue damage. Current monitoring techniques, however, are 
limited to intermittent bedside evaluation of capillary refill among other factors. 
The aim of this study was to assess whether cerebral and limb regional tissue 
oxygen saturation (rSO2) values reflect changes in various patient-related pa-
rameters during venoarterial ECLS (VA-ECLS). 
This retrospective observational study included adults assisted by femorofemo-
ral VA-ECLS. Bifrontal cerebral and bilateral limb tissue oximetry was per-
formed for the entire duration of support. Hemodynamic data were analyzed 
parallel to cerebral and limb rSO2. 
A total of 23 patients were included with a median ECLS duration of 5 [1-20] 
days. Cardiac arrhythmias were observed in 12 patients, which was associated 
with a decreased mean rSO2 from 61±11% to 51±10% during atrial fibrillation 
and 67±9% to 58±10 during ventricular fibrillation (P<0.001 for both). A presum-
ably sudden increase in cardiac output due to myocardial recovery (n=8) result-
ed in a significant decrease in mean cerebral rSO2 from 73±7% to 54±6% and 
from 69±9% to 53±8% for the left and right cerebral hemisphere, respectively 
(P=0.012 for both hemispheres). Also, right radial artery partial gas pressure for 
oxygen decreased from 15.6±2.8 to 8.3±1.9 kPa (P=0.028). No differences 
were found in cerebral desaturation episodes between patients with and without 
neurologic complications. In six patients, limb rSO2 increased from on average 
29.3±2.7 to 64.0±5.1 following insertion of a distal cannula in the femoral artery 
(P=0.027). Likewise, restoration of flow in a clotted distal cannula was neces-
sary in four cases and resulted in increased limb rSO2 from 31.3±0.8 to 
79.5±9.0; P=0.068. 
Non-invasive tissue oximetry adequately reflects events influencing cerebral 
and limb perfusion and can aid in monitoring tissue perfusion in patients assist-
ed by ECLS. 
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Introduction 
Despite the increasing experience and continuously improving technology ap-
plied in extracorporeal life support (ECLS), femoral access is still associated 
with regional variations in arterial saturation driven by an impaired oxygen de-
livery.1 Specifically, femoral artery cannulation may compromise perfusion of the 
lower limbs, causing limb ischemia and concomitant tissue damage.2,3 Besides 
impaired limb perfusion, veno-arterial ECLS (VA-ECLS) is linked with the deliv-
ery of hypoxic blood to the brain (i.e., differential hypoxia or two-circulation syn-
drome), resulting in an increased risk of brain damage.4 Although maintaining 
adequate tissue oxygenation is vital in critically ill patients, current monitoring 
techniques are often limited to bedside observation of capillary refill, limb tem-
perature, and limb color. Continuous non-invasive tissue oximetry could be of 
added value to monitor regional tissue oxygen saturation (rSO2) in patients 
supported by ECLS. This monitoring method is based on the Beer-Lambert law 
and uses near-infrared spectroscopy (NIRS) to assess local tissue oxygena-
tion.5 Tissue oximetry readings are proposed to reflect hemodynamic parame-
ters in real-time, serving as a potential early marker for distal limb and cerebral 
ischemia.5-7 The literature describing the application of this monitoring technique 
in patients supported by VA-ECLS, however, remains scarce.8-10 
 
The aim of this study was to assess the efficacy of cerebral and limb tissue 
oximetry during VA-ECLS. 
Materials and Methods 
Patients 
In this retrospective study, data from adult patients assisted by peripheral fem-
oro-femoral VA-ECLS were consulted. Institutional approval was granted based 
on a retrospective quality analysis of our patient database (trial number 14-4-
194). Due to the retrospective nature of the study, informed consent was 
waived. 
 
Patients were fully sedated and on mechanical ventilation. Support was provid-
ed by either a Permanent Life Support system (Maquet Cardiopulmonary AG, 
Hirrlingen, Germany) or a CardioHelp-mounted HLS Advanced 7.0 module 
(Maquet Cardiopulmonary), both Bioline-coated. Extracorporeal cardiopulmo-
nary resuscitation patients were actively cooled to a rectal temperature of 33ºC 
for 24 hours and thereafter gradually rewarmed to 37°C using a heater-cooler 
unit (HCU 30, Maquet Cardiopulmonary). Arterial cannulation was performed 
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using a 19Fr. or 21Fr. HLS cannula (Maquet Cardiopulmonary), whereas ve-
nous cannulation was performed using a 26Fr. or 29Fr. multi-stage HLS cannu-
la (Maquet Cardiopulmonary). An additional 8Fr. or 10Fr. cannula (Super Arrow-
flex percutaneous sheath introducer set, Teleflex Medical Europe Ltd, West-
meath, Ireland) was used to provide distal limb perfusion via antegrade cannu-
lation of the femoral artery if necessary. Heparinization was monitored by acti-
vated partial thromboplastin time (targeted between 50 and 70 seconds) and at 
a hematocrit value less than 25% patients received transfusion of packed red 
blood cells (PRBCs). 
Data collection 
Bi-frontal cerebral and bilateral limb rSO2 were routinely monitored using non-
invasive tissue oximetry using NIRS (INVOS 5100C Cerebral/Somatic Oxime-
ter, Medtronic, Minneapolis, MN, USA). Immediately upon initiation of VA-ECLS, 
patients’ forehead (left and right side) as well as the medial site of the musculus 
gastrocnemius (of both limbs) were fitted with a disposable self-adhesive sen-
sor. All sensors were replaced once every seven days during the entire period 
of ECLS. 
 
Data concerning systolic, diastolic and mean radial artery blood pressure, pulse 
pressure, cardiac rhythm, pulse oximetry, limb temperature, blood loss and 
number of transfused PRBCs were retrieved from a critical care and anesthesia 
data system (Philips ICIP Intellispace version F.00.01, Philips, Eindhoven, the 
Netherlands). Arterial blood gas analyses were executed using blood samples 
drawn from the right radial artery during the full period of intensive care unit stay 
according to hospital protocol. Pulse oximetry was performed at the left index 
finger. All data acquisition and analyses were performed anonymously and in 
accordance with the Dutch law for approving medical research. 
Data processing 
Raw data files retrieved from the clinical oximeter contain one data point every 
six seconds, i.e. ten data points per minute. The output files were exported to 
Microsoft Excel (Microsoft Office 2010) for further analysis. 
 
To assess the effect of cardiac rhythm (sinus rhythm, atrial fibrillation (AF), and 
ventricular fibrillation (VF)) on cerebral rSO2, data were analyzed as follows: 
first, all cerebral rSO2 data points per patient were clustered in successive 
groups of 300 data points (30 minutes). For every group, a mean rSO2 value 
was calculated. A relative difference of 5% between two subsequent data points 
was marked as an event. Second, cardiac rhythm and rSO2 data were aligned. 
In case of an event identified in the cerebral rSO2 data, the cardiac rhythm was 
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consulted to see if any arrhythmias occurred. In case of a cardiac arrhythmia, 
the lowest mean cerebral rSO2 value was derived for the duration of the particu-
lar arrhythmia. Also a mean cerebral rSO2 was derived from a 300 data point 
sample during normal sinus rhythm, resulting in a rhythm-specific mean cere-
bral rSO2 per patient. When a difference of ≥5% was found between the left and 
right cerebral hemisphere rSO2, values of both hemispheres were used for data 
presentation. In case of no difference between the left and right cerebral hemi-
sphere, rSO2 data were presented as one mean value for both hemispheres. 
 
The effect of distal limb perfusion on limb tissue oxygenation was determined by 
comparison of mean rSO2 values before (pre-event) and after (event) placement 
of a distal cannula in the femoral artery. Mean rSO2 values were determined by 
averaging 300 data points before and after placement of the distal cannula. The 
latter sample was selected immediately following limb rSO2 stabilisation. For 
comparison of tissue oxygenation values prior to (pre-event) and following 
(event) distal cannula clot removal, mean rSO2 values were calculated in a simi-
lar fashion using 300 data points per sample. 
 
To investigate the difference in cerebral desaturation between patients who did 
and did not suffer from neurologic complications, a mean cerebral rSO2 was 
calculated for 30-minute intervals in both cerebral hemispheres for the entire 
duration of ECLS. A desaturation episode was defined as a mean unilateral 
cerebral rSO2 below 50% over a period of 30 minutes. Consecutively, the sum 
of desaturation episodes was compared between patients with and without neu-
rologic complications. 
Statistical analysis 
Numerical variables are depicted either in mean±standard deviation or as medi-
an [interquartile range] depending on data distribution. Comparison of rSO2 
values between the different cardiac rhythms, pre-event samples and event 
samples was performed using the related samples Wilcoxon signed-rank test. A 
P-value <0.05 was considered statistically significant. All analyses were per-
formed using the Statistical Package for Social Sciences version 22.0 (SPSS 
Inc., Chicago, IL, USA). 
Results 
Twenty-three adult patients assisted by femorofemoral VA-ECLS were included 
in this retrospective study. Mean age was 59±13 years and a total of 18 females 
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and 5 males were included. The median duration of ECLS support was 5 [1-20] 
days with a mean full ECLS pump flow of 4.5±0.9 L/min. 
 
Of the 23 patients, 16 were assisted by femorofemoral VA-ECLS upon resusci-
tation following an out-of-hospital cardiac arrest. Assistance by VA-ECLS was 
provided in three postcardiotomy cases. In the remaining four cases, life sup-
port was initiated following detection of, for example, pulmonary embolism. Dis-
tal cannulation was provided in six cases. Nine patients developed AF, whereas 
in three patients VF was observed. Development of abnormal cardiac rhythm 
was immediately followed by a decrease in mean rSO2 from 61±11% to 51±10% 
during AF and from 67±9% to 58±10 during VF (P<0.001 for both). No signifi-
cant differences were found between the left and right cerebral hemisphere 
rSO2 (P=0.750). An example of a decrease in bifrontal cerebral rSO2 during AF 
is shown in Figure 1. 
 
In case of a presumably increased cardiac output resulting from myocardial re-
covery during full ECLS (n=8, mean flow 4.45±0.6 L/min), a decrease in cerebral 
rSO2 was observed from 73% to 54% and from 69% to 53% for the left and right 
cerebral hemisphere, respectively (P=0.012 for both), as depicted in Table 1. 
 
 
Table 1. Cerebral tissue oxygen saturation values in case of an im promptu increase in cardiac 
output while on extracorporeal life support.a,b  
  before increased CO during increased CO P-value 
cerebral rSO2 (%) left 73±7 54±6 0.012 
 right 69±9 53±8 0.012 
arterial oxygen saturation (%)  99±1 85±8 0.028 
arterial PO2 (kPa)  15.6±2.8 8.3±1.9 0.012 
pulse oximetry (%)  99±1 97±5 0.075 
mean pressure (mmHg)  70±7 80±15 0.012 
Abbreviations: CO, cardiac output; Left, left cerebral hemisphere; right, right cerebral hemisphere; 
rSO2, regional tissue oxygen saturation; PO2, partial gas pressure for oxygen. 
an=8 
bValues presented as mean±standard deviation. 
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Figure 1. Example of a decrease in bi-frontal cerebral oxygen saturation during consecutive periods 
of atrial fibrillation and sinus rhythm. AF, atrial fibrillation; ECLS, extracorporeal life support; rSO2, 
regional tissue oxygen saturation; rSO2-left, regional tissue oxygen saturation left cerebral hemi-
sphere, rSO2-right, regional tissue oxygen saturation right hemisphere; SR, sinus rhythm. 
 
 
Concomitant partial gas pressure for oxygen (PO2) decreased from 15.6±2.8 to 
8.3±1.9 kPa (P=0.012). Arterial saturation values derived from blood gas anal-
yses showed a significant decrease from 99±1% to 85±8% (P=0.028), while 
pulse oximetry decreased from 99%±1% to 97%±5% (P=0.075). In Figure 2 the 
change in cerebral rSO2 values is shown in case of a sudden increased cardiac 
output during ECLS without concomitant adjustment of ventilator settings. After 
approximately one hour, the ventilatory settings were adjusted, resulting in 
gradual rSO2 normalization. 
 
In the current study, a total of 11 patients (47.8%) died while on VA-ECLS due 
to neurologic complications, deep cardiogenic shock, sepsis, pneumonia, lung 
edema, myocarditis, multi-organ failure, or intestinal ischemic damage. The total 
number of cerebral desaturation episodes did not differ between patients who 
did or did not survive until ECLS weaning (19 versus 12 episodes, respectively, 
p=0.695). Five patients (21.7%) developed neurological complications while on 
VA-ECLS, which included intracerebral hematoma or extensive ischemic dam-
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age diagnosed with computed tomography imaging, critical illness neuropathy, 
and absence of the direct light pupil reflex. 
 
 
Figure 2. Example of a decrease in bi-frontal cerebral tissue oxygen saturation with an im promptu 
increase in cardiac output during full extracorporeal life support. rSO2, regional tissue oxygen satu-
ration; rSO2-left, regional tissue oxygen saturation left cerebral hemisphere; rSO2-right, regional 
tissue oxygen saturation right hemisphere. 
 
 
Three out of five patients died due to the consequences of neurologic complica-
tions while in the remaining two cases one patient died due to lung edema and 
another survived weaning from ECLS. In the five patients with neurological 
complications, a median of 13 cerebral desaturation episodes (sum of left and 
right hemisphere) were observed, while in patients without neurological compli-
cations a median of 14.5 desaturation episodes were found (P=1.000). In pa-
tients with neurologic complications, the median number of desaturation epi-
sodes per day on VA-ECLS was 6.5, while the median number of desaturation 
episodes in patients without neurologic complications amounted to 3.0 
(P=0.914). 
 
Regarding tissue oximetry performed at the distal limb, rSO2 values of the non-
cannulated limb amounted to 65±6% (mean value) and remained constant 
throughout the entire duration of ECLS. In six patients (26%), additional cannu-
lation of the femoral artery proved necessary to ensure adequate blood flow to 
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the limb. Following insertion of a distal cannula in the femoral artery, limb rSO2 
increased from 29.3±2.7 to 64.0±5.1 (P=0.027) as shown in Table 2. An exam-
ple of a limb rSO2 pattern is provided in Figure 3. 
 
 
Figure 3. Example of an increase in limb tissue oxygen saturation after restoring blood flow by 
inserting a distal cannula in the femoral artery. rSO2, regional tissue oxygen saturation; rSO2-left, 
regional tissue oxygen saturation left limb; rSO2-right, regional tissue oxygen saturation right limb. 
 
Complications with distal cannulation of the femoral artery were observed in 
four patients (17.4%) following insertion of the distal cannula, including bleeding 
and thrombus formation. Due to clotting of the distal cannula, which was the 
most common complication associated with distal cannulation, limb rSO2 values 
decreased (Table 2). Blood flow in the distal cannula restored following clot 
removal by aspiration using a syringe, as reflected by the increase in limb rSO2 
(from 31.3±0.8 to 79.5±9.0, P=0.068). Furthermore, a decrease in temperature 
was noted in the cannulated limb. Notably, changes in limb temperature be-
came evident after a clear time delay as compared to changes observed in limb 
rSO2 (Figure 4). 
All patients received PRBC transfusion or infusion of fluids (e.g., Ringer lactate 
and/or Gelofusin 4%). Transfusion of 38 PRBC units (275 mL per unit) for 13 
anemic patients did not result in a significant change in cerebral rSO2. In con-
trast, rSO2 levels increased >10% after infusion of >1000 mL of fluids within one 
hour (P<0.001, Table 3). 
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Table 2: Restoring limb tissue oxygen saturation by inserting a distal cannula in the femoral artery 
(n=6) and clotting of the distal cannula (n=4).a 
patient # 
limb rSO2 prior 
cannulation (%) 
limb rSO2 post 
cannulation (%) 
limb rSO2 clotted 
cannula (%) 
limb rSO2 after clot 
removal (%) 
4 24±2 63±3 32±3 66±4 
5 28±1 60±3 31±2 89±5 
10 32±2 70±4 - - 
11 30±1 59±2 30±1 86±1 
16 31±2 72±2 - - 
28 31±3 60±5 32±2 77±3 
Abbreviation: rSO2, regional tissue oxygen saturation. 
aData presented as mean±standard deviation. rSO2, regional tissue oxygen saturation. Difference 
between limb rSO2 prior to distal cannulation and limb rSO2 post cannulation (n=6): P=0.027. Differ-
ence between limb rSO2 in case of a clotted distal cannula and limb rSO2 after clot removal (n=4): 
P=0.068. 
 
 
Table 3: Effect of transfusion of PRBC and fluid infusion on mean bi-frontal cerebral tissue oxygen 
saturation.a 
 pre transfusion post transfusion P-value 
PRBC (n=13) 60±13 60±13 0.686 
infusion <1000 mL fluids (n=11) 62±13 63±13 0.102 
infusion >1000 mL fluids (n=10) 60±15 70±10 <0.001 
Abbreviation: PRBC, packed red blood cells. 
aFluid infusion concerns Ringer lactate or Gelofusin. Data are presented as mean±standard devia-
tion. 
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Figure 4. Example of a decrease in limb tissue oximetry values in case of a clotted distal cannula 
positioned in the left femoral artery. rSO2, regional tissue oxygen saturation; rSO2-left, regional 
tissue oxygen saturation left limb; rSO2-right, regional tissue oxygen saturation right limb. 
Discussion 
This observational study focused on the application of continuous non-invasive 
tissue oximetry in patients supported by peripheral VA-ECLS. Our results 
showed cerebral and limb tissue oximetry readings adequately reflect both he-
modynamic instability and compromised limb perfusion. 
 
Fluctuations in mean arterial pressure, pulse oximetry values, arterial pO2, and 
oxygen saturation reflect variations in cardiac output and are often the first signs 
of hemodynamic instability in patients on ECLS.11,12 Maintaining adequate car-
diac output is important to prevent ischemic episodes, which can potentially 
result in complications such as congestive heart failure, neurocognitive impair-
ment, renal dysfunction, infections, and irreversible multi-organ failure.12-16 A 
decreased cardiac performance resulting in lowered cardiac output has been 
associated with decreased cerebral and microvascular perfusion, which is re-
flected by lowered rSO2 values.17 As a compensatory mechanism, brain oxygen 
extraction has shown to increase in case of reduced cardiac performance with 
concomitant lowered rSO2.18,19 A possible cause of reduced cardiac perfor-
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mance can be an abnormal cardiac rhythm such as AF.20 In the current study, 
AF was noted in nine patients, whereas in three patients VF was observed. Our 
results confirm that cerebral tissue oxygenation is lowered during episodes of 
AF and VF. These results indicate a high positive predictive value, suggesting 
that tissue oximetry can aid in timely recognition of hemodynamic instability in 
VA-ECLS patients, contributing to early detection of impaired cerebral perfu-
sion. 
 
Femoro-femoral cannulation is a common access technique for VA-ECLS pro-
cedures.21 A consequence of this cannulation method specifically is the devel-
opment of so-called ‘’differential hypoxia’’ or ‘’isolated hypoxia’’ in the upper 
body.22,23 The phenomenon of differential hypoxia can be explained as follows: 
during full ECLS, the right heart is fully unloaded, the resultant lung circulation is 
minimal, and mechanical lung ventilation is reduced accordingly. If under these 
circumstances an increase in cardiac output occurs due to, for example, cardiac 
recovery, blood ejected by the left ventricle remains hypoxic as a result of the 
reduced ventilatory settings. Blood pumped by the ECLS system via the arterial 
femoral cannula retrograde into the aorta is fully saturated with oxygen and 
encounters the desaturated blood ejected by the left ventricle. When both blood 
flows meet in the near descending aorta, hypoxic blood will flow through the 
cervical arteries, whereas fully saturated blood will be diverted to, for example, 
the left subclavian artery. Subsequently, the brain suffers from an inadequate 
oxygen delivery, reflected by lowered cerebral rSO2.9,22,23 One may assume that 
the phenomenon of differential hypoxia occurred in eight of our patients in 
whom a presumably sudden increase in cardiac output occurred without timely 
adjustment of mechanical lung ventilation settings (Table 3). In line with this 
hypothesis, a significant decrease in cerebral rSO2 and right radial artery pO2 
values were found, while pulse oximetry values (measured at the left index fin-
ger) remained unaffected. However, due to the retrospective nature of this 
study, this could not be confirmed by echocardiographic imaging. Nonetheless, 
these results suggest that cerebral oximetry enables early identification of dif-
ferential hypoxia in patients on ECLS. When cardiac recovery is confirmed and 
a patient becomes candidate for weaning from ECLS, immediate adjustment of 
mechanical lung ventilation is warranted to prevent differential hypoxia and min-
imize the risk of neurological complications resulting from cerebral desaturation. 
The current results indicate that increased lung perfusion without accompanying 
adapting ventilator settings might be detected by careful (multimodal) monitor-
ing with tissue oximetry. After multidisciplinary discussion, additional treatments 
might be planned such as fluid unloading or inotropic support to further improve 
myocardial and lung recovery. In addition, an observed decrease in rSO2 may 
indicate an increased oxygen extraction and thereby a relative decrease in cer-
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ebral perfusion, increasing the risk of poor neurologic outcome.24 Future studies 
should therefore focus on neurological outcome of patients weaning from VA-
ECLS. 
 
The number of desaturation episodes did not differ between patients with or 
without a diagnosis of neurologic complications. Although this finding might 
seem contradictive, one must take into account that the evidence for a causal 
relationship between cerebral oximetry derived measurement values and neuro-
logic outcome is still lacking.25 Obviously, the development of neurologic com-
plications is a very complex process and not in all cases reflected by clear re-
duction in rSO2 values. One explanation can be found in the fact that the cere-
bral autoregulatory activity is not considered when measuring regional rSO2. In 
the case of cerebral hyperperfusion, for example, cerebral rSO2 values may 
appear normal while the intrinsic neuroprotective mechanism of cerebral auto-
regulation is severely affected, predisposing the patient to an increased risk of 
neurologic complications. 
Moreover, patients on VA-ECLS are subject to complex physiologic interactions 
including a whole-body inflammatory response, translating into high morbidity 
and mortality rates. This, in combination with the limitations inherent to the 
measurement technique of tissue oximetry using NIRS may be part of the ex-
planation why a clear link between rSO2 and clinical outcomes could not be 
established. Nevertheless, the results clearly indicate that cerebral tissue oxi-
metry adequately reflects episodes of hemodynamic instability which is also a 
known factor contributing to postoperative morbidity and mortality. 
 
A possible adverse effect of femoral cannulation is inadequate perfusion of the 
cannulated limb caused by occlusion of the femoral artery cannula. The limited 
antegrade flow in the distal artery is exacerbated due to delayed use of a distal 
artery perfusion cannula.26 This may result in lower extremity ischemia, fasci-
otomy, or even limb amputation.27 In the current practice, capillary refill as well 
as temperature and color of the limb are systematically evaluated for detection 
of ischemia. Changes in these parameters, however, are subjective with a pos-
sible risk of delayed intervention in the case of circulatory compromise. The 
current study showed that limb rSO2 adequately reflected distal cannula clotting 
as well as restoration of blood flow (Figure 4). Hence, tissue oximetry aids in 
early recognition of compromised limb perfusion and contributes to timely inter-
vention by identifying the need for an additional distal cannula. This exemplifica-
tion underlines the clinical benefit of using noninvasive tissue oximetry in pa-
tients assisted by VA-ECLS. 
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Packed red blood cell transfusion increases the oxygen content and improves 
tissue oxygen saturation.28 Based on the fact that tissue oximetry enables rapid 
evaluation of tissue oxygenation, one can expect that transfusion of PRBCs 
result in an immediate increase in rSO2 values.28-30 However, our data did not 
support this hypothesis. A possible explanation can be found in the critical he-
modynamic conditions of our patients who received PRBC transfusion, since 
twelve patients suffered from severe bleeding. In this case, transfusion of 
RPBCs may have compensated for the decrease in cardiac output due to blood 
loss, resulting in a restored cardiac output and thereby preserving bi-frontal 
cerebral rSO2 (Table 3). Another explanation for the lack of an increase in cere-
bral rSO2 following PBRC transfusion can be found in the use of vasopressors, 
considering a study by Brassard et al. showing a decreased cerebral rSO2 due 
to phenylephrine administration.30 Nine of our patients received a relatively high 
dose of norepinephrine (1.94 μg/kg/min at maximum) that could have led to a 
decrease in cerebral rSO2, masking the effect of PRBC transfusion on rSO2 
readings. The study of Brassard et al., in contrast, included young (26±7 years) 
and healthy subjects. Our patients had co-morbidities including Q-fever, liver 
ischemia, pulmonary emboli, and an adenine nucleotide transporter deficiency. 
In addition, three patients in whom rSO2 was unaffected by PRBC transfusion 
were diagnosed with either endocarditis or pericarditis. The limited effect of 
PRBC transfusion in infective patients has been described by Creteur et al. who 
attributed this effect to diminished microcirculation.31 Therefore, it remains de-
batable whether tissue oximetry is appropriate for assessing the effects of 
PRBC transfusion on tissue oxygenation in patients assisted by VA-ECLS. On 
the other hand, when fluid suppletion exceeded 1000 mL/h, cerebral rSO2 did 
increase, which was most likely due to a concomitant increase in cardiac output 
together with timely adjustment of the ventilator settings. 
 
One study limitation that needs to be considered when interpreting the current 
study results is the relatively small sample size. Despite this fact, the authors 
were able to show alterations in cerebral and limb rSO2 as a reflection of 
changes in several patient-related factors including hemodynamic stability and 
limb perfusion. In addition, due to the retrospective design of the study, it was 
not possible to include data regarding blood flow in the distal perfusion cannu-
lae and hemoglobin. 
 
In conclusion, non-invasive tissue oximetry is a viable monitoring method for 
assessing cerebral and distal limb tissue perfusion is patients assisted by ECLS 
and should therefore be part of routine monitoring. 
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Abstract 
Objective: To evaluate parameters of the vascular occlusion test (VOT) before, 
during, and after pulsatile cardiopulmonary bypass (CPB). 
Design: Prospective, observational study. 
Setting: Single-center university hospital. 
Participants: Adult patients undergoing elective cardiac surgery with pulsatile 
CPB. 
Interventions: An oximeter sensor and adult-sized pneumatic tourniquet were 
positioned at the right forearm. A VOT with a predefined ischemic time of 3 
minutes was performed before, during, and after CPB. Changes in tissue oxy-
gen saturation were recorded. 
Measurements and main Results: Thirty-four patients who underwent cardiac 
surgery were enrolled in the study. The lowest tissue oxygen saturation meas-
ured during the ischemic challenge differed between all 3 stages of surgery, 
with median values of 62.9% before, 57.5% during, and 59.3% afer perfusion 
(P<0.05). Both occlusion (P<0.001) and reperfusion (P<0.05) slopes were 
steeper after bypass compared to before initiating bypass, whereas the reperfu-
sion time remained constant between the different time points. 
Conclusions: The microcirculatory function as demonstrated by changes in VOT 
parameters was enhanced during and after normothermic pulsatile CPB. Clini-
cal relevance, however, needs to be further explored.  
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Introduction 
Microvascular alterations after cardiac surgery with cardiopulmonary bypass 
(CPB) and impaired tissue oxygen saturation (StO2) have been associated with 
adverse patient outcome.1-5 Shear stress and contact with foreign surfaces 
cause transient microcirculatory dysfunction by activation of inflammatory and 
hemostatic systems.6,7 Tissue trauma and anesthesia also influence microcircu-
lation,8,9 which may be aggravated by severe total blood volume shifts during 
surgery. Although the microcirculation is shown to be adversely affected by 
surgery with CPB10, monitoring of the microcirculatory function is still not part of 
routine practice. Continuous real-time monitoring may aid in early detection of 
tissue malperfusion. Measuring StO2 using near-infrared spectroscopy with a 
reproducible ischemia-reperfusion challenge (ie, vascular occlusion test [VOT]) 
has shown to be a non-invasive method suitable for assessment of microcircu-
lation.9,11,12 The VOT is an application in functional hemodynamic monitoring in 
which the response to an artificially induced ischemic stress can be followed. 
This method highly correlates to strain gauge plethysmography, which has been 
used extensively for measuring vascular function.13,14 Furthermore, to the best 
of the authors’ knowledge, only a few reports combining near-infrared spectros-
copy and VOT in patients undergoing nonpulsatile CPB have been published to 
date.9,15-17 On the other hand, pulsatile CPB has been shown to preserve micro-
vascular function associated with improved patient outcome.2,18,19 Therefore, the 
aim of this study was to assess dynamic microcirculatory function using the 
VOT during cardiac surgery in patients undergoing pulsatile CPB. 
Methods 
Patients 
After approval by the local ethical committee (reference number 1-4-087), a 
prospective explorative study was conducted. A total of 34 adult patients were 
included after they provided written informed consent. The inclusion criterion 
was elective cardiac surgery with CPB. Exclusion criteria were a body mass 
index >30 kg/m2, chronic advanced peripheral vascular disorders (including 
subclavian artery stenosis, Diabetes Mellitus, Raynaud's disease, and Ray-
naud’s syndrome), a state of cardiogenic shock (emergency procedures), or 
patients diagnosed with New York Heart Association class IV. 
Anesthesia 
General anesthesia was induced using 0.5 to 1.0 µg/kg of sufentanil (Hameln 
Pharmaceuticals, Hameln, Germany), 0.6 to 1.0 mg/kg rocuronium bromide 
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(Fresenius Kabi Nederland, Zeist, The Netherlands), and 0.1 mg/kg of midazo-
lam (Roche Nederland BV, Woerden, The Netherlands). After endotracheal 
intubation, patients were ventilated with volume-controlled ventilation with tidal 
volumes of 7 to 8 mL/kg and a positive end-expiratory pressure of 5 cmH2O. 
The respiratory rate was adjusted to maintain normocapnia. Oxygen saturation 
measured from a pulse oximeter was maintained between 95 and 100%. Anes-
thesia was maintained with 0.5 to 0.8 minimum alveolar concentration of 
sevoflurane (AbbVie BV, Hoofddorp, The Netherlands) and continuous intrave-
nous administration or boluses of sufentanil. During bypass, sevoflurane was 
replaced by infusion of 4 to 6 mg/kg/h of propofol (Fresenius Kabi), which was 
continued until patient arrival at the intensive care unit. Inotropes and vasocon-
strictors were administrered according to the hemodynamic status of the indi-
vidual patient. 
Patients were kept normothermic throughout the entire cardiac surgical proce-
dure using a warming blanket (Bair Hugger 505; 3M Deutschland GmbH, 
Neuss, Germany). 
Cardiopulmonary bypass 
Target flow rates of ≥2.6 L/min/m2 body surface area were maintained through-
out normothermic (36.3°C) CPB. Pulsatile flow (radial artery pulse pressure ≥25 
mmHg) was used only during the period of cross-clamping, with a frequency of 
70 bpm, a base flow of 30%, and a pulse width of 50%. Mean arterial blood 
pressure (ABP) was maintained between 70 and 95 mmHg by titration of 0.4 
mg/mL phenylephrine (pharmacy of Radboud UMC, Nijmegen, The Nether-
lands), if necessary. The sweep gas and fraction of inspired oxygen settings for 
the oxygenator were titrated to maintain normocapnia (partial pressure of car-
bon dioxide, 4.5 - 5.5 kPa) and normoxia (partial pressure of oxygen, 11.0 - 
14.0 kPa). All patients received 2 mg of tranexamic acid (Pfizer BV, Capelle a/d 
IJssel, The Netherlands) during CPB. The transfusion trigger during CPB was 
set at a hematocrit level <25%. 
Vascular occlusion test 
The Fore-Sight tissue oximeter sensor (CAS Medical Systems Inc., Branford, 
CT) was used for assessing local tissue oxygen saturation, providing absolute 
StO2 data, which was measured continuously. This device utilizes laser light of 4 
different wavelengths (690, 780, 805, and 850 nm) to estimate the oxygen con-
tent.20 A medium-sized sensor (emitter/diode spacing 15 and 40 mm for the first 
and second light path, respectively) was placed at the internal surface of the 
proximal third of the right forearm, and an adult-sized pneumatic tourniquet was 
positioned at the right brachial artery. After StO2 signal stabilization (<2% varia-
tion in 30 seconds), the cuff was inflated until pressure reached 30 mmHg 
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above the patient’s systolic blood pressure. Inflation took 3 to 4 seconds after 
which the cuff was kept inflated for 3 minutes. Then the cuff was deflated rapidly 
(within 0.5 seconds), and the response in StO2 was monitored. The VOT was 
performed at the following 3 predefined time points: after induction of anesthe-
sia and prior to initiation of bypass (T0), after initiation of bypass and aortic 
cross-clamping (T1), and after termination of bypass (T2). 
 
Tissue oximetry readings were recorded and stored locally using the Fore-Sight 
oximeter before the data were transferred and saved in Microsoft Office Excel 
(Microsoft, Redmond, WA) format. The following VOT parameters were calcu-
lated: StO2 before occlusion (%), occlusion slope (StO2%/min), lowest StO2 in 
VOT (%), reperfusion slope (StO2%/min), reperfusion time (min), StO2 at end of 
recovery (%), hyperemic area (StO2%/min), and StO2 at end of hyperemia (%). 
As a baseline measurement for every VOT, StO2 before occlusion was deter-
mined by calculating the average StO2 over a 30-second interval prior to tourni-
quet inflation. Occlusion and reperfusion slopes were calculated over the entire 
slope between occlusion to the lowest StO2 value in VOT and the complete 
slope between the lowest StO2 value during occlusion and the first data point of 
StO2 back at baseline level, respectively (Fig 1). After the the reperfusion phase, 
the hyperemic area was determined using integration of the area under the 
curve (see Fig 1). 
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Fig 1. Example of a vascular occlusion test performed in an individual patient. 
1, start of the occlusion phase; 2, lowest oxygen saturation observed after 3 minutes of occlusion; 
3, end of reperfusion phase; 4, hyperemic area; 5, end of hyperemic area where the oxygen satura-
tion has reached pre-VOT values. 
The occlusion slope was calculated as the change in oxygen saturation for the interval between 
data points 1 and 2 divided by 3 minutes. Time for recovery was calculated using the interval be-
tween data points 2 and 3. Calculating the reperfusion slope required dividing the change in oxygen 
saturation for the interval between data points 2 and 3 by the time for recovery. The hyperemic area 
was calculated as the area under the curve between datapoints 3 and 5. 
StO2: tissue oxygen saturation. 
 
Statistical analysis 
Continuous variables are depicted as mean ± standard deviation or median 
(interquartile range) depending on data distribution. Statistical analysis was 
performed using the Statistical Package for Social Sciences, version 22.0 (IBM 
Corp, Armonk, NY). Distribution of data was tested using the Shapiro-Wilk test. 
To analyze for differences in VOT parameters before, during, and after CPB, 
the related-samples Friedman 2-way analysis of variance by ranks was com-
puted. If statistically significant, the related-samples Wilcoxon signed rank test 
was performed to test pairwise comparisons. A P-value of <0.05 was consid-
ered statistically significant. 
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Results 
Patient demographics and surgery-related variables are summarized in Table 1. 
In two patients no recognizable VOT curves could be obtained before and after 
perfusion; therefore, only data points at T1 were taken into analysis for these 
patients. Intraoperative hemoglobin and ABP data are depicted in Table 2. He-
moglobin values differed significantly differed at every predefined time point and 
every other time point (P<0.001), with the lowest value recorded at T1 (4.8 
mmol/L). The median ABP was higher at both T0 (83 mmHg, p<0.001) and T2 
(80 mmHg, P=0.003) compared with T1 (69 mmHg). 
VOT parameters at different time points are presented in Table 3. Values for 
StO2 at the end of the occlusion phase the lowest at T1 (57.5%). The occlusion 
slope was steeper at both T1 (4.7%/min, p<0.001) and T2 (5.1%/min, P<0.001) 
compared with T0 (3.8%/min). Analyzing reperfusion slopes revealed a steeper 
slope at T2 (36.8%/min) compared with T0 (32.8%/min, P<0.05). Changes in 
StO2 values prior, during, and after bypass are presented in Figure 2. 
 
 
Table 1. Patient demographics and surgery-related variables. 
demographic variables     
gender (F/M), n (%) 10(29.4%)/24(70.6%) 
age (years) 68.6±10.7 
  BMI (kg/m2) 26.0±3.5 
type of surgery CABG 14 (41.2%) 
CABG+valve replacement 8 (23.5%) 
valve replacement 9 (26.5%) 
  other* 3 (8.8%) 
  CPB time (min) 82.0 (71.8-106.0) 
  aortic occlusion time (min) 54.0 (49.5-75.0) 
NOTE. Numerical values are depicted either as mean ± standard deviation or median (interquartile 
range), unless specified otherwise. 
Abbreviations: BMI, body mass index; CABG, coronary artery bypass grafting; CPB, cardiopulmo-
nary bypass. 
*Other types of surgery include ascending aorta replacement with or without CABG or valve sur-
gery. 
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Table 2. Overview of perioperative hemoglobin and blood pressure data. 
 T0 (n=32) T1 (n=34) T2 (n=32)  
hemoglobin (mmol/L)* 8.5(7.8-9.0) 4.8 (4.1-5.4) 5.8 (5.2-6.6) 
mean ABP (mmHg)† ,‡ 83 (76-94) 69 (62-76) 80 (71-92) 
systolic pressure (mmHg)†,§ 117 (101-132) 84 (76-93) 115 (107-126) 
diastolic pressure (mmHg)† 62 (58-79) 56 (49-63) 60 (54-68) 
pulse pressure (mmHg)†,§ 53 (39-62) 26.9 (23-37) 54 (49-61) 
NOTE. Numerical values are depicted as median (interquartile range). 
Abbreviations: ABP, arterial blood pressure; T0, before onset of bypass; T1, during bypass; T2, after 
cessation of bypass. 
* Values all differ from each other (P<0.001). 
† Difference between before and during perfusion (P<0.001). 
‡ Difference between during and after perfusion (P=0.003). 
§ Difference between during and after perfusion (P<0.001). 
 
 
Table 3. Vascular occlusion test-derived parameters before, during, and after cardiopulmonary 
bypass. 
  T0 (n=32) T1 (n=34) T2 (n=32) 
StO2 before occlusion (%)* 76.4 (72.8-79.4) 74.1 (72.1-78.6) 76.2 (74.1-78.8) 
occlusion slope (StO2%/min)†,‡ 3.8 (3.3-5.4) 4.7 (3.3-6.6) 5.1 (3.8-6.2) 
lowest StO2 in VOT (%)*,§,║ 62.9 (55.8-68.6) 57.5 (53.1-64.3) 59.3 (53.2-66.2) 
reperfusion slope (StO2%/min)║ 32.8 (20.0-47.6) 35.3 (23.6-47.0) 36.8 (27.9-57.1) 
reperfusion time (min) 0.43 ([0.33-0.49) 0.43 (0.33-0.51) 0.37 (0.32-0.52) 
StO2 at end of recovery (%) 76.2 (72.3-78.6) 73.8 (71.0-77.2) 75.4 (74.1-77.2) 
hyperemic area (StO2%/min) 7.3 (3.6-14.3) 6.0 (4.7-8.7) 8.0 (5.1-9.9) 
StO2 at end of hyperemia (%)*,§ 76.3 (73.7-80.1) 74.0 (71.8-77.9) 77.0 (73.9-78.5) 
Numerical values are depicted as median (interquartile range). 
Abbreviations: T0, before bypass; T1, during bypass; T2, after cessation of bypass; StO2, tissue 
oxygen saturation; VOT, vascular occlusion test. 
* Difference between T1 and T2; P<0.05. 
† Difference between T0 and T1; P<0.01. 
‡ Difference between T0 and T2; P<0.001. 
§ Difference between T0 and T1; P<0.005. 
║Difference between T0 and T2; P<0.05. 
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Fig 2. Results of tissue oxygen saturation in the right forearm during the ischemic challenge before, 
during, and after bypass. 
Median values were calculated from all 34 patients (32 during bypass). StO2, tissue oxygen satura-
tion; T0, prior to bypass; T1, during bypass; T2, after cessation of bypass. 
Discussion 
Intraoperative monitoring of peripheral microvascular reactivity enables detec-
tion of alterations in microcirculatory function and thereby may contribute to 
preventing impaired tissue perfusion.3,4,17,21 This prospective study showed sig-
nificant changes in VOT parameters between the different stages of cardiac 
surgery, implying altered vascular reactivity in patients undergoing cardiac sur-
gery with CPB. 
 
The occlusion slope (also referred to as the desaturation slope or rate of deoxy-
genation) is one of the parameters that reflects the current state of microcircula-
tion and ought to represent the rate of mitochondrial oxygen consumption and 
local tissue metabolism.22 A steeper occlusion slope therefore would be indica-
tive of a relatively high local metabolic rate, as reflected by the rapid local de-
crease in oxyhemoglobin concentration. The results of this study showed a sig-
nificantly steeper occlusion slope at both T1 and T2 compared to T0, indicating 
increased oxygen consumption during and after CPB compared with before 
initiation of CPB. This effect has been previously described and represents the 
effect of general anesthesia with propofol on oxygen delivery and extraction as 
well as capillary blood flow.9,23-25 Contrastingly, Smith et al. found the occlusion 
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slope to be similar across different stages of surgery,17 which may be explained 
partially by methodologic differences that consequently affect the values of 
VOT-derived parameters. For example, their study did not apply any exclusion 
criteria, such as Raynaud’s disease, which may logically may affect StO2. 
 
Another VOT-derived parameter is the lowest value found during the ischemic 
period, which provides information regarding the absolute oxygen reserve in the 
microcirculatory system. The observed decline in the lowest StO2 value at T1 
suggested that the absolute oxygen reserve was affected during perfusion, 
probably in part due to hemodilution. This also was reflected by the decreased 
hemoglobin values during bypass (see Table 2). 
Since the time required for recovery did not change, it can speculated that per-
fusion recovery occurred in a more efficient manner while the patient was on 
bypass. This observed effect can be attributed to an increased blood flow veloc-
ity in minor hemodilution by a decrease in systemic vascular resistance.26-27 In 
addition, reduced blood viscosity adds to the increase in blood flow in the capil-
laries and thereby compensates for the effect of dilution, contributing to main-
taining adequate tissue oxygenation.27 
 
The reperfusion slope (also referred to as the recovery slope or rate of reperfu-
sion) represents the time required to wash out stagnant blood from the micro-
vasculature and the local reperfusion reserve.9,22 Our results did show an in-
creased reperfusion slope at T2 compared to T0, suggesting altered peripheral 
microvascular reactivity. The duration of reperfusion remained unchanged, pos-
sibly indicating enhanced reperfusion efficiency. It has been proposed that the 
reperfusion slope is directly proportional to tissue perfusion while that reperfu-
sion time is inversely proportional to tissue perfusion.11 Therefore, it can specu-
lated that the observed changes reflect an enhanced tissue perfusion when the 
patient is on bypass. Hence, our results could not confirm that CPB worsens 
microcirculatory function. Smith et al., in contrast, reported a decreased reper-
fusion slope at T1 compared with T0, implying impaired peripheral microvascular 
reactivity.17 They also found a successive decline in reperfusion slopes with 
increasing duration of CPB, denoting worsened microcirculatory function. Pos-
sible factors contributing to these discrepancies are measurement site and CPB 
protocol. StO2 measurements in the study presented here were performed at 
the internal surface of the forearm, which may result in different values for VOT-
derived parameters compared with positioning the measurement probes at the 
thenar eminence. 
Another VOT-derived parameter considered to reflect vascular reactivity is the 
hyperemic area,4,17 which is reflective of tissue oxygen consumption.28 Do-
erschug et al. reported a significantly lowered reactive hyperemic response in 
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septic patients and attributed this finding to a dysregulated microvascular oxy-
gen balance.28 In the current study, the hyperemic area did not differ between 
time points, which was in concordance with previous studies and adds to the 
notion of preserved peripheral microcirculation during and after CPB.9,17 
 
Discrepancies between previously published studies and the results of this 
study could be the result of differences in the ischemic challenge protocol. The 
choice of probe, probe positioning, and duration of ischemia affect the values of 
VOT-derived parameters.29 However, a standardized protocol of VOT is not yet 
established. One method is the application of a fixed target StO2 for termination 
of the ischemic period (absolute value for StO2 of 40%).9 Because a target tis-
sue saturation level may be difficult to reach due to decreased metabolic rate 
and increased oxygen content during surgery, the study presented here used a 
fixed interval of 3 minutes occlusion time, similar to another study.17 Moreover, 
position of sensors and probe spacing affect the values of VOT-derived pa-
rameters. It was described previously that baseline as well as reperfusion and 
occlusion slopes were affected by probe placement.29 Both this study and the 
study by Smith et al. used medium-sized probes placed on the brachial artery.17 
Previous studies report VOT protocols with placement of oximetry sensors at 
either the forearm or the thenar eminence.9,15-17 However, StO2 measured at the 
thenar muscle may be subject to the body-finger temperature difference in a 
larger extend than StO2 measured at the forearm.30 Inconsistent probe sizing 
and placement in prior studies make interpretation and comparison of data chal-
lenging, and future studies therefore should aim at developing a standardized 
protocol. 
Another source of variation in the reported results could be differences in calcu-
lation methods. For example, in the study presented here, data of the entire 
downward slope were used for calculation of the desaturation slope, whereas 
others selected a 1-minute interval commencing with StO2 decreasing below 
baseline17 or defined the occlusion slope as the first 25% of StO2 descent.9 Re-
garding the reperfusion slope, other studies used either solely StO2 values from 
the first 14 seconds of reperfusion,4 values from the release of occlusion to 85% 
StO2 recovery,17 or values of the entire reperfusion interval, similar to this 
study.9 
Although differences in protocol apparently influence the values of VOT-derived 
parameters, it is unlikely that the observed changes between the different phas-
es of surgery are affected. Nonetheless, it remains unclear whether these dif-
ferences significantly contribute to the seemingly opposite physiologic effects 
described in published reports, underlining the importance of standardizing the 
VOT in future research. In addition, both baseline and dynamic VOT parameters 
may be affected by patient-related factors, including differences in subcutane-
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ous adipose tissue depth.31,32 High interindividual variability makes comparison 
among patients challenging, hence the study presented here focussed on dif-
ferences between time points. 
The influence of propofol on the microcirculatory responsiveness and metabolic 
rate was precluded in the analysis, which potentially could influence VOT re-
sults.9,23-25 However, in the study presented here, the focus predominately was 
on the effect of CPB rather than the anesthesia protocol. In addition, the use of 
an α1-antagonist (eg, phenylephrine) also may affect VOT-derived parameters 
because it causes vasoconstriction, thereby reducing capillary blood flow. In the 
study presented here, however, the administered dose of phenylephrine was 
considerably lower compared with the study by Maier et al. that described the 
effects of phenylephrine on sublingual microcirculation in patients undergoing 
CPB.33 Therefore, it may assumed that the effects of phenylephrine on the mi-
crocirculation in the current study were limited. 
Conclusion 
The microcirculatory function as demonstrated by changes in VOT parameters 
was enhanced during and after normothermic pulsatile CPB. Clinical relevance, 
however, needs to be further explored.  
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Abstract 
Introduction: Post-operative monitoring of a free flap transplant in the form of a 
deep inferior epigastric perforator flap (DIEP-flap) is crucial for early detection of 
vascular compromise. The aim of the current study, therefore, is to gain insight 
whether non-invasive tissue oximetry is suitable for assessment of tissue perfu-
sion following DIEP-flap surgery and whether it can serve as an early marker for 
vascular compromise. 
Methods: Patients (n=29) undergoing secondary unilateral DIEP-flap surgery 
were included in this prospective explorative study. Non-invasive tissue oxygen 
saturation (StO2) measurements were performed using one sensor positioned 
on the DIEP-flap and another positioned on the native breast. Measurements 
were performed directly after the surgical procedure until 24 h post-operatively. 
Results: Tissue oxygenation response was swift in the native breast (on aver-
age 11.9%/h for 84 min, n=28), whereas the DIEP-flap showed a lower and 
more extended tissue recovery phase of approximately 7.5%/h for 6 h (n=23). In 
some of these latter cases (n=14), an acute and second more prolonged re-
sponse was observed in the DIEP-flap. The average difference between the 
DIEP-flap and native breast StO2 was 4% across the entire measurement 
(P=0.043). Two patients underwent post-operative re-exploration of the DIEP-
flap, in which an immediate and constant enlarged difference between DIEP-
flap and native breast StO2 (≥38%), and a decreased DIEP-flap StO2 (≤43%) 
was observed. 
Conclusion: Continuous non-invasive tissue oxygen saturation is suitable for 
postoperative monitoring of DIEP-flaps, and StO2 pattern may aid in early identi-
fication of vascular compromise in DIEP-flaps.  
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Introduction 
Increasing awareness of complications associated with silicone breast implants 
(haematomas, infections, sensory changes, peri-implant capsule for-
mation/contraction and implant perforation or contracture) has generated high 
interest in breast reconstruction following mastectomy using solely autologous 
tissue.1 Success or failure of a particular free skin transplant, however, is de-
pendent on continuous arterial and venous outflow through patent microvascu-
lar anastomoses.2 Therefore, postoperative monitoring of a DIEP-flap is crucial 
for early detection of vascular compromise to maximise chances of flap sal-
vage.3 Loss of free flaps due to vascular compromise is a detrimental complica-
tion and has been reported to occur in 3.6-6% of cases, while re-exploration is 
performed in 5-25% of cases.4,5 
 
In daily practices, clinical observation of skin colour, temperature and capillary 
refill are used to assess flap perfusion and viability, as well as results obtained 
by Doppler ultrasonography.6 However, these monitoring methods are only 
performed intermittently and are rather subjective, relying on the experience of 
the evaluator. Additionally, the results of a literature review conducted by Smit 
and colleagues implicate that solely performing clinical evaluation for postopera-
tive flap monitoring is unfavourable due to the time needed for clinical signs to 
become evident.7 
 
Non-invasive tissue oximetry using near-infrared spectroscopy (NIRS) is a 
method that could be used for continuous monitoring of tissue perfusion in free 
skin flaps. Previous studies suggest that tissue oximetry is capable of early 
detection of tissue hypoxia in free skin flaps.3,8-10 However, these studies only 
performed unilateral tissue oxygenation measurements. In the current study, 
tissue oxygen saturation (StO2) is monitored simultaneously in the DIEP-flap 
and native breast (personalised reference value). The present study aims to 
gain insight in whether non-invasive tissue oximetry is suitable for assessment 
of tissue perfusion following reconstructive breast surgery with a DIEP-flap and 
if bilateral tissue oximetry values can potentially serve as an early marker for 
vascular compromise. 
Materials and methods 
Patients 
Female patients undergoing unilateral secondary DIEP-flap surgery were in-
cluded in this prospective explorative study. A prerequisite was a DIEP-flap 
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dimension of at least 50 mm x 85 mm, to allow proper sensor placement. Prima-
ry DIEP-flap procedures were not included because the abdominal skin island 
on the breast is smaller following a primary procedure as compared to a sec-
ondary procedure. An exclusion criterion for this study was objection in the pa-
tient hospital records against consultation of patient and surgery-related infor-
mation for research or educational purposes. Data acquisition and analyses for 
this explorative study were performed anonymously and in accordance with the 
Dutch law for approving medical research. 
Measurements 
Non-invasive tissue oximetry uses NIRS based on the Lambert-Beer law. In 
short, light of several wavelengths within the near-infrared spectrum is absorbed 
by chromophores in an oxygen-dependent manner.5,11 Characteristic absorption 
spectra of the chromophores oxyhaemoglobin and deoxyhaemoglobin allow 
estimation of their concentrations after measuring the optical signals exiting the 
tissue.12 The ratio of oxygenated haemoglobin relative to the total local concen-
tration of deoxygenated haemoglobin is then used to quantify the oxygen con-
tent in local tissue.5,11,12 
 
In our study, non-invasive tissue oxygenation monitoring was performed using 
the INVOS 5000C Oximeter (Somanetics Corporation, Troy, Michigan, USA). 
One self-adhesive disposable NIRS sensor (INVOS SAFB-SM Adult SomaSen-
sor) was positioned on the DIEP-flap below the staple markings and served to 
measure the Doppler flow on the lower medial site of the flap. The other sensor 
was positioned on the lower side of the native breast right below the areola and 
served as a personalised reference value. Since revisions of the anastomoses 
are mostly performed in the first critical hours following surgery3,13, tissue oxi-
metry readings were initiated directly after completion of the surgical procedure 
and continued until 24 hours postoperatively at the ward. Protocolled transfer of 
the patient from the operating theater to the recovery room was accommodated 
after adequate blood flow identification by Doppler ultrasonography. 
 
Flap weight, ischaemia time and postoperative complications emerging before 
hospital discharge were recorded. Post-operative complications were defined as 
circulatory failure at the recipient site (DIEP-flap) requiring immediate return to 
the operating room for re-exploration. 
Statistical analysis 
For the a priori sample size calculation a 10% difference in StO2 was consid-
ered a relevant change, considering the inaccuracy of the INVOS 5000C clinical 
oximeter of 4.7%. With an α set at 0.05, a statistical power (1-β) of 0.95, and σ 
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of 13.75 (maximum - minimum divided by 4, i.e., 99-44/4), the estimated sample 
size amounted to 28 patients. 
 
Data were analysed according to the absolute tissue oxygen saturation differ-
ence (ΔStO2, depicted in %) between the DIEP-flap and the native breast. Nu-
merical values are expressed as mean ± standard deviation. Depending on data 
distribution, either a paired t-test or Wilcoxon signed-rank test was used for 
comparison of DIEP and native breast StO2. 
Results 
From a practical point of view, a total of 29 patients were included in the study. 
The mean age and body mass index were 50±10 years and 26.3±3.3 kg/m², 
respectively. The ischaemia time varied from 23 to 75 min (mean 48±12 min) 
and the weight of the transplant varied from 250 to 1324 g (mean 645±237 g). 
On average, StO2 of the native breast amounted to 85±3% in the first 24 h post-
operatively, whereas StO2 measured in the DIEP-flap was significantly lower, 
amounting to 81±4% (Wilcoxon signed-rank test, P=0.043) (Table 1). 
 
 
Table 1. Study population characteristics. 
 n=29 case 1 case 2 
age (y) 50±10 52 61 
BMI (kg/m²) 26.4±3.3 30.0 23.5 
weight DIEP-flap (g) 649±240 1000 688 
ischemia time DIEP-flap (min) 48±12 60 37 
mean StO2 DIEP-flap (%)* 81±4 43±0 44±1 
mean StO2 native breast (%) 85±3 86±4 82±2 
BMI: body mass index, DIEP flap: deep inferior epigastric perforator-flap, StO2: tissue oxygen satu-
ration. *P-value for comparison of the mean StO2 DIEP-flap and mean StO2 native breast: P=0.043 
(Wilcoxon signed-rank test). 
 
 
In the majority of patients, a rapid post-surgical tissue oxygenation response 
was noted in the native breast, amounting to 11.9%/hour for 84 min (mean val-
ues for 28 patients). One patient lacked an identifiable tissue response, showing 
stable StO2 values throughout the entire measurement duration. Following tis-
sue oxygenation recovery, native breast StO2 values remained constant 
(85.9±7%). The DIEP-flap, on the other hand, showed a more extended tissue 
oxygenation response of 7.5%/h for 6 h (mean value for 23 patients). In some of 
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these patients (n=14), an acute and second more prolonged tissue response 
could be identified (Graph 1). In those cases, a slope of 12.8%/h was observed 
in the DIEP-flap immediately after initiation of the measurement for 71 min 
(mean value), while the second and more prolonged recovery slope amounted 
to 6.9%/h for 165 min (mean value). After tissue oxygenation recovery, DIEP-
flap StO2 values remained stable (81.8±12%). In one individual patient with the 
shortest ischaemia time observed (23 minutes), DIEP-flap and native breast 
StO2 showed very similar values throughout the entire measurement (Graph 2). 
In 6 of 29 patients, no clear tissue oxygenation recovery could be identified as 
tissue oximetry values obtained from the DIEP-flap remained relatively similar 
throughout the measurement. In three of these patients, DIEP-flap and native 
breast StO2 also consistently showed comparable values (absolute ΔStO2 ≤10% 
throughout the entire measurement duration). 
 
 
 
Graph 1. Tissue oximetry readings of an individual patient with an uncomplicated postoperative 
recovery. 1. Acute tissue oxygenation recovery phase, 2. Second prolonged tissue oxygenation 
recovery phase. DIEP: deep inferior epigastric perforator, REF: internal reference measurement, 
StO2: tissue oxygen saturation. 
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Graph 2. Tissue oximetry readings from a patient with the shortest observed ischemia time (23 
minutes). DIEP: deep inferior epigastric perforator, REF: internal reference measurement, StO2: 
tissue oxygen saturation. 
 
 
Most patients showed an uncomplicated postoperative course and were dis-
charged from the hospital after 5 days. In two patients (7%), however, re-
exploration of the DIEP-flap was performed within 24 h following clinical signs of 
vascular compromise and aberrant results obtained by Doppler ultrasonogra-
phy. An immediate and constant enlarged ΔStO2 (on average 43%) and de-
creased DIEP-flap StO2 (43%) was observed in case 1 (Table 1, Graph 3), 
which could be explained by a non-patent anastomosis. In this particular pa-
tient, the epigastric perforators were anastomosed to the thoracodorsal vessels 
after failure to locate the internal mammary vessels. A second anastomosis was 
performed to ensure sufficient tissue perfusion and DIEP-flap salvage. In an-
other patient experiencing postoperative re-exploration, similar ΔStO2 values 
(on average 38%) and decreased DIEP-flap StO2 (44%) were noted (Table 1, 
Graph 4). In case 2, re-exploration of the DIEP-flap was performed within 24 h 
because of vascular compromise that was suspected based on flap discoloura-
tion; however, an evident circulatory defect could not be identified. On the fifth 
postoperative day, partial necrosis on one side of the DIEP-flap was sensed as 
palpable firmness identified by physical examination. 
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Graph 3. Case 1: Tissue oximetry readings from a patient with a non-patent anastomosis. 
DIEP: deep inferior epigastric perforator, REF: internal reference measurement, StO2: tissue oxygen 
saturation. 
 
 
Graph 4. Case 2: Tissue oximetry readings from a patient complicated with partial fat necrosis of the 
DIEP-flap observed on the fifth postoperative day. DIEP: deep inferior epigastric perforator, REF: 
internal reference measurement, StO2: tissue oxygen saturation. Due to dislodgement of measure-
ment probes, data was lost between the 3rd and 20th postoperative hour. 
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Discussion 
This explorative clinical study identified several patterns of tissue oximetry read-
ings in the first 24 h following unilateral secondary DIEP-flap surgery. Most pa-
tients showed a gradual recovery of DIEP-flap tissue oxygenation. To the best 
of our knowledge, this is the first study linking tissue oximetry readings including 
a personalised reference value to clinical outcome following DIEP-flap surgery. 
 
Although most patients showed a subtle or more pronounced tissue response in 
the DIEP-flap, some patients showed relatively stable tissue oxygenation values 
throughout the measurement. Possibly in the latter group of patients (n=6) the 
tissue response did not exceed the threshold of a detectable StO2 change. In 
three of these patients, DIEP-flap StO2 did not only lack an identifiable recovery 
slope but also showed comparable values to the native breast StO2 throughout 
the entire measurement (≤10% absolute difference). A possible explanation for 
these findings is that in this group of patients, DIEP-flap StO2 recovery had al-
ready occurred prior to initiation of the measurement. 
 
Following flap elevation, primary ischaemia begins whenever the vascular pedi-
cle is transected - in this case, the vessel responsible for perfusion of the DIEP-
flap. When the anastomosis is completed and vascular clamps are removed, 
the initial reperfusion phase starts. Generally, an increased ischaemia time 
leads to a decreased survival rate of free skin flaps; therefore, one may expect 
the chance of vascular compromise to be increased with a prolonged ischaemia 
time.14 However, our results do not reflect this statement, as the re-explored 
DIEP-flaps underwent an ischaemia time of 37 and 60 min, which is within the 
range of the mean value ± one standard deviation (36-60 min, Table 1). One 
could therefore hypothesise that in the studied cases, the ischaemia time was 
too short to contribute to impaired postoperative tissue recovery. 
 
In total, 2 out of 29 studied patients underwent re-exploration of the DIEP-flap. 
In case 1, the anastomosis was insufficient to adequately perfuse the entire 
DIEP-flap, which was reflected by a ΔStO2 of 43% and a DIEP-flap StO2 of 
43%. More specifically, an inadequate venous outflow resulted in venous con-
gestion of the DIEP-flap. In contrast, in case 2 no evident cause for impaired 
tissue perfusion could be identified. Preceding partial necrosis noted on the fifth 
postoperative day, a consistently lowered StO2 concomitant with an increased 
ΔStO2 was measured in the DIEP-flap of this particular patient. These results 
imply that both an enlarged ΔStO2 (≥38%) and decreased StO2 measured in the 
DIEP-flap (≤43%) are indicative of inadequate flap perfusion. In both patients, 
an increased ΔStO2 as well as a decreased DIEP-flap StO2 were observed im-
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mediately after initiation of the measurement, suggesting that tissue oximetry 
was capable of providing an early warning of impaired tissue perfusion. 
 
Nevertheless, when determining a clear StO2 or ΔStO2 threshold necessitating 
prompt intervention. it is important to consider the limitations of tissue oximetry. 
Clinical oximeter devices are destined for either trend or absolute StO2 monitor-
ing, as they use an algorithm which requires the assumption of a fixed ratio of 
arterial to venous blood in the vascular bed. This algorithm, however, cannot 
adapt to all possible applications of tissue oximetry. Hence, one must be cau-
tious when interpreting absolute StO2 values derived from measurements per-
formed in different areas. When interpreting the current results, it is important to 
consider the fact that DIEP-flap and personalized reference StO2 reflect the 
oxygen balance in different types of tissue. Therefore, it can be expected that 
absolute values derived from both measurements (native breast tissue and 
abdominal wall tissue) differ to a certain extent, although in the vast majority of 
patients, the absolute ΔStO2 was ≤10% after tissue oxygenation recovery. This 
latter suggests that comparison of DIEP-flap and native breast StO2 is of added 
value in patients with vascular compromise. 
 
Additional factors to take into account when establishing StO2 thresholds are 
the clinical oximeter device and type of sensor used. Previous studies used 
different oximeter devices and NIRS sensors, which makes comparison of study 
results challenging. In a study by Hyttel-Sorensen and colleagues, three differ-
ent oximeters were compared.15 They found differences in median absolute 
values, repeatability and dynamic measurements across the different devices, 
underlining the importance of standardised application of tissue oximetry. Addi-
tionally, tissue oxygen saturation values are not only dependent on sensor posi-
tioning but are also affected by near-infrared transmitter-receiver spacing, which 
may vary between sensor types.16 The current study used sensors with an es-
timated depth of measurement of 20 mm, while other studies used oximeters 
with varying measurement depths of 0-5 mm13, 4-6 mm8, or more similar to our 
study, up to approximately 23 mm.3 Different monitoring devices also use vary-
ing numbers and wavelengths of near-infrared light, which also affects estima-
tion and calculation of StO2.17 
Conclusion 
Continuous non-invasive tissue oxygen saturation patterns may aid in early 
identification of vascular compromise following DIEP-flap surgery. Future stud-
ies should aim at establishing clinically relevant tissue oxygenation thresholds. 
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A number of different technologies have been developed to measure tissue 
oxygenation with the goal of identifying tissue hypoxia and guiding therapy to 
optimize end-organ tissue oxygenation, to ultimately, prevent ischemic tissue 
damage. In specific cases, tissue oximetry may indicate decreased tissue oxy-
genation such as that occurring during acute brain ischemia. However, the cau-
sation between tissue hemoglobin-oxygen desaturation in one organ (e.g., brain 
or muscle) and global outcomes such as mortality, intensive care unit length of 
stay, and remote organ dysfunction remains speculative. In this thesis, the cur-
rent state of evidence for predicting clinical outcomes from tissue oximetry is 
described and several issues that need to be addressed to clarify the link be-
tween tissue oxygenation and outcomes are identified. The analysis finds that 
despite the increasing amount of literature focusing on the application of tissue 
oximetry, the association between desaturation episodes and clinical outcomes 
remains assumptive. Major lacunae include clinically relevant threshold or pre-
diction values for tissue desaturation-related injury in specific organs. Further-
more, defining the types of required interventions to correct changes in tissue 
oxygenation and defining the effect of these interventions on clinical outcomes 
is warranted. 
Tissue oximetry for brain monitoring 
Neurological complications following cardiac surgical interventions are among 
the most detrimental adverse outcomes, affecting 1.5-11% of the patient popu-
lation.1-3 Several studies elaborated on the factors that play a role in the obvi-
ously multifactorial development of neurological complications. Regional tissue 
oxygen saturation (rSO2) reflects the balance between arterial oxygen supply 
and demand in real-time, thus a decrease in oxygen supply or increase in oxy-
gen extraction by metabolic demand in tissue results in a decrease in tissue 
oximetry readings.4 In essence, rSO2 is thought to reflect the local venous oxy-
gen reserve, indicating that any factor that modulates either oxygen supply, 
oxygen extraction ratio, or both (e.g., anesthetics or cerebrovascular dysfunc-
tion) directly affects cerebral rSO2. Cerebral oximetry, however, does not pro-
vide any information regarding the cause of a changing rSO2, thus it remains 
unknown whether the rSO2 changes are attributable to modifiable factors or not. 
Although several observational and few experimental studies conclude that 
continuous brain monitoring using near-infrared spectroscopy (NIRS) is a viable 
method for early detection of cerebral hypoxia, proof for a clear link between 
cerebral rSO2 and postoperative neurologic complications (PNC) is still lacking. 
As discussed in Chapter 2, this can be partially explained by the fact that tissue 
oximetry, due to its measurement principle, is unable to take the intrinsic auto-
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regulatory activity of the cerebral vasculature into account. This is illustrated by 
the observation of seemingly normal cerebral rSO2 values during cerebral hy-
perperfusion (i.e., ‘’brain luxury perfusion’’), while the cerebral autoregulatory 
activity is impeded.5 Cerebral autoregulation (CA) is known to be intact within a 
certain range of physiologic cerebral perfusion pressures, and prevents both 
hypoxia and hyperoxia. The autonomous cerebral protective system prevents 
hyper- and hypoperfusion by continuous control and modification of cerebro-
vascular resistance, assuring constant cerebral blood flow. Consequently, im-
paired CA permits fluctuations in cerebral perfusion pressure which may result 
in either brain hyper- or hypoperfusion, predisposing the patient to an increased 
PNC risk. Rather than solely focusing on preserving cerebral rSO2 within certain 
predefined limits, maintaining intact CA should be of primary importance in min-
imizing PNC risk. The clinical relevance of statistically significant decreasing 
rSO2 values requires further elucidation, therefore it remains of utmost im-
portance to take all available clinical information into account when interpreting 
rSO2 readings. 
 
One factor contributing to the lack of evidence on the association between cer-
ebral rSO2 and PNC may be the different perfusion protocols applied across 
studies. As indicated by Ganushchak et al.6, the cardiopulmonary bypass (CPB) 
technique affects PNC risk though variations in hemodynamic parameters such 
as mean arterial pressure, systemic vascular resistance, and arterial pulse 
pressure. Moreover, a prospective study by Ševerdija et al. clearly illustrated 
that the levels of arterial carbon dioxide level and the extent of hemodilution 
need to be controlled within a certain range to enable optimal cerebrovascular 
reactivity and thus intact CA.7 The primary requisite for intact CA is a mean 
arterial blood pressure (ABP) within the lower and upper autoregulatory limit, 
which are reported to lie around 60 and 150 mmHg, respectively.8 These val-
ues, however, are subject to interpersonal variations, for example differences in 
sympathetic nervous activity, as is the case in chronic hypertension.9 In clinical 
practice, this may pose a challenge to warrant CA integrity based on preopera-
tive measurements. Besides intraoperative ABP, arterial partial gas pressure of 
carbon dioxide also needs to be maintained at predetermined levels to enable 
sufficient autoregulatory activity (Chapter 3). Moreover, maintaining stable he-
modynamics during CPB will contribute to lowering the PNC risk.6 Therefore, 
standardization in the form of strictly regulating patients’ hemodynamics be-
tween the anticipated autoregulatory limits will contribute to preservation of CA 
(Chapter 4). Ultimately, this will aid in decreasing the PNC incidence in surgical 
patients by avoiding unnecessary exposure to CA disturbances. 
 
CHAPTER 9 
118 
Despite the shortcomings of cerebral oximetry inherent to its measurement 
technique, rSO2 readings can still serve as an additional source of information 
regarding the current balance between oxygen delivery and consumption. In 
Chapter 5, we showed that cerebral oximetry effectively reflects tissue oxygena-
tion changes resulting from several iatrogenic events in cardiac surgical pa-
tients. Onset of CPB and placement and removal of the aortic cross-clamp were 
events that resulted in a decreased rSO2, whereas anesthetic induction, place-
ment of the sternal retractor and termination of CPB were associated with an 
increase in rSO2. We also illustrated that phenylephrine administration has no 
relevant effects on cerebral oxygen saturation. This observation is in contrast 
with the findings of an interventional study by Moerman et al., who concluded 
that cerebral rSO2 decreases following phenylephrine infusion.10 The authors 
hypothesized that this effect was a functional myogenic response, part of cere-
bral autoregulatory activity. The reported changes in rSO2 in their publication 
were statistically significant, but only very small in magnitude (on average 
1.8%). It is therefore unlikely that vasopressor (e.g., phenylephrine) administra-
tion has clinically relevant effects with regards to cerebral tissue perfusion. A 
previous study by Brassard and colleagues11 did show a decrease in cerebral 
tissue oxygenation following phenylephrine administration, however, this effect 
was exclusively observed in a specific subset of patients (diabetics) included in 
the study. The proposed negative effect of phenylephrine on cerebral rSO2 is, 
therefore, probably not of any clinical importance in non-diabetic patients. 
In addition, Chapter 5 illustrates that cerebral oximetry using NIRS is sensitive 
enough to detect subtle and potentially relevant changes in rSO2 through sev-
eral stages of CPB. Nonetheless, further clinical studies are warranted to inves-
tigate the relationship between subtle and pronounced cerebral desaturations 
identified by cerebral oximetry and PNC. 
 
Tissue oximetry may also be helpful in continuous assessment of tissue perfu-
sion in patients undergoing long-term cardiopulmonary support, such as veno-
arterial extracorporeal life support (VA-ECLS). Maintaining adequate cardiac 
output is especially important in VA-ECLS patients in order to prevent ischemic 
episodes which can potentially result in cerebral and microvascular malperfu-
sion, contributing to the risk of complications including PNC, congestive heart 
failure, renal dysfunction, infections, and irreversible multi-organ failure.6,12-15 
Hemodynamic instability is reflected by fluctuations in oxygen saturation and 
could thus be identified by tissue oximetry. In a retrospective study, we identi-
fied several events which were related to significant changes in cerebral rSO2 
(Chapter 6). The analysis showed that cardiac arrhythmias (i.e., atrial fibrillation 
or ventricular fibrillation) cause a decrease in bi-frontal cerebral rSO2 (both the 
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left and the right cerebral hemisphere), most probably as a result of hemody-
namic instability. 
Another event that manifested in a clear rSO2 decrease was the occurrence of a 
presumably sudden change in cardiac output without timely adjustment of the 
ventilator settings. These results indicate that tissue oximetry can aid in timely 
recognition of hemodynamic instability, contributing to early detection of im-
paired cerebral perfusion. 
Surprisingly, administration of packed red blood cells (PRBC) did not cause a 
significant change in cerebral rSO2 readings. One might expect that allogeneic 
blood transfusion would cause an increase in rSO2 values due to its effect on 
oxygen carrying capacity and cardiac output. Part of the explanation for this 
seemingly contradictive finding can be found in the critical hemodynamic condi-
tions of the patients receiving PRBC transfusion. In our study, some patients 
suffered from severe bleeding, which most likely caused blood transfusion to 
have had a compensatory effect on the decreased cardiac output. This, in turn, 
resulted in restoration of cardiac output, and thereby preservation of cerebral 
rSO2 rather than an increased value. 
The study results advocate for the application of non-invasive tissue oximetry as 
a viable monitoring method for assessing cerebral tissue oxygenation during 
ECLS. Although direct interpretation of measurement values continues to be 
challenging due to the lack of application-specific rSO2 thresholds, inclusion of 
tissue oximetry in routine bedside monitoring could aid in early recognition of 
threats to hemodynamic stability. 
Tissue oximetry for somatic monitoring 
Besides the originally intended use of tissue oximetry (brain monitoring), several 
other clinical applications have been described in the literature. The two most 
commonly used oximeter devices (Fore-Sight Elite, CAS Medical Systems, Inc., 
Branford, CT, USA and INVOS 5100C, Medtronic, Minneapolis, MN, USA) pro-
vide the option to simultaneously measure cerebral and somatic tissue oxygen 
saturation with an adapted algorithm for the calculation of local oxygen content 
in muscle tissue. 
Patients undergoing long-term cardiopulmonary support (e.g., VA-ECLS) specif-
ically may benefit from somatic tissue oximetry. In VA-ECLS, femoral artery 
cannulation is a commonly used technique, however this access technique of-
ten compromises perfusion of the lower limbs, causing limb ischemia and con-
comitant tissue damage. In some cases, placement of a distal cannula is re-
quired to prevent fasciotomy or even limb amputation. Chapter 6 shows that 
tissue oximetry aids in early recognition of compromised limb perfusion and 
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contributes to timely intervention by identifying the need for a distal cannula. 
Moreover, tissue oximetry even appeared superior in terms of early detection of 
malperfusion as compared to repeated bedside evaluation of limb temperature. 
In case of clotting in the distal femoral cannula, our analysis showed clear 
changes in limb rSO2 values before a decrease in limb temperature became 
evident. 
 
Another potential target for somatic tissue monitoring are free skin transplants. 
The use of autologous skin and fat tissue supplied by an isolated perforator 
vessel has gained popularity over the recent years in plastic reconstructive sur-
gery. Free skin-fat transplants, in the literature referred to as a flaps, are in-
creasingly used for autologous breast reconstructive surgery. In the late eighties 
and early nineties, the deep inferior epigastric perforator (DIEP)-flap was intro-
duced as an alternative to the transverse rectus abdominis myocutaneous 
(TRAM)-flap. While the latter involves rectus abdominis muscle and fascia exci-
sion, the abdominal muscles remain intact in DIEP-flap surgery. 
Maintaining abdominal wall integrity contributes to decreased postoperative 
pain and risk of complications by minimizing donor-site morbidity as compared 
to TRAM-flap surgery.16 The DIEP-flap, however, is particularly susceptible to 
ischemia in which the quality of the microsurgical anastomoses determines flap 
perfusion and thereby its viability. Circulatory failure in a DIEP-flap is a detri-
mental complication that can cause partial or even complete flap loss. While 
previous reports suggest that non-invasive tissue oximetry might be of added 
value in perioperative DIEP-flap monitoring, these studies only performed uni-
lateral measurements. In this specific application of tissue oximetry, the direct 
comparison with an internal or personalized reference value is crucial. Rather 
than aiming at maintaining stable rSO2 values, which is the commonly used 
strategy in brain monitoring during cardiac surgery, the intended use of tissue 
oximetry in free skin transplants is to assess tissue reoxygenation or tissue 
recovery. 
In a prospective explorative study, we identified several patterns of tissue oxi-
metry readings in the first 24 hours following unilateral secondary DIEP-flap 
breast reconstructive surgery (Chapter 8). Most patients showed a gradual re-
covery of DIEP-flap tissue oxygenation and an uncomplicated postoperative 
course. Two of the studied patients, however, underwent re-exploration of the 
DIEP-flap due to a non-patent anastomosis. This was reflected by an enlarged 
ΔrSO2 (absolute difference in regional tissue oxygen saturation values between 
DIEP-flap and native breast), as well as a decreased rSO2 measured in the 
DIEP-flap as observed in both complicated cases. These aberrant rSO2 values 
were apparent immediately following initiation of the measurement. In this ex-
plorative study, we used tissue oximetry readings in the native breast as a per-
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sonalized reference value. Although the DIEP-flap concerns a different tissue 
type than the native breast, this personalized reference measurement enabled 
direct discrimination between cases with apparent circulatory failure of the per-
forator vessels and uncomplicated cases. These results suggest that the native 
breast can serve as an internal reference measurement and that non-invasive 
tissue oximetry values provide an early marker for impaired DIEP-flap perfusion. 
Nevertheless, in order to enable prompt intervention, further studies are needed 
to identify optimal ΔrSO2 thresholds. 
Microvascular reactivity 
Apart from cerebral and/or somatic tissue oximetry, NIRS can also be used to 
gain insight in dynamic parameters, such as microvascular reactivity. Intraoper-
ative monitoring of peripheral microvascular reactivity enables early detection of 
alterations in microcirculatory function and may contribute to preventing im-
paired tissue perfusion and adverse patient outcome. Combining continuous 
non-invasive tissue oxygenation monitoring with a reproducible ischemia-
reperfusion challenge allows assessment of vascular reactivity and potentially 
early recognition of altered vascular reactivity and function (Chapter 7). Through 
a prospective study, 34 adult patients undergoing cardiac surgery with CPB 
were studied. A vascular occlusion test (VOT) was performed by occluding the 
brachial artery using a pneumatic tourniquet inflated 30 mmHg above the pa-
tient’s systolic blood pressure for a fixed time frame of 3 minutes. Somatic rSO2 
was continuously monitored at the internal surface of the proximal third of the 
forearm to assess the rate of tissue deoxygenated and reperfusion following the 
VOT. One of the studied parameters included the occlusion slope, which de-
scribes the decrease in rSO2 directly following occlusion of the brachial artery. 
According to previous studies, this parameter represents the rate of mitochon-
drial oxygen consumption and local tissue metabolism.17 The results showed an 
increased occlusion slope during and following CPB as compared to prior to 
CPB, indicating increased oxygen consumption during and after CPB. This 
change has been described previously, and is explained by the effect of general 
anesthesia with propofol on oxygen delivery and extraction as well as capillary 
blood flow. Another VOT-derived parameter which showed significant changes 
throughout the cardiac surgical procedure is the lowest rSO2 value measured 
during the ischemic period. This parameter in particular provides information 
regarding the absolute oxygen reserve in the microcirculatory system. During 
CPB, this value was lowered as compared to prior to and following CPB, sug-
gesting an effect of CPB on the absolute oxygen reserve. Supported by the 
decreased hemoglobin values during bypass, part of this effect could be ex-
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plained by hemodilution. Interestingly, the time necessary for rSO2 recovery did 
not change through the different phases of cardiac surgery. Therefore, one can 
speculate that reperfusion or tissue oxygenation recovery occurred in a more 
efficient manner during CPB. A possible explanation can be found in the in-
creased blood flow velocity in minor hemodilution by a decrease in systemic 
vascular resistance in combination with a reduced blood viscosity. In this case, 
the increased blood flow in the capillaries compensated for the effects of he-
modilution with regards to local rSO2 values. 
Another parameter that provides information regarding microcirculatory function 
is the reperfusion slope or recovery slope. This VOT-parameter reflects the time 
required to wash out stagnant blood as well as the local reperfusion reserve. In 
our study, an increased reperfusion slope was seen after termination of CPB 
compared to prior to CPB, suggesting altered peripheral microvascular reactivi-
ty. The duration of reperfusion remained unchanged, which may be indicative of 
enhanced reperfusion efficiency. Contrastingly, a previous interventional study 
concluded that CPB worsened microvascular reactivity with decreased microcir-
culatory function, as illustrated by a successive decline in reperfusion slopes 
with increasing CPB duration.18 Possible factors contributing to this discrepancy 
include differences across studies with regards to CPB protocol, measurement 
site, tissue oximetry probe, and ischemic challenge protocol. Besides interindi-
vidual variations, VOT-derived measurements are obviously affected by the 
duration of occlusion as well as the algorithm used to calculate the occlusion 
and reperfusion slopes, amongst other factors. In addition, the clinical relevance 
of alterations identified by dynamic measurements of peripheral tissue oxygena-
tion remains to be further explored. Since the current literature describes a vari-
ety of measurement protocols and calculation methods, further studies are war-
ranted to determine the optimal approach in performing the VOT. 
Considerations of tissue oximetry application 
Despite the need for superior continuous and non-invasive monitoring methods 
in patient care, tissue oximetry is not yet part of standard routine practice. A 
multitude of anecdotal reports and recent reviews have tempered the enthusi-
asm for routine use of rSO2 by questioning whether it leads to improved patient 
outcomes or not.19 One of the causative factors is the lack of intervention-
guided trials linking disturbances in tissue oxygen saturation to adverse clinical 
outcome. Although multiple studies reported an association between tissue 
oxygen desaturation and post-surgical complications, it remains unclear if this is 
part of a causal relationship or just a reflection of overall morbidity. In addition, 
some studies elaborated that intraoperative optimization of rSO2 will result in 
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fewer complications, however, these studies were mostly observational or un-
derpowered to detect any significant effects. Moreover, in a systematic review 
conducted by Zheng et al., it was concluded that intraoperative correction of 
cerebral rSO2 is not associated with improved neurologic outcome.20 The role of 
intrinsic autoregulatory activity was most probably neglected when previous 
studies attempted to link decreased rSO2 to clinical outcome. 
Another factor precluding routine use of tissue oximetry is the lack of clear ap-
plication-specific rSO2 thresholds requiring immediate intervention. When de-
termining a clear threshold rSO2 or change in rSO2 necessitating prompt inter-
vention, it is important to take the limitations of the tissue oxygenation meas-
urement into account. Clinical oximeter devices are destined for either trend or 
absolute rSO2 monitoring, utilizing an algorithm that requires the assumption of 
a fixed ratio of arterial to venous blood in the vascular bed in the area of inter-
est. This algorithm, however, cannot adapt to all possible applications of tissue 
oximetry. Hence, one must be cautious when interpreting absolute rSO2 values 
derived from measurements performed in different areas. 
To date, there are no clear indications when intervention to correct rSO2 is war-
ranted. One may argue that this is partially due to the fact that studies up untill 
now failed to demonstrate a causal relationship between tissue oxygen desatu-
rations identified by tissue oximetry and adverse clinical outcome. 
Additionally, the use different monitoring devices used across studies makes 
standardised application of cerebral oximetry even more challenging. Oximeter 
devices from different manufacturers each use different algorithms for estima-
tion of local oxygen content, and utilize varying numbers and wavelengths of 
near-infrared light. Furthermore, since every single device differs in terms of 
hardware as well as software (data acquisition, filtering and processing), each 
device should be used in concordance with a device-specific and application-
specific set of desaturation thresholds. 
Not only the specific measurement device but also the different applications in 
tissue oximetry directly affect the measurement and derived rSO2 values. While 
originally developed for cerebral tissue monitoring, tissue oximetry has been 
increasingly applied in different clinical settings, including somatic tissue moni-
toring in autologous tissue transplants21 or peripheral tissue, including mus-
cle,22-24 as well as monitoring of the central nervous system by assessing spinal 
perfusion.25 Development of standardized desaturation thresholds for the differ-
ent applications will aid in interpretation of rSO2 values and thereby establish 
routine use of tissue oximetry. 
 
The main goal goal of continuous rSO2 measurement is to prevent or minimize 
hypoxemia by early detection of decreased oxygen delivery. The relationship 
between clinical outcome and changes in rSO2 readings remains doubtful, de-
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spite the large amount of literature desribing the application of tissue oximetry in 
surgical patients. Nonetheless, it is clear that the measurement technique is 
capable of identifying hemodynamic fluctuations. In general, microvascular al-
terations associated with microcirculatory dysfunction are predominant factors 
in the process of tissue hypoxia. Microcirculatory dysfunction is known to pre-
cede tissue hypoxia, and if left untreated results in ischemic tissue damage. 
Adopting microcirculatory monitoring as the standard of care may prove to be 
the next big frontier in critical care management. Monitoring microcirculation at 
the bedside, however, poses several practical challenges, nor is it easy to esti-
mate tissue perfusion from standard physiological monitoring modalities. Now 
the limitations inherent to using NIRS in non-invasive tissue oximetry are identi-
fied, the focus should be on determining the optimal measurement protocol for 
bedside microvascular monitoring and interpretation of measurement values. 
Physiologic knowledge, including definition of thresholds for 
tissue damage that are associated with adverse outcomes 
This is a critical issue that remains unresolved to date. In previous studies, 
mostly arbitrary cut-offs are used for analysis of rSO2 values. One difficulty is 
that injury thresholds may vary among individuals because of differences in 
age, cerebral metabolism, anaesthetic and sedative regimen, body temperature, 
and other factors. However, if the technology accounts for changes in oxygena-
tion because of changes in flow and blood volume in the sensor field, then auto-
regulation of cerebral blood flow should not be a confounder in establishing 
threshold values, since autoregulation affects vessel diameter and thereby 
blood flow. The other issue is the “area under the curve” problem: is 3 hours at 
a 10% reduced cerebral saturation equivalent in injury to a 1 hour interval at 
30%? Greater knowledge in this area is critical for study designs because inter-
ventions need to be assigned to an appropriate threshold and duration for po-
tential tissue injury. Without appropriate thresholds, interventions will be initiated 
that are either unnecessary or it may be too late to succesfully alter the chance 
of adverse patient outcome. Furthermore, interventions have their own risks; for 
example vasopressors may decrease blood flow in unintended ways, and trans-
fusion of blood products expose patients to a variety of risks. 
Conclusion 
Many studies have been conducted implicating a link between changes in re-
gional tissue oxygen saturation observed by tissue oximetry and clinical out-
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comes. Despite this fact, the evidence for a causal relationship between tissue 
oximetry readings and outcome remains questionable. Well-designed prospec-
tive studies testing the hypothesis that monitoring oxygenation status in one 
organ is predictive for more general patient outcomes still needs to be conduct-
ed. Application-specific variables as well as measurement technique-related 
factors play a role in the failure of studies to demonstrate a clear relationship 
between tissue oximetry readings and complications resulting from tissue is-
chemia. 
Moreover, there is a lack of intervention-guided studies identifying organ-
specific thresholds associated with concomittant ischemic tissue damage. 
Therefore, more work that defines regional variations in tissue oxygenation in 
critical organs is warranted. Such studies will contribute to the inclusion of moni-
toring and imaging of tissue oxygenation in routine practice in the care of high-
risk patients because the monitors will provide outputs that direct therapy to 
improve clinical outcomes.  
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The introduction of near-infrared spectroscopy for assessment of regional tissue 
oxygenation was an important landmark in the history of tissue perfusion moni-
toring. Since then, non-invasive tissue oximetry gained wide interest with sub-
sequent studies addressing the clinical importance of continuous monitoring of 
tissue perfusion. An increasing amount of literature including many observa-
tional and few intervention-guided studies elucidated on the added value of 
primarily regional cerebral oximetry in terms of predicting neurologic outcome 
following cardiopulmonary bypass. Some studies even suggested that cerebral 
oximetry can be used as an organ index, meaning that maintaining adequate 
tissue oximetry levels is beneficial for all vital organs. Furthermore, continuous 
tissue oximetry proved to be a valuable addition in various clinical applications 
(short-term and prolonged cardiopulmonary support, and monitoring graft viabil-
ity ensuing transplant surgery), as it effectively identifies changes in tissue oxy-
genation following several iatrogenic events. 
 
Despite these proposed benefits, routine use of tissue oximetry in the clinical 
setting is, as of now, far from evident. For a compelling part this is due to the 
lack of well-designed interventional studies showing a clear association be-
tween tissue oximetry values and outcome, as well as discordance regarding 
clinically relevant and application-specific tissue oxygenation thresholds predic-
tive for adverse outcome. Moreover, different applications of tissue oximetry 
require different interpretation strategies due to the absence or presence of 
regional vascular autoregulatory activity. Especially during cerebral oximetry, 
intact or any extent of temporary or permanently disturbed cerebral autoregula-
tion directly affects oxygen delivery. In this case, assumptions as part of the 
algorithm used for calculation of oxygenated and deoxygenated hemoglobin 
may contribute to interpretation errors in apparent normal tissue oxygenation. 
Therefore, it remains of utmost importance to include all available clinical infor-
mation when performing tissue oximetry. 
 
Taking the aforementioned into account, non-invasive tissue oximetry aids in 
prompt assessment of tissue oxygenation and may thereby contribute to pre-
vention of complications associated with hypoxia. The latter catalyzes indiverti-
ble developments for various prospective clinical applications.  
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De introductie van nabij-infrarood spectroscopie voor het regionaal monitoren 
van weefseloxygenatie was een belangrijke mijlpaal in de geschiedenis van 
weefselperfusie monitoring. Sindsdien is non-invasieve weefseloxymetrie meer 
onder de aandacht gekomen en richten studies zich op het klinische belang van 
continue weefselmonitoring. Een toenemende hoeveelheid literatuur waarvan 
enkele interventionele en vele observationele studies focust op voornamelijk 
regionale cerebrale oxymetrie in de context van het voorspellen van neurolo-
gische complicaties na cardiopulmonale bypass. Sommige studies suggereren 
zelfs dat cerebrale oxymetrie als een orgaanindex kan worden toegepast, het-
geen betekent dat behoud van adequate weefseloxymetrie waarden gunstig 
zou zijn voor alle vitale organen. Continue weefseloxymetrie is een bewezen 
waardevolle aanvulling in verscheidene klinische toepassingen (kort- en lang-
duringe cardiopulmonale ondersteuning en monitoren van de levensvatbaarheid 
van een transplantaat), daar het effectief blijkt in identificatie van veranderingen 
in weefseloxygenatie ten gevolge van verschillende iatrogene gebeurtenissen. 
 
Ondanks deze voorgestelde voordelen is routinematig gebruik van weefseloxi-
metrie in de klinische setting bij lange na niet vanzelfsprekend. De oorzaak 
hiervan kan deels gezocht worden in het gebrek aan correct opgezette interven-
tionele studies die een duidelijke associatie tussen weefseloxymetrie waarden 
en relevante uitkomsten aantonen. Daarbij bestaat ook tegenstrijdigheid in kli-
nisch relevante en applicatie-specifieke grenswaarden voor weefseloxygena-
tiewaarden die gelinkt zijn aan nadelige gezondheidseffecten. Tevens behoe-
ven de verschillende afzonderlijke toepassingen van weefseloxymetrie verschil-
lende interpretatiestrategieën vanwege de aan- of afwezigheid van regionale 
autoregulatoire vasculaire acitiviteit. Vooral bij cerebrale oxymetrie is intacte 
cerebrale autoregulatie, of een verstoring hiervan, direct van invloed op de 
zuurstofvoorziening van het brein. In beide gevallen dragen aannames, welke 
onderdeel uitmaken van het algoritme dat gebruikt wordt voor de berekening 
van geoxygeneerd en gedeoxygeneerd hemoglobine, bij aan interpretatiefouten 
bij ogenschijnlijk normale weefseloxygenatie waarden. Het is daarom van groot 
belang om rekening te houden met alle beschikbare klinische informatie bij het 
toepassen van weefseloxymetrie. 
 
Met inachtneming van de voorgenoemde zaken kan gesteld worden dat non-
invasieve weefseloxymetrie bijdraagt in directe beoordeling van weefseloxyge-
natie en daarbij preventie van complicaties ten gevolge van hypoxie. Laatsge-
noemde katalyseert de onvermijdbare ontwikkeling van nieuwe klinische toe-
passingen.  
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Non-invasive tissue oximetry – an integral puzzle piece 
Inadequate tissue oxygen delivery is known to result in complications, contrib-
uting to morbidity and mortality following or during medical procedures. In order 
to minimize the risk of adverse outcome, close monitoring of patient’s hemody-
namic status at all times is indispensable. Non-invasive tissue oximetry is a 
monitoring method for continuous assessment of tissue oxygenation, which may 
aid in detection of hemodynamic instability and otherwise unnoticed hypoxia. 
 
To date, numerous studies (of which mostly observational) focused on the use 
of non-invasive tissue oximetry in surgical patients, proposing its predictive val-
ue in relation to clinical outcome. Cerebral oximetry in particular has been the 
focus in the context of preventing neurological complications following cardiac 
surgery. These complications, including stroke which appears to be the most 
detrimental, are complex in nature and elicited by a multitude of preoperative 
and perioperative factors. Intraoperative cerebral hypoxia resulting from hy-
poperfusion is generally accepted as a factor contributing to the risk of adverse 
neurologic outcome.1,2 Although the exact etiology is not yet completely under-
stood, continuous assessment of tissue perfusion may aid to a better under-
standing of the role of tissue hypoxia in the development of postoperative cogni-
tive complications. 
 
While the incidence of neurological complications may seem relatively low, the 
effects on the patient’s physical and psychological health are tremendous with 
serious implications for the quality of life.3 The reported incidence of stroke fol-
lowing cardiac surgery varies around 4.2%, meaning that every year 33 patients 
are affected based on 800 procedures annually.4 Postoperative stroke entails 
prolonged hospital stays of on average seven days with an incremental in-
crease of hospital resources.5,6 In the United States, for each affected patient 
the estimated added costs make up to $18,552, of which $1,000 are attributable 
to each additional day of hospitalization.7 
 
Another type of neurological complication that may emerge following cardiac 
surgery is delirium, which is characterized by a state of confusion and inatten-
tion. Although often seen as a reversible condition, delirium contributes to per-
sistent functional decline and significant morbidity and mortality risk.8 Postoper-
ative delirium is associated with only four extra hospitalization days, but is far 
more common as compared to stroke, with incidence rates varying around 
55%.9,10 If non-invasive tissue oximetry could help to prevent part of the neuro-
logic complications, such as hypoxia-related stroke or delirium2,11, the odds of 
an uncomplicated prosperous recovery would increase and a substantial pro-
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portion of hospital costs could be saved. The costs of performing the measure-
ment include the purchase of disposable self-adhesive sensors (usually two, for 
bilateral measurement of tissue oxygenation), which in the United States cost 
around $200 per patient12, and a one-time investment for purchasing the oxime-
ter device. The costs for routine application of clinical oximetry, however, are 
only marginal compared to the major additional expenses associated with is-
chemic-related stroke and delirium13, let alone the deleterious long-term effects 
of these complications, i.e. the quality of life. 
 
The pathophysiology of neurologic postoperative complications is complex and 
multifactorial in nature. Therefore, some neurologic complications are nearly 
impossible to prevent due to unforeseen events occurring in the perioperative 
period (e.g. embolism originated from the cardiopulmonary bypass circuit) and 
the role of certain patient characteristics is not subject to change (pre-existing 
co-morbidities and positive family history of adverse neurovascular events). 
Another substantial proportion with less of a complex etiology is caused by 
modifiable factors and therefore theoretically concerns preventable cases. For 
example, hemodynamic instability is known to affect the risk of hypoxia. Moreo-
ver, hypercapnia and excessive hemodilution are thought to alter the risk of 
neurologic complication (chapter 3).14 The cardiopulmonary bypass protocol is, 
therefore, an important factor in enabling and maintaining adequate tissue per-
fusion and should be critically evaluated in order to minimize the risk of neuro-
logic complications. Strict monitoring routines concern another factor of im-
portance in preserving hemodynamic integrity, specifically monitoring at the 
tissue level since general hemodynamic factors may not adequately represent 
local tissue oxygenation status.15 
 
With non-invasive tissue oximetry on the rise and being increasingly applied as 
a brain monitor, the technique appears to be a viable assessment method for 
diverting adverse neurologic outcome. On that note, cerebral oximetry showed 
to adequately reflect real-time changes in tissue oxygenation readings following 
several iatrogenic events. Despite the abundance of studies implying that oxy-
gen desaturations detected by cerebral oximetry predict neurological outcome, 
evidence for a causal relationship remains scarce. Part of the explanation can 
be found in the fact that the development of neurological complications is a 
complex process, as mentioned beforehand, which is still not entirely under-
stood. Deoxygenation episodes detected by cerebral oximetry should probably 
be considered as a contributor, rather than an independent causative factor for 
clinical neurologic damage and evident changes in neurocognitive function 
(chapter 2). 
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In addition to the latter, when performing cerebral oximetry it is important to 
consider the intrinsic system of cerebral autoregulation. When intact, reactive 
vasoconstriction and vasodilatation ensures adequate tissue oxygenation, 
providing cerebral protection. Although often unacknowledged, disturbances in 
autoregulatory function have shown to result in neurologic complications and 
thus should be avoided at all times. In this thesis, several modifiable factors 
requiring strict regulation in order to maintain intact cerebral autoregulation are 
identified. In turn, a perfusion protocol that includes maintaining these factors 
within the physiologic range confers to the observed low incidence of neurologi-
cal complications by enabling intact autoregulatory function. 
 
Taking these practical considerations into account, one may conclude that tis-
sue oximetry, inherently due to its measurement technique and thus non-
invasive nature, cannot independently predict the occurrence of complications 
with a multifactorial nature such as ischemic stroke or delirium. Similar to most 
non-invasive monitoring tools and methods, tissue oximetry readings should be 
interpreted in the context of all clinical information available. The scientific value 
of this thesis is that non-invasive tissue oximetry derived measurement values 
should be viewed as an integral piece of information rather than a superior mon-
itoring method. 
 
Besides its original intended use (i.e. brain monitoring), non-invasive tissue 
oximetry is increasingly applied in somatic tissue monitoring. One example is 
assessment of distal limb perfusion in patients supported by veno-arterial extra-
corporeal life support (VA-ECLS). Femoral access techniques often used in VA-
ECLS may compromise limb perfusion, therefore predisposing the patient to 
concomitant tissue damage with potential disastrous effects. Tissue oximetry 
performed at the calf muscle proved effective for identification of endangered 
limb perfusion by showcasing aberrant tissue oximetry readings before any 
other clinical parameters showed any evident change (chapter 6). 
 
Another example of somatic tissue oximetry applies to monitoring autologous 
breast reconstructive surgery, in which abdominal wall tissue is transplanted to 
the chest area using microsurgical anastomoses. Graft failure, in the worst 
case, could lead to loss of the entire tissue flap with a major additional risk of 
physical and psychological burden for the patient. By immediately depicting 
deviant measurement values as compared to the expected physiologic tissue 
response, tissue oximetry appears superior to other applied monitoring tech-
niques, which solely provide delayed timing of alarm signals. Tissue oximetry 
could aid in timely detection of circulatory compromise and thereby lower the 
rate of complications resulting from ischemic tissue damage. Successively, 
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avoiding complications contributes to minimizing postoperative morbidity and 
mitigating health care costs. As is the case in brain monitoring, the costs for 
performing tissue oximetry are only marginal compared to the costs associated 
with postoperative complications. In case of arterial or venous thrombosis, sur-
gical re-intervention is necessary to increase the chance of successful flap sal-
vage. This will add around $76,000 per hour spent in the operating room to the 
hospital costs. Also, patients experiencing complications generally consume two 
extra hospital days, leading to another $7,000 in added costs per patient oper-
ated in the United States.16 In uncomplicated cases, tissue oximetry eliminates 
the need for prolonged intensive monitoring with savings of $1,337 (or 6.3%17) 
that far outweigh the costs associated with routine use of tissue oximetry.17,18 
 
The relationship between aberrant tissue oximetry readings and clinical out-
come appears to be more clear in the somatic applications of tissue oximetry. 
Complications arising from peripheral tissue ischemia (e.g. the distal limb and 
autologous breast flaps) are elementary in nature due to the absence of an 
intrinsic homeostatic autoregulatory system. In cerebral oximetry, one attempts 
assessing an entire organ system that is only represented by a regional as-
sessment of tissue oxygenation in the prefrontal cortex. In somatic tissue oxi-
metry on the other hand, the readings appear more representative for clinical 
outcome. 
 
The versatility of tissue oximetry in the clinical setting may broaden the scope 
for future studies to focus on new potential applications. One prospective appli-
cation is assessment of the microcirculatory function. Since microcirculatory 
dysfunction precedes tissue hypoxia, adopting tissue oximetry as a part of 
standard microcirculatory monitoring may prove to be the next big frontier in 
critical care management. 
 
With the limitations of non-invasive assessment of tissue oxygenation being 
identified, future studies should focus on interpretation of measured data and 
aim at determining clinically relevant and application-specific threshold values 
for tissue desaturation-related injury. Furthermore, the types of interventions 
necessary for correcting tissue oxygenation values and its effects on clinical 
outcome require further clarification. 
 
Overall, non-invasive tissue oximetry is a promising tool for (regional) assess-
ment of tissue oxygenation. Its measurement readings should be considered as 
an integral source of information, a puzzle piece that together with all clinical 
information can aid in decision making and minimizing the risk of postoperative 
complications.  
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Daar zijn we dan, het dankwoord van het proefschrift. Een toch wel veel gele-
zen onderdeel van het boekje. Er zijn zovelen die ik graag wil bedanken, zove-
len die op hun eigen manier een steentje hebben bijgedragen aan dit proef-
schrift, direct of indirect. Zonder elk van hen was dit proefschrift er niet geweest. 
Daarom wil ik, zonder iemand tekort te doen, een aantal mensen in het bijzon-
der bedanken. 
 
Allereerst Jos Maessen, mijn promotor, bedankt voor het in mij gestelde ver-
trouwen. Ik ben ontzettend dankbaar voor de kans om van mijn onderzoeken, 
beginnend als stagiaire, mijn promotie te maken, bedankt! 
 
Mijn copromotores, Patrick en Steven, bedankt voor de steun en feedback die ik 
van jullie heb mogen ontvangen. Door jullie input zijn de manuscripten iedere 
keer sterker geworden. Patrick, heel erg bedankt voor alles! Het vertrouwen dat 
je in mij toonde heb ik zeer op prijs gesteld, en gaf mij ook vertrouwen in mijzelf 
en mijn kunnen. Bedankt voor de feedback en de lange gesprekken, face to 
face of per telefoon, waarin we álles doorspraken; alle lopende projecten, toe-
komstige projecten, overwinningen klein en groot, en struikelblokken. Vele uren 
in het provisorium maar ook op andere locaties onder het genot van een califor-
nia roll. Daar waar ik ogenschijnlijk beren op de weg zag, wist jij altijd een alter-
natieve route te vinden! Je enthousiasme voor onderzoek heeft me aangesto-
ken, ontzettend bedankt! 
Steven, ontzettend bedankt voor alle inzicht en kennis die je met mij hebt ge-
deeld. Jouw blik op zaken en mijn gestelde vragen heeft mij geholpen om de 
projecten tot een hoger niveau te tillen en ook mijn eigen blik aan te scherpen. 
Je feedback met betrekking tot (de mogelijkheden en valkuilen in) data analyse 
en statistische toetsing hebben mij enorm geholpen, dat merkte ik niet alleen bij 
het werken aan de onderzoeksprojecten maar ook tijdens mijn studies. 
 
Anouk en Juan, mijn paranimfen, dank voor de hulp bij het regelwerk. Jullie tijd 
en toewijding om deze promotie te laten lopen zoals ik dat voor ogen had, heeft 
dé dag gemaakt tot ‘mijn’ dag. Ik ben blij met jullie aan mijn zijde, op ‘’de grote 
dag’’ en gedurende het proces. Met me meedenken, overleggen, ‘’oké, maar 
wat als we het zo of zó doen?’’, ‘’maar wat denk jij?’’, ‘’kom, we doen even een 
koffie’’, het zijn deze momenten die misschien niet in eerste instantie niet zo 
belangrijk lijken in het hele proces, maar toch… 
 
Anouk, dankjewel voor de altijd prettige samenwerking! Alhoewel we vaak alle-
bei belachelijke agenda’s hadden, was je altijd bereid tijd voor mij vrij te maken. 
Die vele malen dat ik je in de weekenden of op onmogelijke tijdstippen bevroeg 
over zaken waar ik tegenaan was gelopen heb je altijd getolereerd en me nog 
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geholpen ook! Juan, bedankt voor je betrokkenheid en enthousiasme. Jouw 
dedication is bewonderenswaardig! En natuurlijk ook voor ‘’take me home coun-
try roads’’, die zal ik niet snel vergeten! 
 
En dan natuurlijk mijn lieve perfusiecollega’s en oud-perfusiecollega’s, ik ben 
jullie dankbaar voor de ontzettend leuke en leerzame tijd. Ik was de stagiaire 
die eerst nog even bleef plakken, weer even terug naar school ging en daarna 
weer terugkwam, jullie kwamen maar niet van me af. Allen bedankt voor jullie 
luisterend oor, jullie hulp in praktische en inhoudelijke zaken en jullie interesse 
in wat mij bezighield. Er was altijd plek voor een grapje, wat de samenwerking 
prettig maakte. Ik ben dankbaar dat ik onderdeel mocht zijn van een team als 
deze. Yvonne, Nicole, Diana, Zaheer, Yuri, Rik, Erik, Ervin, Nico, Arne, Susan, 
en 
Cheryl, bedankt! 
 
Antoine, wat hebben we samen veel gelachen en ook gediscussieerd, gemop-
perd, zaken voor Ervin’s promotie geregeld, en chocolade gegeten (of ander 
foute zoetigheden). Bedankt voor al je hulp. Je hebt me wegwijs gemaakt toen 
ik net begon als stagiaire, en nu nog sta je altijd voor me klaar. Dank daarvoor! 
 
Professor van der Hulst, René, bedankt voor de prettige (multidisciplinaire) sa-
menwerking! Het is een bijzonder iets om deel uit te mogen maken van een 
project als de DIEP-flap studie. Ondanks dat cardiothoracale chirurgie en plasti-
sche chirurgie ogenschijnlijk zo ver van elkaar verwijderd zijn, hebben we sa-
men toch een mooi en voor mij heel belangrijk project opgezet. 
 
De leden van de beoordelingscommissie, prof. dr. Roekaerts, prof. dr. Bekers, 
prof. dr. Boer, prof. dr. Bogers, en dr. Houben, bedankt voor jullie tijd en in-
spanningen om mijn proefschrift te lezen en goedkeuring te verlenen. 
 
Monique Loo, bedankt voor de hulp en het meedenken, door je oplettendheid 
heb ik spoedig het een en het ander in gang kunnen zetten. 
 
Ajay, it was a pleasure working with you. You helped me writing and presenting 
important parts of my research. Thank you for sharing your perspectives and 
suggestions, workwise and otherwise. 
 
Lieve vriendjes en vriendinnetjes, Leonie ‘Leo’, Veronica ‘Vero’, Ilse, en Magne, 
bedankt voor de nodige afleiding; samen uit, verjaardagen vieren, maar vooral 
samen lachen, eten en cocktails drinken. Niks blijft onbesproken en ik kan altijd 
mijn ei kwijt wanneer we weer een avondje met de squad hebben. Ik kijk nu 
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Tamara ‘Tamaar’, bedank veur dien hulp! De woars altied bereid mich te helle-
pe, aug wanneer ig zelf neet doa koos zeen veur ’n meting te starte bie de 
DIEP. Doe stings veur mich kloar en heelps mich oet de brand. Aug al wirkse al 
’n tiedje neet mier bie de perfusie, ig bin blie dat v’r nog ummer good contac 
hubbe. 
 
Dank aan de patiënten die bereid waren deel te nemen aan mijn onderzoeken, 
zonder hen was het klinische aandeel van het proefschrift niet tot stand kunnen 
komen. 
 
Philipp, although I could easily fill a whole page, let me keep is short and sweet. 
Thank you for never getting tired of me trying to get some work done when you 
wanted to go watch a movie. Most importantly, thank you for always standing by 
my side. 
 
Last but not least; pa, ma, dank veur uch onveurwaardelikke steun. Al die joare 
van studeren hub geer miene kal aan motte heure euver vanalles en nog get. 
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